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Abstract 
Introduction: Obesity and related cardio-metabolic complications have 
acquired global epidemic proportions. Suboptimal nutritional 
environment in early life induces adaptations in energy homeostasis, 
metabolism and adipose tissue development that may confer short-term 
survival advantages but are detrimental in later life, particularly if 
nutrient supply is restored.  
Brown adipose tissue (BAT) has a unique role in energy homeostasis 
because it can provide a potential compensatory mechanism against 
excess weight gain via cold or diet-induced adaptive thermogenesis.  
Brown adipocytes also have a potential role in lipid and glucose 
metabolism and BAT activation can increase clearance of lipids and 
glucose from the circulation. Pericardial fat, particularly epicardial 
adipose tissue (fat present between the myocardium and the visceral 
layer of the pericardium), is anatomically and clinically related to cardiac 
morphology and function and is believed to be a metabolically active 
organ that affects cardiac function and the evolution of cardiac 
pathologies. High expression of mRNA for uncoupling protein (UCP) 1 
in adult human epicardial adipose tissue suggests that this may be a 
depot of BAT. 
Hypotheses: In my thesis, I hypothesised that pericardial adipose 
tissue is a depot of brown fat in humans and sheep. I also hypothesised 
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that suboptimal nutrition in early life will affect adiposity and 
development of BAT in this depot. 
Methods: UCP1 mRNA expression and protein abundance and other 
BAT and white adipose tissue related genes were studied in pericardial 
adipose tissue. In the first study, pericardial fat was sampled from 
newborn and 30 day old sheep born to mothers fed with 100% or 60% 
of their total metabolisable energy (ME) requirement from 110 day 
gestation to term. In the second study, pericardial fat was sampled from 
near-term (140 day gestation) fetuses delivered to mothers fed 100% or 
60% of total ME requirement from 28 to 80 days and then fed ad 
libitum. Gene expression was measured by reverse transcription-
polymerase chain reaction and protein abundance by Western blotting 
and immunohistochemistry.  
To confirm the presence of BAT in the human epicardial fat depot, 
relative abundance of UCP1 was measured by Western Blotting in 
epicardial, paracardial, and subcutaneous fat samples taken from 
adults. In the final study, epicardial fat samples were collected from 63 
children (0-18 years of age) undergoing cardiac surgery and gene 
expression of UCP1 and other BAT and WAT related genes identified 
by microarray. The presence of UCP1 was confirmed by 
immunohistochemistry.  
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Results: Pericardial adipose tissue is a depot of BAT in fetal and 
newborn sheep. Suboptimal maternal nutrition in late gestation reduces 
the abundance of UCP1 and downregulates other BAT related genes 
whilst suboptimal maternal nutrition in early-to-mid gestation followed by 
ad libitum feeding to term, increases adiposity, enhances UCP1 
abundance and upregulates genes involved in brown and white 
adipogenesis.  
Epicardial fat from newborn infants, children, adolescents and older 
adults contains UCP1 confirming that it is a BAT depot in humans.  
UCP1 gene expression in infancy and early childhood in humans is 
downregulated in children with poor nutritional states.  
Conclusions: I have shown that adipose tissue depots present around 
the heart are a repository of brown fat, at least in humans and sheep. In 
view of the potential role of BAT in regulation of lipid and glucose 
metabolism, this may have therapeutic implications for treatment of 
cardiovascular complications of obesity. Suboptimal nutrition in utero 
and during early life compromises BAT development. Although the 
exact mechanism of how these changes affect the propensity towards 
obesity and metabolic dysregulation remains to be elucidated, a 
reduction in thermogenesis presents a plausible mechanism for the 
increased metabolic efficiency associated with nutritional deprivation in 
early life. BAT persists beyond the neonatal period in to adult life and, 
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therefore, presents a potential target for long lasting nutritional 
manipulations to promote better health. 
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1 Introduction 
1.1 Obesity 
Obesity and overweight are defined by abnormal or excessive fat 
accumulation which may impair health. Although there is no universal 
GHILQLWLRQRI³KHDOWK\ZHLJKW´WKH:RUOG+HDOWK2UJDQLVDWLRQ:+2
expert committee has proposed a classification of overweight and 
obesity using body mass index (BMI) (WHO 1995). According to this 
widely accepted definition, an individual with a BMI of equal to or more 
than 30kg/m2 is classified as obese, whilst a BMI in the range 25kg/m2 
to 29.9kg/m2 is defined as overweight. 
1.1.1 Obesity is a global epidemic 
Using the above definition, just over a quarter (26%) of adults in 
England are classified as obese (NHSIC 2012). Similar trends are seen 
in other Western countries and the WHO have reported that, in Europe, 
the prevalence of obesity has risen up to three-fold in the last two 
decades and that the epidemic of obesity poses one of the most serious 
public health challenges (WHO 2006). With the adoption of the 
³:HVWHUQOLIHVW\OH´ involving decreased physical activity and 
overconsumption of energy-dense food, the obesity epidemic has 
spread to the developing world where it is estimated that rates of 
obesity have tripled in the past two decades (Hossain et al. 2007). 
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Similar to the trend amongst adults, childhood obesity is also increasing 
to epidemic proportions. Forty-three million children were estimated to 
be overweight or obese in 2010 and the worldwide prevalence of 
childhood obesity and overweight has increased from 4.2% in 1990 to 
6.7% in 2010 with an expected rise to over 9% by 2020  (de Onis et al. 
2010). In the U.K., although, year on year, children are entering 
reception class weighing less, they are leaving primary school weighing 
more (Figure 1.1); in 2012, at the end of school Year 6 (11-12 year of 
age)RIER\VDQGRIJLUOVZHUHFODVVLILHGDVREHVH%0,
95th centile of the British 1990 (UK90) growth reference) (CMO 2012).  
1.1.2 Childhood obesity tracks into adulthood 
Overweight and obese children are at a significantly high risk of growing 
into overweight and obese adults (Singh et al. 2008) and have an 
increased risk of premature mortality and obesity related adult 
morbidities, particularly due to cardio-metabolic conditions such as type 
2 diabetes, coronary heart disease, hypertension, and stroke (Reilly and 
Kelly 2011). Childhood obesity also has an adverse impact on social 
and economic outcomes in adulthood; obesity at a young age increases 
the risk of economic productivity losses (Neovius et al. 2008) and 
increases the risk of receiving disability allowance in later life (Karnehed 
et al. 2007). 
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Figure 1.1. Prevalence of obesity in school age children in England by year of measurement, school year and gender 
&KLOGUHQZHUHFODVVLILHGDVREHVHZKHUHWKHLU%0,WKFHQWLOHRIWKH%ULWLVh 1990 (UK90) growth reference. Adapted from Chief 
0HGLFDO2IILFHU¶V5HSRUW (data source Public Health England)  (CMO 2012). 
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1.1.3 Obesity is a burden on physical and mental health of 
individuals and the society 
Obesity is associated with a significant increase in morbidity and 
mortality and is a major public health problem. It causes, or 
exacerbates, many health problems both independently and in 
association with other conditions such as Type 2 diabetes (Kopelman 
2000). 
Obesity is associated with a significantly higher risk of several 
conditions such as the metabolic syndrome, hypertension, coronary 
heart disease (CHD), insulin resistance, Type 2 diabetes, 
dyslipidaemias, obstructive sleep apnoea, certain types of cancers and 
musculoskeletal disorders such as osteoarthritis (Kopelman 2000, 
Visscher and Seidell 2001). Being overweight or obese can decrease 
life expectancy. In the Framingham Heart Study, the risk of death within 
26 years of entering the study increased by 1% for each extra pound 
(0.45kg) increase in weight between the ages of 30 and 42 years, and 
by 2% between the ages of 50 and 62 years (Hubert 1986).  
In addition to the direct physical consequences, obesity also has a 
major impact on the psychological wellbeing and quality of life of adults 
(Jia and Lubetkin 2005) and in children (Friedlander et al. 2003). 
Systematic reviews of the relationship between mental health problems 
and overweight and obesity reveal that increase in the risk of 
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depression (Luppino et al. 2010), anxiety (Gariepy et al. 2010) and 
general emotional disorders (Scott et al. 2008). 
1.1.4 Obesity is a socio-economic burden 
The consequences of obesity are not limited to its direct impact on 
health. Overweight and obesity can also have adverse social 
consequences for the individual, for example leading to social 
discrimination, personal loss of earnings and effects on the wider 
economy through loss of productivity and increased use of benefit 
payments from government (NOO 2010). Estimates of the direct costs 
of treating obesity and its related morbidities to the National Health 
Service (NHS) in England were over four billion pounds in 2008 (NOO 
2010). The long-term cost of childhood obesity is estimated to be £588-
686 million per year (CMO 2012) whilst the indirect costs associated 
with obesity are estimated to be even higher and could be between £2.6 
to £15.8 billion (NOO 2010). 
1.1.4.1 The metabolic syndrome 
A cluster of interrelated risk factors for cardiovascular disease and 
diabetes including elevated fasting blood glucose, raised blood 
pressure, dyslipidaemia, high cholesterol and obesity (particularly 
central obesity, measured as elevated waist circumference) have 
become known as the metabolic syndrome (Alberti et al. 2009). 
Individuals with the metabolic syndrome have an elevated risk of CHD, 
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stroke, myocardial infarction and cardiovascular mortality (Isomaa et al. 
2001, Bonora et al. 2004). With or without obesity (as measured by 
BMI), metabolic syndrome is a major health problem and is a vital 
contributor to the ill health caused by increasing adiposity. 
1.1.5 Causes of obesity 
Obesity develops when energy intake exceeds energy expenditure over 
a significant period of time. Body weight is ultimately determined by 
complex interactions between genetic, environmental and physiological 
mediators of food intake and energy expenditure and the debate 
whether obesity is caused by over-eating, lack of physical activity or 
genetic predisposition is unresolved (Visscher and Seidell 2001). 
Epidemiological trends indicate that changes in dietary and physical 
activity patterns are a cause of increasing obesity on a global scale. 
However, epidemiological, genetic and metabolic studies reveal that 
some individuals appear to have a greater predisposition to become 
obese and acquire obesity-related co-morbidities than others. An 
increasing body of epidemiological and experimental evidence suggests 
that factors in the periconceptional period, in utero and early childhood 
may determine this susceptibility to obesity and its associated illnesses 
in later life (Gillman 2005).  
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1.2 Influences of early life nutrition on obesity, 
metabolic syndrome and cardiovascular diseases 
in adult life 
It is now accepted that the origins of childhood and adult obesity may lie 
in the early years including the time in utero and even the pre-
conception period. The recent demographic shift of populations in most 
parts of the world and of varied genetic backgrounds towards a more 
obese phenotype suggests the influence of factors other than solely 
genetics (Finucane et al. 2011). The idea that maternal wellbeing is 
crucial for the future health of the baby is well recognised and, 
gradually, the concept of developmental origins of health and diseases 
has become well established (Gillman 2005).  
1.2.1 Consequences of undernutrition in early life 
In 1977, Forshdahl linked mortality from arteriosclerotic heart disease in 
a Swedish cohort with infant mortality in the same cohort and suggested 
that poverty in childhood and adolescence followed by prosperity, is a 
risk factor of cardiovascular diseases (Forsdahl 1977). Later, Barker 
and colleagues demonstrated a similar relationship in the population of 
England and Wales (Barker and Osmond 1986). Barker et al. also 
investigated how periods of undernutrition at different stages of fetal life 
were associated with birth phenotypes and with later metabolic 
abnormalities in adulthood (Barker et al. 1993). Barker and Hales 
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proposed WKH³WKULIW\SKHQRW\SHK\SRWKHVLV´ proposing that the 
epidemiological associations between poor fetal and infant growth and 
the subsequent development of type 2 diabetes and the metabolic 
syndrome result from the effects of poor nutrition in early life, which 
produces permanent changes in metabolism that later manifest as 
disorders of metabolic homeostasis (Hales and Barker 2001).  
This link between early life environment and health in later life is 
described aV³GHYHORSPHQWDOSURJUDPPLQJ´(Lucas 1991). The term 
defines a process by which a stimulus or an insult during a critical 
period of development has lasting effects on the structure or function of 
tissues and body systems. Tissues and systems of the body go through 
critical periods of growth and development while in utero and during 
early childhood. Adverse environmental influences, such as inadequate 
nutrition, during these critical periods can permanently alter the 
structure and function of tissues and organs and these early life 
changes can subsequently render affected individuals more susceptible 
to disease in later life. For example, the metabolic, functional or 
structural changes that occur in response to suboptimal nutrition in 
utero and in early life in order to enable the individual to survive the 
adversity experienced in the fetal period become detrimental later in life 
if the environment changes to one of nutrient excess, leading to 
increased risk of metabolic syndrome, obesity and cardiovascular 
diseases.  
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Nutrition in fetal life is a central stimulus of programming for 
susceptibility to diseases in later childhood and adulthood. Long term 
follow up of the offspring of pregnant women who suffered 
undernutrition during the Dutch famine of 1944-45 provides 
epidemiological evidence of the effects of prenatal exposure to maternal 
undernutrition on adult health such as those who were exposed to 
famine in early gestation had a more atherogenic lipid profile 
(Roseboom et al. 2001), higher risk of CHD (Roseboom et al. 2000) and 
higher BMI (Ravelli et al. 1999).  
Adipose tissue is present from very early in fetal development and 
changes in maternal nutrition during various stages of pregnancy can 
alter fetal adiposity and programme later obesity (Symonds et al. 2007). 
Various mechanisms such as alterations in glucocorticoid metabolism 
(Budge et al. 2005), insulin and glucose homeostasis (Gardner et al. 
2005), alterations in the hypothalamo-pituitary-adrenal (HPA) axis 
(Vieau et al. 2007) and increase in fetal adiposity (Budge et al. 2005) 
contribute to the programming of adipose tissue.  
1.2.2 Consequences of overnutrition in early life 
Risk of obesity and metabolic syndrome in adult life can be influenced 
by both extremes of nutrition in early life and the relationship between 
birth weight and adult obesity is actually J- or U-shaped with increases 
in adult BMI seen both in those born small and in those born large for 
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gestation age in comparison to those who were of appropriate birth 
weight (Curhan et al. 1996). This association between early 
overnutrition and later obesity and metabolic syndrome has been 
GHVFULEHGDVWKH³GHYHORSPHQWDORYHUQXWULWLRQK\SRWKHVLV.´This 
hypothesis advocates that high glucose, fatty acid and amino acid 
concentrations during critical periods of development result in 
permanent changes in appetite control, neuroendocrine functioning 
and/or energy metabolism which increase the risk of obesity and 
metabolic syndrome in later life (Armitage et al. 2008). 
Both animal experimental data and human epidemiological evidence 
converge to suggest that the nutritional environment during fetal 
development impact upon specific physiological control systems and 
induce permanent changes that produce a lifelong susceptibility to 
obesity and the metabolic syndrome. Preventative strategies to reduce 
the burden of obesity and the metabolic syndrome should, therefore, be 
targeted to children and started in early life or even before birth. 
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1.3 Adipose tissue 
In mammals, adipose tissue is the only tissue that has an unlimited 
potential to grow. It varies in amount and distribution between 
individuals and is generally considered to exist in two compartments ± 
subcutaneous adipose tissue, located beneath the skin, and visceral 
adipose tissue, located around the internal organs.  
1.3.1 Classification of adipose tissue 
Mammalian adipose tissue is classified into white adipose tissue (WAT) 
and brown adipose tissue (BAT). In addition, a novel type of adipocyte, 
³EURZQ-in-ZKLWH´RU³EULWH´RU³EHLJH´DGLSRF\WHKDVQRZEHHQ
recognised. All the three types of adipocytes are characterised by large 
intracellular stores of fat but are otherwise dissimilar in embryological 
origin, structure and/or function (Figure 1.2). 
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Figure 1.2 The three types of adipocytes 
Three different types of adipocytes arise from the pleuripotent 
mesenchymal stems cells: Classic brown adipocytes that arise from the 
dermatomyotome, via Myf5+ precursors, express classic BAT markers 
VXFKDV8&3DQG3&*ĮDVZHOODVQRYHOPDUNHUV=LFDQG/K[
7KHVHFHOOVUHVLGHLQFODVVLF%$7GHSRWV³EULWH´DGLSRF\WHVWKDWDUH
brown adipocytes within WAT depots that possess the total machinery 
for adaptive thermogenesis but have a different gene expression 
pattern (absence of myogenic markers, Zic1 and Lhx8) and arise from 
preadipocytes, and white adipocytes that express leptin and S-100 
surface markers. 
UCP: uncoupling protein; Myf5: myogenic factor 5; En1: engrailed 1;  
Figure adapted from Kajimura et al. 2010 (Kajimura et al. 2010). 
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1.4 Adipogenesis 
The biogenesis of adipocytes comprises the differentiation of 
mesenchymal stem cells to committed precursor cells called 
preadipocytes, followed by terminal differentiation into mature 
adipocytes (Rosen and Spiegelman 2000) (Figure 1.2). 
1.4.1 Commitment of stem cells to adipose lineage 
When appropriately stimulated, pluripotent mesenchymal stem cells 
undergo commitment to the adipocyte lineage. The exact mechanisms 
behind this commitment remain unresolved but several drivers have 
been identified. Bone morphogenetic protein (BMP) signalling is 
implicated in the commitment of stem cells to the adipocyte lineage and 
BMP4 and BMP2 both induce mouse stem cells to form preadipocyte-
like cells which can differentiate into cells with adipocyte phenotype 
(Tang and Lane 2012). Other signalling pathways, such as Wnt 
signalling, activate this lineage commitment of mouse stem cells while 
Hedgehog (Hh) signalling has an inhibitory effect. 
1.4.2 Terminal differentiation of adipocytes 
The next step of adipogenesis is the terminal differentiation of 
committed precursors to adipocytes. In this process the adipocytes 
acquire characteristics such as the machinery for lipid transport and 
synthesis, insulin action and secretion of adipocyte specific proteins. 
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Several transcriptional regulators and extranuclear factors come 
together to orchestrate adipocyte differentiation. Induction of 
differentiation is marked by the activation of C/EBP-ȕDQG&(%3-į
which directly induce the expression of PPAR-ȖDQG&(%3-Į7KHVH
are key regulators of adipocyte differentiation (Tang et al. 2005). In 
addition, several other transcription factors such as the Kruppel-like 
factors, steroid regulatory element binding transcription factors and 
cyclic AMP response element-binding protein (CREB) promote 
differentiation of preadipocytes into adipocytes whilst others, such as 
members of the forkhead and GATA families, repress adipogenesis 
(Moreno-Navarrete and Fernandez-Real 2012).  
Extranuclear regulation of adipogenesis is controlled by hormones, 
cytokines and growth factors. Insulin and insulin-like growth factor-1 
(IGF-1) promote adipogenesis via multiple pathways including the 
phosphorylation of CREB (Klemm et al. 2001). Thyroid hormones 
induce adipogenesis via thyroid receptor alpha 1 which are highly 
expressed in subcutaneous fat of obese subjects while another type of 
thyroid receptor, type alpha 2, antagonises this action (Ortega et al. 
2009). Over excretion of cortisol (hypercortisolism) promotes 
adipogenesis and adipose tissue redistribution. Adipose tissue 
VHQVLWLYLW\WRJOXFRFRUWLFRLGVLVUHJXODWHGE\ȕ-hydroxydehydrogenase 
ȕ+6'ZKLFKSURPRWHVDGLSRVLW\DQGLVPHGLDWHGE\WKH
glucocorticoid receptors (Budge et al. 2005). Fibroblast growth factors 
15 
 
also show adipogenic activity in human preadipocytes (Hutley et al. 
2004). Recent advances in this field have highlighted the role of 
epigenetic factors and microRNAs in adipocyte differentiation and these 
remain an area of intense research interest and activity (Hilton et al. 
2013).  
1.4.3 Brown and white adipogenesis occurs via two distinct 
pathways 
Despite differences in morphology and physiological functions, brown, 
white and brite adipoytes share several similar transcriptional cascades 
VXFKDV&(%3VDQG33$5ȖZKLFKFRQWUROWKHLUWerminal differentiation. 
However, there are key differences that specifically promote one 
genetic programme over the other and white and brown adipogenesis 
occur along two parallel pathways with distinct sets of transcription 
factors governing each process (Kajimura et al. 2010) (Figure 1.3). 
Genes such as BMP 7 (Tseng et al. 2008), PR (PRD1-BF1-RIZ1 
homologous)-domain-containing protein (PRDM16) (Seale et al. 2007), 
CCAAT-HQKDQFHUELQGLQJSURWHLQ&(%3ȕ(Kajimura et al. 2009), 
peroxisome proliferator-DFWLYDWHGUHFHSWRUȖ33$5ȖDQG33$5ȖFR-
activator (P*&Į(Fruhbeck et al. 2009) are expressed along the 
brown adipogenic pathway whilst another set of transcription factors 
including BMP4 (Schulz and Tseng 2009), adipose differentiation 
related protein (ADRP) and homobox (Hox) C9 (Cantile et al. 2003) is 
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specific to white adipogenesis. The extent to which these separate 
processes can be reset in utero has not yet been established. 
Brown adipocytes arise from the dermomyotomal precursors that are 
positive for the myogenic factor 5 (Myf5) gene, an early marker of 
myocyte development. The induction of the brown fat programme 
requires several transcription factors including PRDM16 which 
increases the transcriptional activity of 3*&Į which itself is a master 
regulator of mitochondrial biogenesis and oxidative metabolism in most 
cell types, including brown adipocytes and muscle cells (Kajimura et al. 
2010).  
The third type of adipocyte, described as brown-in-white (brite or beige) 
cells and present in WAT depots, has a distinctive pattern of gene 
expression and is believed to differentiate via a discrete developmental 
pathway from mesodermal stem cells that are not positive for Myf5. 
Thus, through the differentiation process, mesenchynal precursors 
transform into three distinctive types of adipocytes ± white, brown and 
brite cells (Figure 1.2).
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Figure 1.3. Genes involved in brown and white adipogenesis  
White and brown adipogenesis occur along two parallel pathways with distinct sets of 
transcription factors governing each process. UCP: uncoupling protein; KCNK: 
potassium channel, subfamily K, member 3; BMP: bone morphogenetic protein; 
ADRP: adipose differentiation related protein; Hox: homobox; RIP: receptor 
interacting protein; PRDM: PR (PRD1-BF1-RIz1 homologous)-domain-containing 
protein; PGC1ĮSHUR[LVRPHSUROLIHUDWRU-activated receptor-ȖFRDFWLYDWRUC/EBP: 
CCAAT enhancer binding protein.
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1.4.4 Development of adipose tissue in fetal life 
Fetal adipose depots possess the dual characteristics of brown and 
white adipose tissue (Merklin 1974). Although WAT cannot be 
macroscopically detected during embryogenesis in rodents, in humans 
WAT development begins well before birth and distinct WAT deposits 
can be detected around the head by 14 weeks (Poissonnet et al. 1984). 
In a study of 488 human abortuses of both sexes, Poissonnet et al. 
identified that early to mid-gestation was the crucial period for adipose 
tissue development (Poissonnet et al. 1984). Thus, macroscopic 
evidence of adipose tissue development in the human fetus is first seen 
in early to mid-gestation with demonstrable aggregations of 
mesenchymal cells and adjacent proliferation of blood vessels present 
by 14 weeks of gestation. WAT progressively appears in the trunk, then 
the limbs and by 28 weeks adipose deposits are present in all potential 
visceral and subcutaneous sites. Further development in the third 
trimester occurs mostly as a result of increase in size of the pre-existing 
fat lobules (Poissonnet et al. 1984). In human fetus, BAT appears 
before WAT and is present in several locations in the human fetus and 
newborn infant (Aherne and Hull 1966).  
The development of adipose tissue in the ovine fetus follows a similar 
pattern with an early proliferative phase marked by high expression of 
Ki-67 (Pope et al. 2013), a gene expressed in all active phases of the 
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cell cycle but absent in the resting cells (Scholzen and Gerdes 2000), 
followed by a preparative phase during which adipose depots continue 
to grow and accumulate lipid (Pope et al. 2013). 
1.5 White adipose tissue 
WAT forms the major bulk of adipose tissue in adult humans and has 
the primary function of lipid synthesis and storage. White adipocytes are 
leptin and S100-B immunoreactive spherical cells, with most of their 
volume taken up by a single cytoplasmic lipid droplet, and a small 
nucleus that appears to be squeezed in a corner. In addition, WAT has 
vital roles in intermediary metabolism of glucose and fatty acids, 
regulation of insulin sensitivity, appetite control, and energy metabolism 
and endocrine functions (Gesta and Ronald Kahn 2012).  
1.5.1 Endocrine functions of white adipose tissue 
White adipose tissue expresses numerous receptors that allow it to 
respond to afferent signals from circulating hormones and the central 
nervous system and also secrete a variety of bioactive peptides, known 
as adipokines (or due to their role in inflammation, adipocytokines), 
which act at both local (autocrine and paracrine) and systemic 
(endocrine) levels. The importance of the endocrine role of adipose 
tissue is demonstrated by the myriad metabolic consequences of 
excess adiposity, as in obesity, and adipose tissue deficiency such as 
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lipodystrophy, both of which are associated with the metabolic 
syndrome (Kershaw and Flier 2004). 
1.5.1.1 Leptin 
Leptin is a 16 kDa hormone secreted by adipocytes which acts at the 
hypothalamus to control appetite and energy expenditure (Gesta and 
Ronald Kahn 2012). The circulating concentration of leptin is directly 
proportional to adipose tissue mass, particularly subcutaneous adipose 
tissue, and increases in the postprandial state (Poppitt et al. 2006). 
Leptin expression is also increased by a variety of other factors such as 
LQVXOLQJOXFRFRUWLFRLGVDQGWXPRXUQHFURVLVIDFWRU71)ĮDQGLV
GHFUHDVHGE\JURZWKKRUPRQH))$VDQGȕ-adrenergic stimulation 
(Margetic et al. 2002). 
Leptin acts on the arcuate nucleus in the hypothalamus to inhibit 
orexigenic neuropeptides and activate anorexigenic pathways and thus 
serves as a metabolic signal of energy sufficiency (Gesta and Ronald 
Kahn 2012). It also has a role in regulation of immune functions and 
plays a critical role in regulating proliferation of T lymphocytes (Lord et 
al. 1998). 
Subcutaneous adipocytes express and secrete leptin more than visceral 
adipocytes (Van Harmelen et al. 1998). The plasma concentration of 
leptin correlates with size of body fat mass. In infants born to mothers 
with diabetes, cord blood leptin concentrations are elevated in parallel 
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with infant adiposity (Edwards et al. 2005). Obese individuals have 
increased plasma concentrations of leptin whilst subjects with some of 
the lipodystrophies may have undetectable levels (Maffei et al. 1995). 
Plasma concentrations of leptin are elevated after high-fat meals and 
reduced by fasting (Poppitt et al. 2006). 
In humans, leptin regulates appetite, body weight and fat mass. Plasma 
concentrations increase after several days of overeating and with 
increased fat mass. This signals satiety and appetite regulators in the 
hypothalamus in order to supress appetite. This resultant anorexic 
response attempts to decrease food intake. Fasting causes a sharp 
decrease in leptin concentrations and the resulting hypothalamic effects 
stimulate appetite.  However, individual responses to leptin are variable. 
In obesity, circulating leptin concentrations are high and may not 
produce appropriate anorexic responses as leptin resistance often 
accompanies obesity. In obese individuals threfore, exogenous leptin 
fails to reduce appetite or increase energy expenditure (Klingenspor et 
al. 1996). 
1.5.1.2 Adiponectin 
Adiponectin is a 30 kDa adipokine with potential anti-inflammatory and 
anti-atherogenic properties and a strong inverse association with insulin 
resistance (Diez and Iglesias 2003). Although the exact role of 
adiponectin is not known, its concentrations are reduced in obese 
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individuals, decline before the onset of obesity and insulin resistance 
(Hotta et al. 2001).(Arita et al. 2012) and increase when insulin 
sensitivity improves after weigh loss (Diez 2003). 
1.6 Brown adipose tissue 
Homeothermic species maintain body temperature by a variety of 
regulatory mechanisms which enable heat generation or heat loss in 
order to survive exposure to environmental temperatures outside the 
thermoneutral range of the organism (Lean 1989). Heat is produced in 
response to cold exposure by an increase in body metabolism, i.e. 
thermogenesis. In addition to the basal metabolic rate and increased 
muscular activity i.e. shivering, mammals possess an additional 
mechanism for generating heat in which a unique organ, BAT, produces 
heat by a process known as non-shivering thermogenesis.  
Although known for more than 500 years (Gessner 1551), BAT has 
been recognised as a heat producing organ only in the last 60 years 
and its varied metabolic roles in mammalian physiology have not yet 
been unravelled. Traditionally, BAT has been viewed as the 
thermogenic organ for maintaining core body temperature in small 
mammals and its role in humans was thought to be restricted to the 
newborn period. However, its recent rediscovery in adult humans 
(Cypess et al. 2009, Saito et al. 2009, van Marken Lichtenbelt et al. 
2009, Virtanen et al. 2009) has re-stimulated interest in this organ.  
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Brown adipocytes are polygonal cells with several smaller lipid droplets 
and numerous large mitochondria. These cells stain for the unique BAT 
protein called uncoupling protein (UCP)1. 
1.6.1 Uncoupling protein 1 ± the unique BAT protein 
The identification of UCP1, the unique BAT protein which drives non-
shivering thermogenesis (Aquila et al. 1985) has increased our 
understanding of BAT function. It was discovered following the 
observation that the inner mitochondrial membrane of isolated brown 
adipocytes has high ion permeability (Nicholls and Bernson 1977). 
UCP1 is expressed exclusively in the inner mitochondrial membrane in 
brown adipocytes and is the only protein which can mediate adaptive 
non-shivering thermogenesis (Nedergaard et al. 2001). 
1.6.1.1 Mode of action of UCP1  
0LWFKHOO¶VFKHPLRVPRWLFK\SRWKHVLVVXJJHVWVWKDWR[LGDWLRQRIQXWULWLRQDO
substrates is coupled to adenosine triphosphate (ATP) generation by 
the movement of electrons through a series of electron transporters 
embedded in the inner mitochondrial membrane (Mitchell 1961). This 
movement establishes a proton electrochemical gradient which is 
dispelled when hydrogen ions (H+) move back into the mitochondrial 
matrix via the FO/F1 ATP synthase. As the H+ ions pass, the ATP 
synthase complex rotates and the rotational forces catalyse the 
generation of ATP from adenosine diphosphate (ADP). UCP1 acts by 
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uncoupling the process of substrate oxidisation and ATP synthesis by 
allowing the protons to pass passively from the intermembrane space to 
the mitochondrial matrix through an alternative channel, thus dissipating 
the proton-motive force without generation of ATP (Figure 1.4). Instead, 
the oxidised energy is released as heat. 
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Figure 1.4. Mechanism of action of uncoupling protein 1  
NAD: nicotinamide adenine dinucleotide; NADH: nicotinamide adenine 
dinucleotide dehydrogenase; ADP: adenosine diphosphate; ATP: 
adenosine triphosphate; FAD: Flavin adenine dinucleotide; FADH: 
Flavin adenine dinucleotide dehydrogenase; H2O: water; H+: hydrogen 
ion; Cyt c: cytochrome c; syn: ATP synthase; I: electron transport chain 
(ETC) complex I; Q: cofactor Q; III: ETC complex III; IV: ETC complex 
IV. 
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1.6.1.2 Activation of UCP1 
Whilst in its active state, UCP1 is a potent proton translocator; in the 
resting state it does not have any residual proton conductance due to 
the presence of inhibitory nucleotides and normal oxidative 
phosphoryation continues undisturbed (Shabalina et al. 2010). Hence, 
for non-shivering thermogenesis to occur, UCP1 activation is required. 
Despite extensive research, a comprehensive understanding of the 
process of activation of UCP1 has not been achieved, although it is 
accepted that the presence of free fatty acids (FFA) is mandatory for 
UCP1 induced thermogenesis (Cannon and Nedergaard 2004).  
1.6.1.3 Regulation of UCP1 biosynthesis 
The human UCP1 gene is located on chromosome 4q31 spanning 
13Kb consisting of 9Kb of transcribed region and is 79% homologous to 
the rat UCP1 gene (Cassard et al. 1990). The molecular mechanisms 
regulating the expression of rodent UCP1 gene have been described 
recently. The gene has a proximal promoter region that contains several 
cAMP response elements (CREs), a silencer region and a complex 
enhancer which can override the action of the silencer (Kozak et al. 
1994). In addition, this region also contains CCAAT enhancer binding 
protein (C/EBP) responsive elements, ZKHUH&(%3ĮDQGȕDSSHDUWR
have similar actions in increasing gene expression (Yubero et al. 1994). 
The upstream region of the gene has a complex enhancer region, with 
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several response elements within a short sequence which regulate the 
specificity of UCP1 expression (Del Mar Gonzalez-Barroso et al. 2000). 
The response elements include the UCP1-gene activating region, 
CREs, brown fat regulatory elements and retinoic acid response 
elements. The region also contains the peroxisome proliferator-
activated receptor (PPAR) response element as well as the thyroid 
hormone responsive element (TRE). TRE functions as a repressor in 
the unliganded state and amplifies the effect of adrenergic stimulation in 
the presence of thyroid hormones (Cannon and Nedergaard 2004). 
The elevation of intracellular cAMP concentration via ȕ-adrenergic 
stimulation is the most well recognised pathway of UCP1 gene 
regulation (Collins et al. 2010). cAMP activates cAMP-dependent 
protein kinase A (PKA) which increases the expression of the gene 
encoding UCP1. A vital mediator of this action is the transcription co-
DFWLYDWRU3*&Į3*&ĮLVDNH\UHJXODWRURIWKHUPRJHQHVLVLQEURZQ
adipocytes and in its absence the cAMP regulated activation of UCP1 is 
severely blunted (Uldry et al. 2006).  
7KHH[SUHVVLRQRI3*&ĮJHQHLVLQWXUQHQKDQFHGE\DN'D
transcription factor called PRDM16 which is expressed selectively in 
brown adipocyte. It functions as a co-UHJXODWRUWRDFWLYDWH3*&ĮDQG
can also directly increase expression of UCP1 and several other key 
BAT specific genes (Seale et al. 2007).  
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1.6.2 Brown fat development  
Brown adipocytes are derived from mesenchymal stem cells (as 
discussed in Section 1.4) but the differentiation pathway by which they 
develop is not completely clear. 
1.6.2.1 Brown adipose tissue develop from myogenic precursors 
BAT and WAT have several common characteristics; both differentiate 
YLDD33$5Ȗ-driven transcription pathway and it was assumed that both 
types of adipose tissue have a common progenitor. The discovery that 
brown fat and skeletal muscle, but not white fat, develop from Myf5 
expressing progenitors (Myf5+) revealed that BAT and skeletal muscles 
share a common lineage (Seale et al. 2008). This was coupled with the 
finding that knockout of PRDM16 in brown fat induces skeletal 
myogenesis including a large increase in expression of myogenic 
genes. Conversely, the ectopic expression of PRDM16 in myoblasts 
suppresses myogenesis and induces expression of BAT genes such as 
UCP1, cell death inducing DFFA-like receptor A (CIDEA) anG3*&Į
(Seale et al. 2008). These findings have revealed a close relationship 
between the developmental origins of skeletal muscles and BAT. Other 
studies also support this relationship. Atit et al. found that Engrailed-1 
(En-1) expressing cells of the central dermomyotome give rise to dorsal 
dermis, epaxial muscles and interscapular BAT in mice (Atit et al. 2006) 
suggestive of a common embryological origin for muscles and BAT. The 
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transcriptional similarities of brown preadipocytes and myogenic cells 
have also been demonstrated in microarray analysis where interlinkage 
between brown preadipocytes and myocytes reflect their common origin 
whilst demonstrating their difference from WAT (Timmons et al. 2007). 
Other similarities between BAT and skeletal muscles are demonstrated 
by studies of mitochondrial proteomic signatures. At transcript and 
proteome levels, BAT mitochondria are similar to mitochondria in 
skeletal muscles and differ from those in WAT (Forner et al. 2009). 
These similarities between BAT and skeletal muscle reflect that both 
tissues are adrenergically regulated organs which control adaptive 
thermogenesis and may explain why, like skeletal muscle, BAT 
primarily functions as an organ of lipid catabolism rather than storage 
(Seale et al. 2008). It also explains the presence of UCP1 expressing 
brown adipocytes interspersed between muscle bundles in obesity 
resistant mice (Almind et al. 2007). 
1.6.3 Adrenergic control of brown adipose tissue 
BAT depots are richly innervated with adrenergic nerves and these 
sympathetic innervations are the major regulator of proliferation, 
differentiation and apoptosis as well as metabolic functions such as 
lipolysis and thermogenesis in brown adipocytes. 
Several different types of adrenergic receptors are present in BAT cells. 
Cells in BAT have all the three types of beta (ȕ) adrenergic receptors 
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(ADR); ȕȕ$'5ȕȕ$'5DQGȕȕ$'5(Rohlfs et al. 1995) 
EXWLQPDWXUHEURZQDGLSRF\WHVȕ$'5VDUHSUHGRPLQDQW(Bronnikov et 
al. 1999) and the most thoroughly investigated. 
1.6.3.1 UCP1 gene expression is regulated by adrenergic 
stimulation  
Cold exposure increases UCP1 in BAT mitochondria due to NE release 
DWȕ$'5QHUYHHQGLQJs on brown adipocytes (Ricquier et al. 1984).  
Adrenergic stimulation increases intracellular cAMP concentration 
which activates the CREs on the UCP1 gene increasing protein 
production (Cannon and Nedergaard 2004). Beta-adrenergic stimulation 
aOVRLQFUHDVHVWKHH[SUHVVLRQRI3*&ĮDQG33$5Ȗfurther optimising 
induction of the UCP1 gene. 
1.6.3.2 Adrenergic systems control brown adipose tissue 
metabolism 
The thermogenic response to NE stimulation is also predominantly 
PHGLDWHGYLDȕ$'5V(Zhao et al. 1994). Activation of these receptors 
promotes lipolysis of stored triglycerides (Collins 2011). Beta adrenergic 
stimulation activates the GTP-binding protein G which, in turn, activates 
adenyl cyclase to increase cyclic adenyl monophosphate (cAMP) 
concentration within the cells. Cyclic-AMP turns on PKA which then 
phophorylates hormone sensitive lipase (HSL) and lipid droplet binding 
proteins such as perilipin. Phosphorylation of perilipin releases 
triglycerides from the lipid droplets enabling the lipases to hydrolyse 
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them into FFA and glycerol. The FFAs are transported to the 
mitochondria by fatty acid transporting protein known as fatty acid 
binding protein 4 (FAB4). The FFAs activate UCP1 and also become 
the thermogenic substrate for the action of UCP1 (Figure 1.5). 
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Figure 1.5. Activation of UCP1 by adrenergic stimulation  
Adrenergic stimuli such as norepinephrine (NE) stimulate ȕ3 adrenergic 
UHFHSWRUVȕ$'55 which activate adenyl cyclase to increase 
intracellular concentration of cyclic adenosine monophosphate (cAMP). 
cAMP stimulates protein kinase A which phosphorylates perilipin and 
lipases. Perilipin breaks the triglyceride (TG) globule while the lipases 
hydrolyse the triglycerides to release free fatty acids (FFA). The FFAs 
are carried by fatty acid binding protein 4 (FABP4) to the mitochondria 
where they activate uncoupling protein 1 (UCP1) and act as the 
substrate for non-shivering thermogenesis. 
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1.6.4 Role of thyroid hormones in BAT thermogenesis 
Thyroid hormones are an important determinant of overall energy 
expenditure (Kim 2008) and are important regulators of BAT function 
(Figure 1.6). NE or cold stress causes a rapid increase in type 2 
iodothyronine deiodinase (DIO2) in BAT (Silva and Larsen 1983). DIO2 
catalyses the conversion of thyroxine (T4) into triiodothyronine (T3). T3 
is a form of thyroid hormone that is 10 times as potent as T4. This 
intracellular conversion of T4 into T3 within brown adipocytes produces 
high intracellular T3 concentration which saturates thyroid hormone 
receptors and induces a rapid increase in UCP1 gene expression and 
protein synthesis (Bianco and Silva 1987). 
Thyroid hormones may also activate BAT by a central mechanism 
involving decreased activity of hypothalamic AMP-activated protein 
kinase (AMPK) and increased sympathetic nervous system activity with 
upregulation of thermogenesis in brown adipocytes (Lopez et al. 2010) 
(Figure 1.6). 
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Figure 1.6 Regulation of brown adipose tissue (BAT) by thyroid 
hormones 
Beta adrenergic stimulants such as norepinephrine (NE) act via ȕ-3 
DGUHQHUJLFUHFHSWRUVȕ$'5) to increase the action of type II 
iodothyronine deiodenase (DIO2). Circulating thyroxine (T4) is 
converted to tri-iodothyronine (T3) by the action of DIO2 within the 
brown adipocyte. T3 activates UCP1 gene expression. Thyroid 
hormones also act on the hypothalamus to decrease cyclic-AMP 
activated protein kinase (PKA) levels and increase adrenergic drive to 
BAT. 
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1.6.5 Other metabolic actions of BAT 
The primary role of BAT in metabolism and energy homeostasis is 
adaptive thermogenesis. Additionally, in the course of this action, it has 
other effects on body metabolism. 
1.6.5.1 Lipid metabolism and BAT 
Lipids derived from circulating chylomicrons are a major thermogenic 
substrate in BAT (Cannon and Nedergaard 2004). Brown adipocytes 
produce and secrete lipopoprotein lipase into the surrounding blood 
vessels. Triglyceride laden chylomicrons and very low density 
lipoproteins (VLDL) are hydrolysed by lipoprotein lipase to produce FFA 
and monoacylglycerols. The FFA are taken up by the brown adipocytes 
(Festuccia et al. 2011) . This mechanism enables BAT to function as a 
lipid clearing organ purging the local circulation of excess lipids (Bartelt 
et al. 2011) (Figure 1.7). The production of lipoprotein lipase in brown 
adipocytes and the subsequent clearance of circulating lipids by BAT is 
enhanced by NE (Carneheim et al. 1984), cold exposure (Bartelt et al. 
2011) DQGH[SRVXUHWR33$5ȖDJRQLVWURVLJOLWD]RQH(Festuccia et al. 
2009). The FFAs taken up by the brown adipocytes are channelled 
towards intracellular stores of triglycerides for use as thermogenic 
substrates later or are used up in thermogenesis by being directly 
transported to the mitochondria (Festuccia et al. 2011). 
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Figure 1.7. Lipid uptake by brown adipocytes 
Brown adipocytes secrete lipoprotein lipase (LPL) that breaks down 
circulating very low density lipoproteins (VLDL) and chylomicrons (CM) 
to release monoacyl glycerol (MAG) and free fatty acids (FFA) which 
are taken up by the adipocytes. Within the cell, the FFAs are esterified 
to acyl co-enzyme A (acyl CoA) and further metabolised to synthesise 
triglycerides (TG) by the process of lipogenesis or directly transferred to 
the mitochondria where they activate uncoupling protein 1 (UCP1) and 
provide the substrate for non-shivering thermogenesis. 
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1.6.5.2 Glucose metabolism and BAT 
Brown adipocytes display a very high rate of glucose uptake per unit 
weight of tissue (Cannon and Nedergaard 2004). This high uptake has 
been amply demonstrated in humans during the identification of BAT in 
adult humans by the uptake of the 18F-labeled glucose analogue 
known as 2-fluoro-2-deoxy-glucose (18F-FDG) during positron emission 
tomography (PET) computerised tomography (CT) scans (Cypess et al. 
2009, Saito et al. 2009, van Marken Lichtenbelt et al. 2009, Virtanen et 
al. 2009). 
Glucose uptake by BAT is enhanced by cold exposure in both rats 
(Greco-Perotto et al. 1987) and in humans (Orava et al. 2011). This 
UHVSRQVHLVPHGLDWHGE\ȕ-adrenergic stimulation via cAMP 
(Chernogubova et al. 2004) which increases de novo synthesis of 
glucose transporter (GLUT) 1 and increases the abundance of GLUT1 
in the brown adipocyte plasma membrane (Dallner et al. 2006). 
The alternative regulation of glucose uptake by brown adipocytes is 
through the insulin stimulated translocation of GLUT4 to the plasma 
membrane of the brown adipocytes (Teruel et al. 1996). This pathway is 
similar to that seen in white adipocytes and is probably more active 
under conditions of decreased thermogenesis (Cannon and Nedergaard 
2004). Circulating insulin binds to insulin receptors (IR) on brown 
adipocytes and activates tyrosine kinase and downstream signalling 
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with pleiotropic effects including increased production and translocation 
of GLUT4 on to the plasma membranes and increased glucose uptake 
in the brown adipocytes (Sugden and Holness 1993). The glucose 
taken up under the influence of insulin is used for de novo fatty acid 
synthesis or may be stored as glycogen. BAT is one of the most insulin 
responsive tissues with respect to stimulation of glucose uptake and 
even in small amounts, it is a potentially significant glucose clearing 
organ (Cannon and Nedergaard 2004). 
1.7 Brite adipocytes - a different type of adipocytes are 
present in white adipose depots 
In addition to the discreet depots of BAT, brown adipocyte like cells are 
also present in WAT depots in adult animals. These cells have been 
variously named brite, brown-in white, brown-like, or beige adipocyte 
(Klingenspor et al. 2012). Brite adipocytes are inducible i.e. islands of 
brown-like adipocytes appear within white fat depots of rodents 
following chronic exposure to ȕ3 adrenergic stimulation or cold (Pisani 
et al. 2011).  
This discovery that adipocytes within WAT depots can be stimulated to 
acquire brown-like characteristics has generated interest in brite 
adipocytes. Adult humans typically have low amounts of BAT; increased 
BAT volume and activity correlates with lower BMI (van Marken 
Lichtenbelt et al. 2009, Virtanen et al. 2009), increased energy 
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expenditure (Cypess et al. 2015), reduced WAT accumulation (Chalfant 
et al. 2012) and improved glucose and lipid metabolism (Ouellet et al. 
2012). UCP1 ablated mice are lean when reared at room temperature 
(Enerback et al. 1997) but rapidly develop obesity when kept at 
thermoneutral conditions (Feldmann et al. 2009) while transgenic 
expression of UCP1 prevents obesity in mice (Kopecky et al. 1995). 
These findings suggest that stimulation of activity of brite cells in WAT 
of humans could potentially improve metabolic health and prevent 
obesity.  
1.7.1 Origin of brite adipocytes 
Precursors of UCP1 positive cells that are present within WAT depots 
are negative for Myf5 indicating that brite adipocytes have origins 
distinct from that of classical brown adipocytes (Petrovic et al. 2010). A 
SRSXODWLRQRISODWHOHWGHULYHGJURZWKIDFWRUĮpositive adipocyte 
progenitors can differentiate into brite or white adipocytes; they acquire 
EULWHFKDUDFWHULVWLFVXQGHUȕ$'5VWLPXODWLRQDQGGHYHORSLQWRZKLWH
adipocytes when the animal is fed a high fat diet (Lee et al. 2012). 
Others studies have also demonstrated that it is possible to convert 
adipocyte precursors found in WAT into mature adipocytes which 
display the full characteristics of brown adipocytes including adaptive 
thermogenesis and respond to various brown adipocyte stimulating 
signals such as ȕ-adrenergic agonists, fatty acids, prostaglandins, 
thyroid hormones and natriuretic peptides (Pisani et al. 2011). Chronic 
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treatment with rosiglLWD]RQHD33$5ȖDJRQLVWLQGXFHVWKHH[SUHVVLRQ
RI8&3DQG3*&ĮDQGPLWRFKRQGULRJHQHVLVLQSUHFXUVRUFHOOVIURP
WAT depots in mice (Petrovic et al. 2010) and in human multipotent 
adipose derived stem cells (Pisani et al. 2011) and the effeFWLV33$5Ȗ
GHSHQGHQWDVH[SRVXUHWRVSHFLILF33$5ȖDQWDJRQLVWDEROLVKHV8&3
mRNA expression. These findings suggest that cellular plasticity exists 
between white and brite adipocytes at the precursor stage and WAT 
depots can be induced to develop brite cells and acquire brown fat-like 
characteristics (Bartelt and Heeren 2014). 
These distinctive brown-in-ZKLWH³EULWH´RU³EHLJH´DGipocytes are not 
classic brown adipocytes as they have a different pattern of gene 
expression (these cells express UCP1 but do not express Zic1 and 
Lhx8, two brown adipocyte specific genes (Walden et al. 2012)) and do 
not express Myf5 in mice (Petrovic et al. 2010) or in human cells (Pisani 
et al. 2011). This also indicates that these distinctive cells do not arise 
from classic brown adipocyte precursors but have a developmental 
origin and molecular characteristics which make them a separate class 
of adipocytes, distinct from both classical WAT and BAT. 
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1.8 Energy balance and its role in obesity 
As discussed earlier in Chapter 1.1.5, obesity and excess adiposity are 
consequences of intake of energy in excess of expenditure over a 
prolonged period. However, this simple mathematical relationship does 
not completely explain differences in the extent of weight gain in 
different individuals within the same obesogenic environment. Body 
weight regulation appears to defy the first law of thermodynamics 
(energy can neither be created nor destroyed, only converted from one 
from to another) until this straightforward physical law is applied in 
conjunction with an understanding of  the  dynamic physiological 
adaptations to altered body weight that lead to changes in both the 
resting metabolic rate as well as the energy cost of physical activity 
(Leibel et al. 1995).  
Leibel and colleagues measured energy expenditure and the thermic 
effect of feeding in obese and normal weight subjects at their usual 
body weights and after losing or gaining 10 to 20% of their body weight 
to demonstrate that maintenance of a reduced or elevated body weight 
is associated with compensatory changes in energy expenditure. These 
compensations oppose the maintenance of a body weight that is 
GLIIHUHQWIURPWKHLQGLYLGXDO¶VXVXDOZHLJKWDQGPD\DFFRXQWIRUWKHSoor 
long-term efficacy of treatments for obesity (Leibel et al. 1995). 
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The complexity of the homeostatic mechanisms that regulate body 
weight presents a challenge to understanding the causes of obesity. 
The concept of energy balance and an understanding of how the body 
achieves and maintains this balance may be a useful framework for 
designing the strategies for prevention or treatment of the condition. 
1.8.1.1 Energy expenditure in humans 
Energy intake in humans occurs as food while energy expenditure is 
composed of several components (Figure 1.8) (Rosenbaum and Leibel 
2010, van Marken Lichtenbelt and Schrauwen 2011). Of the total 
energy expenditure (TEE), 5-10% is spent in digestion and metabolism 
RIWKHLQJHVWHGQXWULHQWV7KHERG\¶VREOLJDWRU\FDUGLR-respiratory work 
such as the works of breathing and maintaining circulation and the 
energy spent in maintaining the ionic gradients across cell membranes 
constitute up to 60% of TEE. This component of TEE is termed as the 
resting energy expenditure (REE). The remaining energy expenditure is 
largely variable. Approximately 30% of TEE can be spent in voluntary 
muscular activity (exercise) whilst a highly variable proportion 
(estimated to be 5-30%) can be spent in non-exercise activity 
thermogenesis such as involuntary muscular activities (other than 
shivering). In addition to these, there is an additional component of TEE 
comprised of non-shivering thermogenesis that can be induced either 
by cold or diet. 
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Figure 1.8 Components of energy balance in adult humans 
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1.8.2 Role of BAT in energy balance in humans 
It is now accepted that BAT plays a role in energy balance in humans 
through the life span. 
1.8.2.1 Cold induced non-shivering thermogenesis in humans 
Thermogenesis mediated by uncoupling of substrate oxidation and ATP 
synthesis by UCP1 in BAT has long been accepted as the mode of 
thermoregulation in the human newborn infant (Bruck 1967). The 
evidence of existence of this mechanism in adults has been available 
for some time (Davis 1961) but it has only become widely accepted 
since the rediscovery of BAT in adult humans (Saito et al. 2009, van 
Marken Lichtenbelt et al. 2009, Virtanen et al. 2009).  
Virtanen et al. showed that, in response to cold exposure, radio-labelled 
glucose (18F-FDG) uptake in the supraclavicular area is higher than that 
in the adjacent WAT suggesting that activation of BAT by cold exposure 
may substantially contribute to energy expenditure (Virtanen et al. 
2009). Adults exposed to intermittent periods of cold over a 10 day 
period reported less shivering and improved tolerance to lower 
temperature (van der Lans et al. 2013). This process of cold acclimation 
was shown to induce BAT recruitment (both volume and activity of BAT 
was increased on 18F-FDG PET-CT scanning) accompanied by an 
increase in non-shivering thermogenesis in the participants. 
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The inverse relationship between cold-activated radio-labelled glucose 
uptake into supraclavicular adipose tissue and adiposity further 
suggests that BAT contributes to energy balance in humans (Saito et al. 
2009). A further role of BAT in metabolism is evidenced by increased 
uptake of non-esterified FFAs during cold exposure suggesting that 
triglycerides are the main source of BAT thermogenesis (Ouellet et al. 
2012). This study showed that in conditions designed to minimise 
shivering, cold resulted in a significant increase in oxidative metabolism 
in BAT. Although the response elicited was variable, enhanced BAT 
activation was associated with 1.8-fold increase in whole-body energy 
expenditure. 
1.8.2.2 Diet induced thermogenesis in humans 
Intake of food induces a thermogenic response known as diet-induced 
thermogenesis (DIT) (Figure 1.8). This increased expenditure of energy 
has two components: an obligatory component including the energy 
required for digestion and assimilation of the ingested nutrients and a 
facultative component which dissipates energy as heat (van Baak 
2008).  
BAT has a role in DIT in rodents (Rothwell and Stock 1979, Glick et al. 
1985). BAT may also play a role in the facultative component of DIT in 
humans. Changes in TEE in response to overfeeding correlate with 
changes seen with mild cold exposure and both correlate with fasting 
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plasma NE concentrations, suggesting a common regulatory 
mechanism which may be BAT activation via sympathetic stimulation 
(Wijers et al. 2007).  
However, currently there is very little evidence of BAT regulated DIT 
being a significant contributor to energy balance in humans and the 
suggestion that BAT maintains energy balance by burning calories in 
response to excess intake has been questioned as being incompatible 
with evolutionary biology (Kozak 2010). Williams and Kolodny found 
that patients who had a high fat, very low carbohydrate meal prior to the 
investigation, had a significantly lower frequency of uptake 18F-FDG on 
PET-CT scan compared to those who fasted suggesting that BAT 
activity was reduced in the postprandial state (Williams and Kolodny 
2008). Similarly, Vrieze and colleagues demonstrated that cold-
stimulated 18F-FDG uptake was significantly more prominent in the 
fasting state when compared to postprandial scan from the same 
individual (Vrieze et al. 2012). The standardised diet ingested by the 
participants in this study contained 34 g of fat, 37 g of carbohydrates, 
and 23 g of protein (respectively, 56%, 27%, and 17% of the energy). 
Both these studies demonstrated reduction in BAT activity as indicated 
by uptake of 18F-FDG, a glucose analogue, following intake of fat-rich, 
carbohydrate-poor meals. The lower glucose uptake in the postprandial 
state in these studies may be due to the higher contribution of lipid 
oxidation in BAT expenditure following intake of a fat-rich meal. This is 
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particularly plausible as fatty acids are the primary substrate for BAT 
metabolism (Cannon and Nedergaard 2004). Vosselman et al. studied 
the effect of a high carbohydrate, low fat meal (78% carbohydrate, 10% 
fat, and 12% protein) and demonstrated the increased postprandial 
uptake of glucose in BAT (Vosselman et al. 2013).These findings 
suggest that BAT may have a role in postprandial metabolism however 
it is as yet unclear if activation of BAT makes a significant contribution 
to energy balance after food intake.  
1.8.3 Role of BAT in obesity in humans 
As described in Section 1.6, the recent rediscovery of BAT in adult 
humans has reignited the debate on the role of BAT in adult humans. 
Following the evidence that BAT plays a part in energy balance in adult 
humans, it is postulated that BAT may play a vital role in obesity 
(Cypess et al. 2009, van Marken Lichtenbelt et al. 2009).  
Early evidence to support the hypothesis that increased BAT can 
induce weight loss came from patients with phaeochromocytomas. 
Phaeochromocytomas are rare neuroendocrine tumours which secrete 
large amounts of NE. In the presence of high circulating NE, brown 
adipocytes may be reactivated and contribute to the weight loss seen in 
this condition (Hadi et al. 2007, Wang et al. 2011).  This suggests that 
adequate stimulation can reactivate BAT in adult humans to such an 
extent that it can have a significant impact on energy balance. 
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Rodent studies show that BAT can produce up to 300W/kg of energy 
when maximally stimulated (Power et al. 1989) and previous estimates, 
made from extrapolation from animal studies, suggested that in 
humans, 40 to 50 g of BAT, if maximally stimulated, would increase 
daily energy expenditure by 20% (Rothwell and Stock 1983). Such 
estimates are considered to be overoptimistic and have been 
challenged in more recent literature (van Marken Lichtenbelt and 
Schrauwen 2011). Cypess et al. compared unstimulated oxygen 
consumption rate in mouse BAT with that in human BAT and found that 
human BAT has an oxygen consumption rate which is nearly 50% of 
the value in mouse BAT, even in the unstimulated state (Cypess et al. 
2013). 
Noticeable amounts of BAT have now been discovered in adult humans 
and the inverse correlation of volume and activation of BAT with BMI 
and adiposity suggests that BAT has a role to play in obesity (Cypess et 
al. 2009, van Marken Lichtenbelt et al. 2009). However, for BAT to have 
its maximal impact on weight control, it needs to be stimulated such as 
by cold exposure as seen in people who work outdoors in cold 
environments (Huttunen et al. 1981). As most individuals in the current 
milieu live in thermoneutral conditions (or compensate for cold 
temperatures by dressing adequately and prevent exposure to cold), 
BAT, even if present in considerable amounts, is unlikely to be fully 
activated. 
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In view of these arguments, it appears that 50g of active BAT would 
amount to only ~2.5-5% of total energy expenditure in human adults. 
This value is conservative when compared to older estimates (Power et 
al. 1989), but is still sufficient to have a substantial impact on energy 
balance and, therefore, on body weight control in adult humans (van 
Marken Lichtenbelt and Schrauwen 2011). In the management of 
overweight or obesity, any measure which can create a consistent 
negative balance over a prolonged period of time is likely to produce 
weight loss. It has been calculated that even as little as negative 
balance of 100 kcal/day can produce weight loss with considerable 
beneficial effects on health of the individual (Fruhbeck et al. 2009). It is 
entirely plausible that this degree of negative energy balance could be 
achieved by activating the relatively small amounts of BAT present in 
adult humans. 
Currently, very little is known about the physiology of BAT in humans. 
Research is needed to study the presence of BAT in various adipose 
tissue depots in humans and investigate the methods by which BAT 
may be activated to promote a negative energy balance which can 
combat excess weight gain. 
1.9 Distribution of adipose tissue 
In 1947, Vague proposed that the regional distribution of adipose tissue 
is an important determinant of the relationship between obesity and the 
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metabolic problems that accompany it (Vague 1947). Several studies 
have shown that excess adiposity in the upper body is better correlated 
with increased mortality and higher risks for metabolic syndrome than 
excess fat in the lower body, gluteofemoral distribution, and further 
investigations have demonstrated that the detrimental influence of 
abdominal obesity on the metabolic process is mediated by visceral 
adiposity (Wajchenberg 2000). The visceral fat depot is contained within 
the body cavity and surrounds the internal organs. The largest 
accumulation is intraabdominal but smaller depots are present around 
other organs such as the heart.  
Visceral fat is uniquely deleterious because of its anatomical site and 
close vascular connections with vital organs, exposing the nearby 
organs to the full and undiluted repertoire of metabolites and 
adipocytokines produced by the visceral adipocytes (Montague and 
O'Rahilly 2000). In addition, visceral adipocytes have a different 
metabolic profile which is more actively lipolytic as compared to 
subcutaneous adipocytes (Hellmer et al. 1992). Visceral adipocytes are 
more responsive to glucocorticoids (Fried et al. 1993), produce less 
leptin (Lefebvre et al. 1998) and secrete more inflammatory adipokines 
(Eriksson et al. 1998). 
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1.10 Pericardial adipose tissue 
Most research in visceral adipose tissue is concentrated around visceral 
abdominal adiposity but there are other areas of visceral fat 
accumulation which can have significant impacts on local organ 
function. The heart and great vessels are surrounded by layers of 
adipose tissue. These layers constitute a complex organ, composed of 
adipocytes, stromal and inflammatory cells, nerves and blood vessels, 
which has a myriad of paracrine influences on the function and structure 
of the heart  (Iozzo 2011). Growing recognition of the importance of 
these ectopic adipose tissue depots in the pathophysiology of 
cardiovascular diseases (Shimabukuro 2009) has generated interest in 
cardiac adiposity.  
1.10.1 Anatomy of adipose tissue in and around the heart 
The various compartments of fat in, and around, the heart have been 
previously described using different terminologies and there appears to 
be a degree of ambiguity in their definitions (Iacobellis 2009, Kaushik 
and Reddy 2011). The term myocardial fat refers to the triglyceride 
droplets within the cardiac myocytes. Outside of this, the heart and the 
great vessels are surrounded by the pericardium. The pericardium has 
two layers ± the inner visceral pericardium, or epicardium, and the outer 
parietal pericardium (Figure 1.9). The adipose tissue present between 
the heart and the visceral layer of the pericardium i.e. in direct contact 
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with the myocardium is called epicardial adipose tissue (Sacks and Fain 
2007) and is mainly located in the atrioventricular and intervertricular 
grooves and along the branches of the coronary arteries, and, to a 
lesser extent, on the ventricular surfaces (Iacobellis et al. 2005). The 
adipose tissue present outside of the visceral pericardium, either within 
the two layers of the pericardium or outside the parietal pericardium has 
been referred to as paracardial fat (Sacks and Fain 2007).  
The distinction between epicardial and paracardial adipose tissue is 
highlighted by the fact that they have different embryological origins. 
Epicardial adipose tissue originates from the splanchnopleuric 
mesoderm (Ho and Shimada 1978), whilst paracardial adipose tissue 
originates from the primitive thoracic mesenchyme (Moore and Persaud 
2003). In parallel to their different embryological origins, the two depots 
derive their blood supply from different sources. The epicardial adipose 
tissue is supplied by the coronary circulation and the paracardial 
adipose tissue is supplied by the mediastinal vasculature including the 
branches of the internal thoracic artery (Taguchi et al. 2001). However, 
several auWKRUVRSWWRXVHWKHWHUPµSHULFDUGLDODGLSRVHWLVVXH¶WRUHIHU
to the fat present around the heart. This is because of the difficulties in 
consistently separating the epicardial and paracardial adipose tissue 
layers at dissection during surgery and on ultrasound and other imaging 
studies (Greif et al. 2009, McAuley et al. 2011, Wong et al. 2011). 
Pericardial adipose tissue is, thus, defined as the adipose tissue 
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present within, and immediately outside, the pericardium and includes 
both epicardial and paracardial adipose tissue (Figure 1.9).
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Figure 1.9 Adipose tissue in and around the heart 
Pericardial adipose tissue is the fat present in the immediate vicinity of the heart: the fat present between the myocardium and the 
visceral layer of the pericardium (epicardial adipose tissue) and the fat present between the two layers of the pericardium and 
immediately outside the parietal pericardium (paracardial adipose tissue).
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1.10.2 Normal physiological functions of pericardial adipose 
tissue 
Several putative physiological functions of adipose tissue present in, 
and around, the heart have been proposed (Rabkin 2007). Like all 
visceral adipose tissue depots, it was traditionally thought to be a 
protective layer of padding around the vital organ (Keegan et al. 2004). 
Anatomically pericardial fat provides mechanical protection of the heart 
and the coronary arteries, buffering them against the torsion induced by 
the arterial pulse wave and cardiac contraction.  
In the recent years, other roles for the tissue have been proposed 
(Iacobellis et al. 2005). Epicadial adipose tissue depot is a site of lipid 
and energy metabolism. Compared to other visceral fat depots, 
epicardial fat has a greater capacity to take up and incorporate, as well 
as, breakdown and release FFAs (Marchington et al. 1989). The 
myocardium takes up FFAs from the coronary circulation and 50-70% of 
the energy consumed by the heart muscles is derived from oxidation of 
FFAs. Epicardial fat, due to its high lipolytic activity and ability to release 
FFA, may be a ready local source of energy for the myocytes during 
periods of high metabolic demand (Marchington et al. 1989). It is also 
proposed that epicardial adipose tissue acts as a buffer to protect the 
myocardium against exposure to excessive levels of FFAs in the 
coronary circulation (Iacobellis and Bianco 2011). By scavenging 
excess FFAs from the coronary circulation and the myocardium itself, 
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and incorporating them in to the intracellular compartment, epicardial 
adipocytes may act a barrier against toxic levels of FFA in the 
myocardium and local coronary circulation (Iozzo 2011).  
Additionally, fat around the heart may have endocrine and/or paracrine 
functions. Adipokines produced by epicardial adipocytes in close 
contact with the coronary vascular adventitia could directly enter the 
coronary circulation by diffusion across the vessel wall and be 
transported downstream. These molecules could also diffuse in to the 
interstitial fluid of the vessel wall and interact with the vasa vasorum, 
endothelial and vascular smooth muscle cells of the coronary arteries or 
travel further via the vasa vasorum to influence other parts of the 
coronary circulation. In lean individuals and in rodents, epicardial fat 
produces protective adipokines such as adiponectin (discussed in 
Section 1.5.1.2), nitric oxide (a potent vasodilator) and prostaglandin I2, 
an inhibitor of endothelial dysfunction (Fitzgibbons and Czech 2014). 
1.10.3 Role of pericardial adipose tissue in cardiovascular 
pathologies  
Under physiological conditions, epicardial adipose tissue is a 
mechanical and possibly biochemical cardio-protective organ, as 
discussed above. However in pathological circumstances, particularly 
when present in excess as in obese individuals, epicardial fat can affect 
the heart and coronary arteries through vasocrine or paracrine secretion 
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of proinflammatory cytokines (Sacks and Fain 2007, Clement et al. 
2009). Atherosclerotic plaques do not develop in myocardial bridges 
where the vessel walls are free of adipose tissue (Ishii et al. 1998) 
suggesting that the local influence of epicardial adipocytes may be 
required for genesis of atherosclerotic plaques.  
Increase accumulation of fat in the pericardial depot in obesity is 
accompanied by structural and functional changes in the adipocytes 
such as cellular hypertrophy, increased lipolysis and a reduction in 
ability to incorporate triglycerides. (Fitzgibbons and Czech 2014). The 
adipose tissue is invaded by increased numbers of inflammatory cells 
such as macrophages with a resultant increase in secretion of pro-
inflammatory cytokines (Mazurek et al. 2003) and reduction in 
production of anti-atherosclerotic adipokines such as adiponectin (Greif 
et al. 2009). In this setting, the beneficial paracrine effects of epicardial 
adipose tissue are lost and the adipocytokines released from epicardial 
adipocytes can readily reach cardiac myocytes and coronary vessels 
(as described in Section 1.10.2) to produce a pro-inflammatory effect 
which may contribute  to the pathophysiology of coronary vascular 
diseases (Clement et al. 2009).  
1.10.3.1 Evidence of association of pericardial adiposity with 
cardiovascular disease in humans 
Adipose tissue around the heart has been of interest to physicians for 
TXLWHVRPHWLPHZLWKUHSRUWVRI³IDWW\KHDUW´DVWKHFDXVHRIVXGGHQ
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death in the Victorian era (Bedford 1972). More recent epidemiological 
data provide evidence for association between pericardial adipose 
tissue volume and several cardio-metabolic pathological conditions 
(Ding et al. 2008, Ding et al. 2009, Greif et al. 2009). Pericardial 
adipose tissue volumes correlate with several cardiovascular metabolic 
risk factors such as hypertension, blood glucose and lipid profile and 
with the presence of coronary artery calcification (Rosito et al. 2008). 
They are more closely associated with coronary artery disease than 
other adipose tissue depots (Taguchi et al. 2001). The prevalence of 
cardiovascular and coronary heart diseases are associated with 
pericardial fat despite adjustment for age, sex, body mass index, waist 
circumference (Ding et al. 2009, Mahabadi et al. 2009). Associations 
have been reported with coronary artery calcification (Liu et al. 2010) 
and severity of coronary artery disease (Taguchi et al. 2001). 
Additionally, this depot of fat appears to affect cardiac function as there 
is evidence that in obese subjects, as pericardial adiposity increases, 
cardiac function decreases (Ruberg et al. 2010).  
A meta-analysis of 15 case control studies (total number of participants 
= 2872) investigating the relationship between epicardial adiposity and 
coronary artery disease found that epicardial fat thickness was higher in 
the patients than in controls and those with coronary plaques had 
significantly higher epicardial fat volumes as compared to those without 
plaques (Xu et al. 2012). Similarly, meta-analysis of studies that 
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measured epicardial fat in patients with or without the metabolic 
syndrome demonstrated that those with the metabolic syndrome have 
significantly higher volumes of epicardial fat (Pierdomenico et al. 2013).  
Pericardial adipose tissue is highly correlated with abdominal and other 
visceral adipose tissue depots (Mahabadi et al. 2009). Some authors 
have suggested that it is possible that pericardial adiposity is a marker 
of general visceral adiposity and its correlation with cardiometabolic risk 
factors could merely be a reflection of general adiposity rather than an 
independent marker of obesity or cardiovascular diseases (Liu et al. 
2010). However, evidence from multifactorial analyses suggests that 
pericardial fat is associated with incident cardiac events independent of 
traditional risk factors and anthropometric measures of obesity (waist 
circumference and BMI) and visceral abdominal adiposity (Ding et al. 
2009, Mahabadi et al. 2009, Thanassoulis et al. 2010). Despite this 
controversy, pericardial adipose tissue remains an important visceral fat 
depot whose proximity to coronary vasculature suggests that it may 
have a paracrine role in the pathogenesis of cardiovascular disease 
and, therefore, may be important in evolution of metabolic syndrome. 
The exact relationship between pericardial adipose tissue and 
cardiovascular pathologies and the metabolic syndrome remains to be 
unravelled. Further research is required to investigate the potential role 
of fat around the heart in the pathophysiology of cardiovascular illness.  
60 
 
1.10.4 Pericardial adipose tissue is a BAT depot in adult 
humans 
Although pericardial fat has the gross appearance of white fat in human 
adults, some of its components, particularly epicardial fat, evolves from 
BAT and has recently been shown to express high levels of UCP1 
mRNA (Sacks et al. 2009). 
In adipose tissue samples collected from 28 patients undergoing 
coronary artery bypass grafting (CABG) for critical coronary 
atherosclerosis, Sacks and colleagues found that UCP1 gene 
expression was 5-fold higher in EAT when compared to substernal fat. 
UCP1 gene expression was even lower (barely detectable) in samples 
taken from subcutaneous adipose tissue from the sternum, abdomen 
and leg (Sacks et al. 2009). The gene expression of other BAT related 
JHQHV35'0DQG3*&ĮZHUHDOVRKLJKHULQ($7ZKHQFRPSDUHG
to subcutaneous fat (Sacks et al. 2009). These findings raised the 
possibility that epicardial fat may be a depot of BAT. However, 
demonstration of gene expression of UCP1 is not conclusive evidence 
of presence of BAT as gene expression does not necessarily equate to 
presence of functional protein (Nedergaard and Cannon 2013). Further 
research to demonstrate the BAT specific protein, UCP1, in pericardial 
adipose tissue is required to confirm that brown fat is present in the fat 
depot around the heart.  
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1.11 Use of animal models 
Epidemiological data from human populations have provided ample 
evidence of the links between early life nutrition and later cardiovascular 
illness and obesity. Prospective investigations into human cohorts 
would be of enormous value to further elucidate this relationship and to 
obtain insight into the underlying mechanisms. However, such 
prospective studies would be complex, expensive and confounded by 
the influences of uncontrollable variables of genetic and environmental 
origin (Taylor and Poston 2007). Randomised trials of nutritional or 
behavioural modifications in pregnant women and young children are 
often unfeasible or ethically impossible and observational studies are 
fraught with confounding variables and the absence of appropriate 
controls (Symonds et al. 2000). It is, therefore, imperative to use animal 
models to explore the impact of in utero nutrition and post weaning 
environments on the development of adipose tissue.  
Nearly 50 years ago, Widdowson and McCance conducted some of the 
first experiments on rat models of altered early nutrition (Widdowson 
and McCance 1963) and since then several investigators have induced 
developmental programming of diseases and health in many animal 
species with use of diverse interventions ranging from alterations in 
maternal nutrition, placental function and modifications of postnatal diet 
and growth (Gillman 2005). Animal studies allow more comprehensive 
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elucidation of cellular changes which occur during the evolution of 
obesity and the mechanisms behind these changes can be studied in 
greater detail.  
1.11.1 Sheep as a model of developmental programming in 
humans  
Like humans, the sheep is a precocial species carrying one or two 
fetuses born, at term, after a long gestation (Symonds et al. 2007). 
Responses to changes in maternal nutrition at different periods of fetal 
and early neonatal development can be better clarified in a sheep 
model as the diet can be manipulated to coincide with precise periods 
of fetal organogenesis which are comparable with those during human 
fetal development (Festing 2006).  
The similarities between sheep and humans also include a variety of 
metabolic functions, particularly in BAT development and function. Both 
species are precocial thermoregulators, BAT is most abundant at the 
time of birth and nonshivering thermogenesis is activated immediately 
after birth in both the species (Symonds et al. 2003).  
In addition, both humans and sheep have mature HPA axes (Fowden et 
al. 1998) and the central neural network of regulation of appetite and 
energy balance (Muhlhausler et al. 2004) is already developed at time 
of birth. Other factors such as organ growth rates, fetal metabolic rate 
and protein turnover are also similar between the two species.  
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In contrast, rodents are small, litter bearing, altricial species with shorter 
gestation and an HPA axis which develops in the postnatal period 
(Bouret et al. 2004). The neural pathways and endocrine mechanisms 
that modulate energy balance and adipose tissue development are 
largely developed in late gestation in both sheep and humans, whilst a 
large part of this development occurs during the postnatal period in 
rodents. Therefore, sheep provide a model for studying the 
developmental programming effects of nutritional variations in early life 
which is more closely aligned to humans. 
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1.12 Hypotheses and aims 
1.12.1 Chapter 3 
Given that UCP1 gene is expressed in epicardial depot of adult humans 
(Sacks et al. 2009), I hypothesised that BAT is present in pericardial 
adipose tissue in newborn sheep.  
Maternal nutrition during different phases of gestation affects 
expression of UCP1 gene and UCP1 abundance in perirenal BAT in the 
fetus (Clarke et al. 1997, Budge et al. 2004). I hypothesised that 
maternal nutrient restriction during late gestation, coincident with 
maximal growth of the fetus, would compromise the abundance and 
development of BAT in the newborn over the first month of life.  
1.12.2 Chapter 4 
Suboptimal nutrition of the fetus during active period of adipogenesis 
may programme later adipose tissue dysfunction such that, in 
adulthood, these adipocytes have an enhanced lipogenic and 
proliferative potential which ultimately leads to obesity (Symonds et al. 
2012). Excess accumulation of fat in the pericardial depot has been 
associated with a number of cardiovascular risk factors (Taguchi et al. 
2001, Ding et al. 2008). 
In the study described in Chapter 4, I hypothesised that, in fetal sheep, 
suboptimal maternal nutrition between early-to-mid gestation followed 
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by ad libitum feeding until term will increase fetal adiposity and 
upregulate the expression of genes which control adipogenesis. 
1.12.3 Chapter 5 
Given that in adult humans, relatively high levels of UCP1 gene 
expression is present in EAT, I hypothesised that UCP1 is significantly 
more abundant in EAT when compared to other adipose tissue depots 
thus confirming that epicardial fat is a depot of BAT in adult humans. 
1.12.4 Chapter 6 
I hypothesised that BAT is present in epicardial depot in infants and 
children and, given that gene expression of UCP1 in human adults is 
inversely proportional to BMI and is higher in women than in men 
(Cypess et al. 2009), that the gene expression of UCP1 is correlated 
with age and weight for age and is higher in girls than in boys. I also 
hypothesised that UCP1 gene expression will be higher in children of 
Caucasian origin when compared to children of Asian (Indian sub-
continent) origin.  
Propranolol is a non-VHOHFWLYHȕ-adrenergic antagonist. As discussed in 
Section 1.6.3, development and metabolism of brown fat as well as 
UHJXODWLRQRI8&3JHQHLVPDLQO\UHJXODWHGE\ȕ-adrenergic receptors 
(ADR) (Cannon and Nedergaard 2004). Therefore, I hypothesised that 
gene expression of UCP1 is downregulated in children receiving regular 
propranolol therapy. 
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2 Materials and methods 
2.1 Procedural and legislative declaration and ethical 
approvals 
2.1.1 Approvals for the animal experiments 
All animal experiments performed in the studies included in this thesis 
were conducted in accordance with the UK Home Office and UK 
Animals (Scientific Procedures) Act (1986) by Professor M.E Symonds 
under Home Office Project Licence Numbers 40/2925, 40/3346 and 
PPL 40/3560. In addition, all experimental procedures were completed 
with ethical approval from the University of Nottingham. 
2.1.2 Approvals for the human studies 
2.1.2.1 Study of brown adipose tissue in epicardial fat of adult 
humans 
Samples included in the study of brown adipose tissue in epicardial fat 
of human adults (Chapter 5) were obtained from participants in the 
Human Epicardial Fat Adipokines and Coronary Atherosclerosis study. 
Ethical approval for this study was obtained from the Baptist Memorial 
Health Care Corporation Institutional Review Board (Appendix 10.1.1) 
and samples were collected after taking written informed consent from 
participants. Adipose tissue samples preserved in dry ice were 
transferred from the Baptist Memorial Health Care Corporation, 
Memphis, Tennessee, to the University of Nottingham. The transfer was 
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conducted with an appropriate tissue transfer agreement between the 
two institutions and all procedures including the storage and transfer of 
the tissue samples were performed in keeping with the Human Tissue 
Act (HTA) 2004. 
2.1.2.2 Study of brown adipose tissue in pericardial fat of 
newborns, infants and children 
The sample collection for the study of pericardial adipose tissue in 
children was conducted with ethical approval from National Research 
Ethics Service Committee (NRES) East Midlands ± Nottingham 2 (REC 
reference number: 12/EM/0214) (Appendix 10.1.2). Further to this, the 
study had institutional approval from the University Hospitals of 
Leicester. The samples were collected only after obtaining informed 
consent from the parents/guardians of the participating children and 
from any young person themselves, if they were deemed by their 
clinical team to possess the capacity to give informed consent. After 
collection, the samples were temporarily stored at the Biomedical 
Research Unit, Glenfield Hospital and transferred by myself or Mrs. 
Victoria Wilson to Academic Child Health, University of Nottingham 
within seven days of sample collection. A tissue transfer agreement, 
under the Human Tissue Act (HTA), was in place to allow the transfer of 
samples from the Glenfield Hospital, University Hospitals of Leicester to 
the University of Nottingham. All procedures including the storage and 
transfer of the tissue samples were performed under the Human Tissue 
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Act (HTA) 2004 and both the Biomedical Research Unit, Glenfield 
Hospital and Academic Child Health, University of Nottingham are HTA 
approved facilities. 'DWDRQSDUWLFLSDQW¶VDJHZHLJKWKHLJKW
medications and other medical conditions were collected as detailed in 
the protocol agreed by the National Research Ethics Service Committee 
(NRES) East Midlands ± Nottingham 2 (REC reference number: 
12/EM/0214). 
2.2 Animal experiments  
2.2.1 Experimental procedure: Effect of maternal nutrient 
restriction on UCP1 and other BAT associated genes 
in pericardial adipose tissue of newborn sheep 
This study (Chapter 3) was undertaken at the University of Nottingham, 
United Kingdom. Animal procedures were performed by Dr Sarah 
Pearce and Professor Michael Symonds. 
Seventeen twin-bearing Border Leicester cross Swaledale sheep of 
similar age, body weight, and fat distribution, and with a known mating 
date were group housed and fed to fully meet their total metabolic 
requirements. At 110 day of gestation, each was individually housed 
and randomly assigned to a nutrition group. Eight mothers were fed and 
consumed 100% of total metabolisable energy requirements for 
maternal body weight and stage of pregnancy, whereas the remaining 
nine were nutrient restricted and fed with 60% of total metabolisable 
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energy requirements until term. The diet comprised chopped hay and 
concentrates and was provided in a 3:1 ratio. All animals had continual 
access to minerals, thus ensuing adequate intake of all vitamins and 
minerals regardless of nutrition group. All mothers delivered twins 
naturally at term. Colonic temperatures were recorded form each lamb 
around the time of birth and all remained normothermic (i.e. between 39 
and 40 Û& 
One offspring was randomly selected for tissue sampling within 12 
hours of birth (day 0) and underwent humane euthanasia by 
intravenous injection of barbiturate (200 mg/kg pentobarbital sodium; 
Euthatal; RMB, Animal Heath, U.K.). Subsequently, each mother reared 
a single lamb until it was 30 days old, during which time mothers were 
fed hay ad libitum and up to 1 kg of concentrate throughout lactation. 
This procedure had no differential effect on the growth of the remaining 
twin or maternal milk production and the second lamb was humanely 
euthanased (as above) and tissue samples at 30 days postnatal age. At 
tissue sampling, pericardial adipose tissue was immediately dissected, 
placed in liquid nitrogen, and stored at -Û&XQWLOIXUWKHUDQDO\VLV$OO
operative procedures and experimental protocols had the required 
Home Office approval as designated by the U.K. Animals (Scientific 
Procedures) Act (1986) and detailed in Section 2.1.1.  
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2.2.2 Experimental procedure: Suboptimal maternal nutrition 
during early-to-mid gestation in the sheep enhances 
pericardial adiposity in the near-term fetus 
The animal procedures for this study (Chapter 4) were performed by Dr 
Lindsay Heaseman and Professor Michael Symonds. Animal protocols 
were designed in accordance with the Animals (Scientific Procedure) 
Act, 1986 under Home Office supervision as described in Section 2.1.1.  
With U.K. Home Office regulatory approval, twelve pregnant Welsh 
Mountain sheep of similar age (median, 3 years), body weight, and fat 
distribution were mated with one of two Texel rams on a known mating 
date and then group housed and fed 100g concentrate/day with access 
to hay ad libitum. All 12 sheep were carrying one fetus each and at 28 
GD\VRIJHVWDWLRQHDFKVKHHSZDVLQGLYLGXDOO\KRXVHG7KHDQLPDOV¶
metabolisable energy (ME) requirement was calculated according to 
body weight, taking into account the requirements for both maternal 
maintenance and growth of the conceptus on the basis of producing a 
4.5kg lamb at term (147 days of gestation) (AFRC 1993). Five mothers 
were randomly assigned to the control group (C) and were fed, and 
consumed, 100% of their total ME requirements, whereas the remaining 
seven were nutrient restricted (NR) and fed with 60% of total ME 
requirement (i.e. a 40% global reduction in macronutrient content) until 
80 days of gestation. Sheep in both groups were then fed to appetite for 
the remaining period of gestation.  
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After 80 days, animals in both groups consumed 8-10.9 MJ/d i.e. 150% 
of their total ME requirement for that stage of gestation. The diets 
contained hay to concentrate in approximately a 3:1 ratio with respect to 
dry weight and had adequate minerals and vitamins. At 140 d gestation, 
each sheep was humanely euthanased by intravascular administration 
of 100mg/kg Phenobarbital sodium (Euthathal (200mg/g Phenobarbital 
sodium), RMB Animal Health, UK). The entire uterus was removed, and 
the fetus was similarly euthanased. Pericardial, and all other, adipose 
tissues were completely dissected, weighed, placed in liquid nitrogen, 
and stored at -80°C until processed and analysed as detailed below. All 
operative procedures and experimental protocols had the required U.K. 
Home Office approvals designated by the Animals (Scientific 
Procedures) Act (1986). 
2.3 Human Studies  
2.3.1 Epicardial fat is a depot of brown adipose tissue in 
adult humans 
The adipose tissue samples for this study (Chapter 5) were provided by 
Professor Harold Sacks and were collected from patients undergoing 
cardiac surgery at The Baptist Heart, Baptist Memorial Hospital, 
Memphis, Tennessee.  
Samples of adipose tissue were taken from EAT (from near the region 
of the right coronary artery), paracardial fat (from the anterior 
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mediastinum), substernal fat, upper abdominal and lower extremity 
subcutaneous adipose depots from individuals undergoing CABG. The 
samples were the remaining tissue from previous studies (Sacks et al. 
2009, Fain et al. 2010, Sacks et al. 2011) and had been preserved 
(frozen at -80°C). With appropriate ethical approval and in keeping with 
the Human Tissue Act 2004, the samples were transferred to the 
Academic Division of Child Health, University of Nottingham on dry ice 
and stored at -80°C until further analysis. 
2.3.2 Brown adipose tissue is present epicardial fat of 
newborn infants, children and adolescents 
Adipose tissue samples for this study (Chapter 6) were provided by Mr 
Attilio Lotto (Paediatric Cardiothoracic Surgeon) and his team. The 
samples were collected from children undergoing cardiac surgery at the 
East Midlands Congenital Heart Centre at the Glenfield Hospital. All 
participants had congenital heart disease. 
Although, due to small volumes, it is difficult to consistently separate the 
fat present around the heart in infants and children in to epicardial 
adipose tissue (i.e. fat present between the myocardium and visceral 
pericardium) and paracardial adipose tissue (i.e. fat present between 
the visceral and parietal layers of the pericardium) at dissection (Greif et 
al. 2009, McAuley et al. 2011, Wong et al. 2011), the fat samples for 
this study were taken from as close to the myocardium as possible and 
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are therefore considered to be primarily epicardial adipose tissue 
samples.   
A sample of epicardial adipose tissue (approximately 5 grams) was 
collected during the dissection of the pericardium as a part of the 
standard process undertaken during cardiac surgery. Cardiac surgery is 
mostly performed through a median sternotomy. The pericardial sac is 
opened to reach the heart and great vessels and pericardiotomy is 
SHUIRUPHGDVDQLQYHUWHGµ7¶7KLVRSHQVWKHSHULFDUGLXPORQJLWXGLQDOO\
with an extension transversally at the level of the diaphragm. Adipose 
tissue is present in this area. A small sample from this fat depot, was 
removed taking care to obtain the sample from as close to the 
myocardium as possible. Approximately 3 grams of tissue were placed 
in a collection tube containing 20 ml of Allprotect Tissue Reagent® 
(Qiagen, West Sussex, UK) for RNA extraction and lipid analysis and 
another 2 grams were placed in a tube containing 3% formalin for 
immunohistochemistry. 
With appropriate ethical approval and in keeping with the Human Tissue 
Act 2004, the samples were transferred to the Academic Division of 
Child Health, University of Nottingham. The samples preserved in 
Allprotect Tissue Reagent® were transferred at room temperature. In 
the laboratory at Academic Child Health, University of Nottingham, the 
samples were removed from the solution, snap frozen in liquid nitrogen 
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and then stored at -80°C until further analysis. The formalin-fixed 
samples were transferred and stored at room temperature until further 
analysis.  
2.4 Laboratory procedures 
All chemicals, reagents and laboratory procedures were assessed and 
LPSOHPHQWHGLQFRPSOLDQFHZLWKWKH8.+HDOWKDQG6DIHW\([HFXWLYH¶V
Control of Substances Hazardous to Health (COSHH, SI NO. 1657, 
1988) and Risk Assessment guidelines. Laboratory procedures were 
carried out at the Academic Child Health Department, School of 
Medicine, University of Nottingham. The procedures used in the study 
were either as recommended by the manufacturers and suppliers or 
optimised within Academic Child Health by myself, Mr M Pope and Mrs. 
V Wilson. All materials were purchased from Sigma-Aldrich (Poole, 
Dorset, UK) unless otherwise specified. Details of suppliers are given in 
Appendix 10.5. 
To maintain the integrity of the tissue, all sheep pericardial adipose 
WLVVXHVDPSOHVZHUHµVQDS¶IUR]HQLQOLTXLGQLWURJHQDQGVWRUHGDW-Û&
until further analysis. Human adipose tissue samples obtained during 
cardiac surgery were immediately emerged in Allprotect Tissue 
Reagent® (Qiagen, West Sussex, UK) and stored at room temperature. 
Within one month of collection, the samples were snap frozen and 
stored at -80°C until further analysis. Each individual tissue sample was 
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stored in labelled double bags and stored in the -Û&IUHH]HUVLQWKH
laboratories of Academic Child Health, University of Nottingham. 
2.4.1 Tissue analysis 
All experiments were performed with precautions to minimise 
contamination of samples and reagents. All equipment used was either 
taken from sterile packs or autoclaved. Filter tips used were sterile and 
all work was carried out wearing gloves. The work space and 
equipment were cleaned with 70% denatured ethanol (Ecolabs, Surrey, 
U.K) and RNAase ZAP® (Ambion, California, USA). Sterile nuclease 
free water (Ambion, Inc, UK) was used for all dilutions and experimental 
preparations. Tissue samples were removed from -80°C freezers and 
transferred on dry ice prior to processing. The desired amount of the 
sample was dissected and placed in labelled containers for later use. 
Remaining samples, if any, were returned to -80°C for storage until 
needed. All experimental work was performed on ice. 
2.4.1.1 Total ribonucleic acid extraction from tissue samples 
2.4.1.1.1 Principle 
To extract total ribonucleic acid (RNA) from tissue, samples are lysed 
and homogenised in a buffer solution that contains guanidine-
isothiocyanate and phenol in a monophase. This causes the denaturing 
and dissolution of all proteins and inhibition of any RNAase activity, 
ensuring that intact RNA will be obtained at the end of the process. This 
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method is adapted from the published and widely used single step 
acidified phenol-chloroform homogenisation method (Cox and Arnstein 
1963). Addition of chloroform and brief incubation followed by 
centrifugation separates the mixture into three layers - the top clear 
aqueous phase has RNA dissolved in it, the intermediate phase has the 
DNA and the lower phase has the dissolved proteins. The upper 
aqueous phase, the aqueous RNA solution, is treated with ethanol to 
provide appropriate binding conditions and then purified by RNA 
centrifuge column where total RNA (>100µg) binds to the membrane. 
Further washing with ethanol and guanidium salt-based buffers 
removes any contamination and final elution of RNA can be performed 
using nuclease-free water. 
2.4.1.1.2 RNA extraction procedure 
For analysis, each sample of adipose tissue was identified by the 
animal/participant number and transferred into a dry ice box. Adequate 
amount of tissue (1000mg) was chopped from each sample and placed 
into Dispomix tubes (Medic Tools, Zurich, Switzerland) on dry ice. For 
the animal studies, approximately 500mg of each tissue sample was 
processed for RNA extraction and for the human studies 100mg was 
processed due to the limited amount of samples available. The 
Dispomix tubes were labelled with randomly allocated numbers to avoid 
any bias during the experiments.  
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Two millilitres of TRI® reagent (Sigma Chemical Co. Poole, UK) was 
added to each sample and the samples were then allowed to thaw on 
ice. Each sample was homogenised in the Dispomix homogeniser 
(Medic Tools, Zurich, Switzerland) at 3000rpm for 40 seconds. The 
homogenate was centrifuged at 3000g for 1 minute and incubated in a 
ZDWHUEDWKDWÛ&IRUPLQXWHV7KHKRPRJHQDWHZDVPL[HGE\
vortexing five times over 30 seconds and centrifuged at 2500g for 5 
minutes at room temperature. The lower aqueous phase was 
transferred into a 2ml eppendorf tube anGȝORIFKORURIRUPZDV
added to it. The solution was mixed by vortexing and allowed to 
incubate at room temperature for 10 minutes. The mixture was further 
FHQWULIXJHGDWJIRUPLQXWHVDWÛ&7KLVFHQWULIXJDWLRQ
separated the mixture into 3 phases such that the upper aqueous phase 
contained the RNA. This was carefully aspirated and placed in a 1.5ml 
eppendorf tube. An equal volume of 70% chloroform (analytical-grade 
chloroform (Fisher Scientific, Leicestershire, UK)) was added and mixed 
by vortexing. 
The following steps of RNA purification were carried out using the 
RNeasy Plus® kit (Qiagen, West Sussex, UK). The RNeasy Plus® 
Universal kit was used for the animal studies while the RNeasy Plus® 
Mini kit was used for RNA extraction form the human adipose tissue 
samples. RNeasy spin columns were prepared for each sample and 
ȝORIWKHVDPSOHDGGHGWRWKHFROXPQ7KHFROXPQZDVFHQWULIXJHG
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at 8000g for 15 seconds and the flow through discarded. This step was 
repeated until the total sample volume (iQȝODOLTXRWVSDVVHG
through the column. The membrane in the RNeasy spin column bound 
all the RNA and the contaminants were washed away in the flow 
WKURXJK1H[WȝORI%XIIHU5:ZDVDGGHGWRHDFK51HDV\VSLQ
column and the column centrifuged at 8000g for 15 seconds to wash 
the spin column membrane. The flow-through was discarded. In the 
QH[WVWHSȝORI53(EXIIHUZDVDGGHGWRWKH51HDV\VSLQFROXPQ
which was then centrifuged at 8000g for 15sec and the flow through 
GLVFDUGHG$QRWKHUȝORI53E buffer was added to the RNeasy spin 
column which was centrifuged at 8000g for 2 minutes and the flow 
through discarded. The RNeasy spin column was centrifuged at 8000g 
for 1 minute in a fresh collection tube to eliminate any possible 
carryover of buffer RPE and to remove any residual flow-through which 
might remain on the outside of the RNeasy spin column. In all these 
steps, the RNeasy spin column was always removed carefully so that 
the column did not come in contact with the flow through and the 
collection tube was always emptied completely. The collection tubes 
were discarded and RNeasy spin column placed in a new 1.5ml 
HSSHQGRUIWXEH7RHOXWHWKH51$IURPWKH51HDV\VSLQFROXPQȝO
of RNase-free water was added to the centre of the column membrane 
and the column centrifuged for 1 minute at 8000g. This step was 
repeated by adding the solvent back to the spin column and repeating 
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the centrifugation to increase the RNA yield. The spin column was then 
discarded.  
2.4.1.1.3 Determination of RNA concentration purity and integrity 
RNA concentration and purity measurements were determined using a 
Nanodrop®ND-1000 (Nanodrop Technologies, Wilmington, USA) 
spectrophotometer. The ratio of the optical density (OD) at 260 and 280 
nm were measured by spectrophometry and a ratio of 1.8-2.2 was 
considered an acceptable indicator of good RNA quality (Manchester 
1996). 
RNA obtained from human adipose tissue were further analysed for 
RNA integrity by the Agilent 2100 Bioanalyzer (Agilent Technologies, 
USA). RNA samples were electrophoretically separated on a micro-
fabricated chip and subsequently detected via laser induced 
fluorescence detection. The use of a RNA ladder as a mass and size 
standard during electrophoresis allowed the estimation of RNA band 
sizes and integrity of the RNA was assessed by visualisation of the 18S 
and 28S ribosomal RNA bands (Figure 2.1). The Bioanalyzer 2100 
software calculated the RNA integrity number (RIN) based on the shape 
of the curve in the electropherogram and samples were selected for 
microarray if the RIN was >7 and intact 18S and 28S bands were 
processed. 
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The extracted RNA was diluted to 1µg/µl to normalise samples for 
quantitative reverse transcription (RT) and stored in appropriately 
labelled tubes at -Û&XQWLOIXUther analysis.  
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Figure 2.1 Chromatograms of micro-capillary electrophoresis from 
two RNA samples showing different degrees of degradation 
Sample 2 had a RNA integrity number (RIN) of 8.2 and the 
electropherogram is typical of high-quality RNA showing a clearly visible 
28/18S ribosomal RNA peak ratio and a small 5S RNA. Sample 22 is 
degraded (RIN = 2.2) as indicated by a shift in the electropherogram to 
shorter fragment sizes and decrease in fluorescent signal as dye 
intercalation sites are destroyed.
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2.4.1.2 Reverse Transcription polymerase chain reaction (RT-PCR) 
2.4.1.2.1 Principle of Reverse transcription polymerase chain 
reaction  
By utilising proper reverse transcription reagents, RNA can be 
transcribed into single-stranded complementary deoxyribonucleic acid 
(cDNA). Following this, DNA polymerisation can amplify this result to 
form multiple copies of the cDNA. 
The extracted purified mRNA is mixed with primers, deoxynucleotide 
triphosphatase (dNTP) mix, Reverse Transcriptase, DNA polymerase 
and RNAase inhibitors. All mRNAs have a poly-A terminal end. The 
reaction is initiated by annealing the oligo-dT primer to its 
complimentary sequence on the mRNA strand where further elongation 
and transcription of the first cDNA strand occurs by the enzymatic 
action of Reverse Transcriptase. The template strand of mRNA is then 
removed by RNAse and the cDNA strand is free for amplification by 
PCR (Figure 2.2). This produces cDNA strands that can be utilised for 
quantitative polymerase chain reactions (Q-PCR). 
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Figure 2.2. Reverse Transcription  
Messenger RNA (mRNA) strands have a poly A tail to which the oligo-
dT primer anneal. Reverse transcriptase enzyme then adds the 
complementary nucleotides to synthesise the complementary DNA 
(cDNA) strand. Action of RNAse removes the mRNA and releases the 
cDNA for further amplification by polymerase chain reaction. 
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2.4.1.2.2 Procedure for Reverse transcription polymerase chain 
reaction  
RT-PCR was performed using the High Capacity RNA-to-cDNA kit 
(Applied Biosystems, Warrington, UK). The kit components were stored 
at -20°C and allowed to thaw on ice prior to the reactions. Two sterile 
0.2ml eppendorf tubes were labelled for each sample, one for the 
reverse transcription (RT+) reaction and one for a no-reverse 
transcription enzyme control (RT-) to ensure transcription efficiency. In 
each tube, 2µg of total mRNA was mixed with 10µl of 2X RT Buffer. 
One microlitre of 20X enzyme mix was added to the RT+ tube and 
volume in both the tubes made up to 20µl by adding nuclease-free 
water. The reaction mixture was centrifuged for 1 minute at 5000g and 
incubated for 60 minutes at 37°C followed by heating to 95°C for 5 
minutes and holding at 4°C in the Techne Touchgene Gradient thermal 
cycler (Techne Incorporate, New Jersey, USA). The cDNA prepared by 
this process was stored at -20°C. 
2.4.1.3 Quantitative Polymerase Chain Reaction 
2.4.1.3.1 Principle of Quantitative Polymerase Chain Reaction 
Polymerase chain reaction (PCR) was developed by Kary Mullis in 1983 
as a revolutionary technique that can amplify a single segment of DNA 
and create billions of copies within few hours. The reaction is initiated 
by annealing of an oligonucleotide sequence, called the primer, to 
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single stranded DNA. Primers are short pieces of custom built 
oligonucleotides which are a complementary match of the segment of 
the DNA that is being copied. Enzymes called DNA polymerase attach 
near the end of the annealed primer and elongate the chain by adding 
more nucleotides. Naturally occurring DNA polymerases are denatured 
at higher temperatures. The DNA polymerase used in laboratories, Taq 
polymerase, is derived from Thermus aquaticus, a thermophilic 
bacteria, and works at 72°C. Amplification of the target sequence 
occurs by repeated cycles of heat denaturation of the double stranded 
DNA, annealing of primers to the complimentary sequence and 
extension of the annealed primer by the action of Taq polymerase. After 
each cycle the amount of DNA is doubled leading to an exponential 
increase. Thus, 2n, where n = the number of thermal cycles, strands of 
DNA are produced at the end of the PCR process (Figure 2.3). 
Quantitative PCR (Q-PCR), also called real-time PCR, allows the 
detection and quantification of a sequence of DNA or mRNA 
simultaneously, without the need for additional steps such as Northern 
blotting. This reduces the time, expenditure, and probability of 
contamination and removes the use of hazardous reagents such as 
ethidium bromide (Kochanowski and Jilg 1999). The simplest method 
involves a DNA binding fluorescent dye, SYBR Green which adheres to 
minor groves on the DNA and fluoresces at a much higher intensity 
when bound to DNA, compared with the dye in free solution (Denman 
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and McSweeney 2005). As the amplification occurs, more copies of the 
DNA are produced and bind to the dye and the resulting intensity of the 
fluorescent signal is proportional to the amount of DNA. The detector 
unit within the Q-PCR instrument will only detect the signal when a 
certain threshold of fluorescence is crossed. The instrument is 
programmed to calculate the baseline, defined as the PCR cycles in 
which a reporter fluorescent signal is accumulating but is beneath the 
limits of detection of the instrument (this is generally from cycles three 
to 15). The computer then determines an arbitrary threshold calculated 
as ten-times the standard deviation of the average signal of the 
baseline fluorescent signal between cycles three to 15. This threshold 
of fluorescence is then used to determine the cycle threshold (Ct) or 
crossing point (Cp) that is the fractional PCR cycle number at which the 
reporter fluorescence is greater than the minimal detection level 
determined by the programme i.e. the threshold fluorescence (Arya et 
al. 2005). The more the number of templates at the start of the reaction, 
the fewer number of cycles needed to cross the threshold and hence Ct 
can be used as the parameter for quantification of initial amount of the 
target template.  
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Figure 2.3. Polymerase chain reaction with Taq polymerase 
$WÛC, the dsDNA (double stranded DNA) denatures into two 
VHSDUDWHVWUDQGV6XEVHTXHQWFRROLQJWRÛ&DOORZVWKHSULPHUVWR
hybridise to the complimentary DNA strands. The sample mixture is 
WKHQUHKHDWHGWRÛ&WRDOORZ7DTSRO\PHUDVHWRV\QWKHVLVHWKH
complementary strands from the primer. The cycle is repeated starting 
ZLWKKHDWLQJWKHPL[WXUHWRÛ&DJDLQ
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2.4.1.3.1.1 The standard curve 
The plot of the log of initial target copy number for a set of known 
standard serial dilutions versus Ct is a straight line (Higuchi et al. 1993). 
This curve, called the standard curve (Figure 2.4) is used to determine 
WKHTXDQWLW\RIDPRXQWRIWKHWDUJHWLQWKH³XQNQRZQ´VDPSOHVRI
interest. The instrument measures the Ct of the unknown samples and 
uses the Ct of the known dilutions on the standard curve to quantify the 
amount of target in the unknown sample (Arya et al. 2005). Generation 
of the standard curve also enables the calculation of efficiency of the 
reaction (E) and correlation coefficients (R2) of the duplicate samples 
and acts as a positive control for verification of the experiment.
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Figure 2.4. Standard Curve  
A linear graph of the exponential polymerase chain reaction is created 
by plotting the cycle number at cycle threshold against logarithm of the 
known dilution series. The standard dilutions are generated by using 
duplicated ten-fold serial dilutions of purified template of the target 
cDNA. The assays have a six log linear dynamic range from 10-2 to 10-7 
copies of the template cDNA.  
90 
 
2.4.1.3.1.2 Excluding non-specific products of PCR 
It is important to note that SYBR green will indiscriminately bind to any 
strand of DNA and the assay must be optimised so that only the specific 
target of interest is amplified and that non-specific products such as 
primer dimers are excluded. The Q-PCR instrument performs a 
GLVVRFLDWLRQFXUYHDOVRFDOOHGWKH³0HOW&XUYH´DQDO\VLVDIWHUWKH
completion of the cycles by monitoring the loss of fluorescence signal, 
as the temperature is slowly raised from 60°C to 95°C causing the 
double-stranded amplicon to dissociate at a given melting temperature 
to release the SYBR green (Denman and McSweeney 2005). A single 
specific amplicon will dissociate at a single specific temperature, 
producing a single sharp dissociation curve (Figure 2.5). Presence of 
non-specific products can be discovered during this analysis by the 
presence of multiple or broader dissociation peaks. 
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Figure 2.5 Melt Curve  
A single peak of melting temperature of all the samples (A-H) indicates 
specificity of the product amplified. In this example, it is apparent that 
the melting temperature of all the amplicons occurs at the same 
WHPSHUDWXUHÛ&1RFRQWDPLQDWLQJSURGXFWVDUHSUHVHQWLQWKLV
reaction as contaminant DNA or primer dimers would show up as an 
additional peak separate from the desired amplicon peak  
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2.4.1.3.1.3  Quantification of gene expression 
To quantify gene expression in any experimental sample, it is important 
to correct the variation in starting RNA abundance. This can be 
achieved by analysing the expression of a gene, called the reference 
gene that is expressed at relatively constant high levels across all cells. 
Relative quantification of gene expression can then be determined 
using a mathematical model called the comparative threshold (2-ǻǻ&W) 
method (Livak and Schmittgen 2001). 2-ǻǻ&W gives the amount of the 
target gene in the sample, normalised to an endogenous reference 
gene and relative to the normalised-calibrator. To obtain valid and 
reliable results from this calculation, the amplification efficiencies of the 
reference and target gene must be approximately equal to each other 
and above 90% (Arya et al. 2005). 
2.4.1.3.2 Selection of the reference gene 
Errors can happen in Q-PCR reactions due to minor differences in the 
starting amount of RNA, quality of RNA or differences in efficiency of 
cDNA synthesis and PCR amplification. These can be minimised by 
using a reference gene, a cellular RNA that is amplified with the target 
and serves as an internal reference against which the target RNA 
values can be normalised. Genes such as 18S, GAPDH, IPO8 and 
YWAZ have been commonly used for this purpose. Theoretically, all 
these genes have a constant level of expression across all cells. 
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However, in practice, none of the genes are ideal references. Thus, 
multiple reference genes are analysed for each set and the crossing 
threshold values for each reference gene processed through the 
geNorm software v3.5 (Primer Design, Ltd, Southampton, UK). This 
software uses an algorithm of the geometric mean and pair wise 
variation of each gene compared to all other genes analysed, to 
calculate a stability value for each gene and selects the most suitable 
gene for use as reference gene (Vandesompele et al. 2002). 
2.4.1.3.3 Development of oligonucleotide primers for Q-PCR 
Primer sequences used in this study were either taken from previously 
published studies or designed in house using the Beacon Designer 4.0 
software (Premier Biosoft,Palo Alto, USA) by Mr Mark Pope and myself 
using sequences from the appropriate species from the National Centre 
for Biotechnology Information (NCBI) online database by Mr Mark Pope 
and myself. Primers were selected such that they flank exon boundaries 
in the intron sequence and have optimum annealing temperatures; 
guanine-cytosine base pair content and length were chosen to achieve 
the most favourable reaction conditions. The NCBI nucleotide Basic 
Local Alignment Search Tool (BLAST) database was used to further 
ensure selection of the correct sequence. DNA standards were 
prepared from the final products of a PCR run on 2% agarose gel 
electrophoresis and extracted using the QIA quick gel extraction kit 
(28704; Quigen, Crawley, UK). A standard curve was generated for 
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each gene to ensure uniformity, efficiency and accuracy for each 96-
well plate. Product validation for each primer was also confirmed by 
product size on gel electrophoresis and, when necessary, gene 
sequencing was performed with the results checked against known 
sequences on the GenBank Database (Benson et al. 2011). Primers 
were manufactured by and acquired from Sigma Aldrich as lyophylised 
power and stored in nuclease free water at a stock concentration of 
100µmol/l.  
All primer sequences used in this study are detailed in Table 2.1. 
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Table 2.1 PCR Primer Sequences for Sheep Studies 
Gene  Primer sequence Reference 
UCP1 
 
Forward 5¶-AGAGGTGGTCAAGGT CAG (Budge et al. 2004) Reverse ¶-ATTCTGTAAGCATTGTAAGTC C 
3*&Į  ¶-GTG TGT GTT TGC CTG GTT TG Primer design (UK) 
BMP7 Forward ¶-GTCCCAAG CGC CCAAGAAC (Pope et al. 2013) Reverse ¶-TGCCTCTGGTCGCTG CTG 
BMP4 Forward ¶- AGTCTGGGGAGGAGGAAGAG (Pope et al. 2013) Reverse ¶- GGGATGCTGCTGAGGTTAAA 
Leptin Forward ¶-CCA GGA TGA CAC CAA AAC C (Bispham et al. 
2003) Reverse ¶-TGG ACA AAC TCA GGA GAG G 
Adiponectin Forward ¶- ATCAAACTCTGGAACCTCCTATCTAC (Pope et al. 2013) Reverse ¶- TTGCATTGCAGGCTCAAG 
Ki67 Forward ¶-TCAGTGAGCAGGAGGCAGTA (Pope et al. 2013) Reverse ¶- GGAAATCCAGGTGACTTGCT 
RIP 140 Forward ¶- CGAGGACTTGAAACCAGAGC (Pope et al. 2013) 
Reverse ¶- TCTTAGGGACCATGCAAAGG 
33$5Ȗ Forward ¶- GACCCGATGGTTGCAGATTA (Pope et al. 2013) 
Reverse ¶- TGAGGGAGTTGGAAGGCTCT 
C/(%3ȕ Forward ¶- ACGACTTCCTCTCCGACCTC (Pope et al. 2013) 
Reverse ¶- CCCAGACTCACGTAGCCGTA 
IPO8 Forward ¶- GCCCTTGCTCTTCAGTCATT (Pope et al. 2013) 
Reverse ¶- GTGCAACAGCTCCTGCATAA 
HOXc9 Forward ¶- GACCTGGACCCCAGCAAC (Pope et al. 2013) 
Reverse ¶- GCTCGGTGAGGTTGAGAAC 
ȕ$'5 Forward ¶-CGCTCACCAACCTCTTCATC Developed in house 
Reverse ¶-CAC ACA GGC TCT CAA TGC TG 
ȕ$'5 Forward ¶-ATTGCCTCCTCCATT GTG TC Developed in house 
Reverse ¶-CATCCTGCTCCACTTGACTG 
ȕ$'5 Forward ¶-CGCCTCCAACATGCCCTAC Developed in house 
Reverse ¶-GCGTAGACGAAGAGCATCAC 
C/(%3Į Forward ¶-CTGGAGCTGACCAGTGACA (Pope et al. 2013) 
Reverse ¶-GGGCAGCTGACGGAAGAT 
GR Forward ¶-ACTGCCCCAAGTGAAAACAGA (Pope et al. 2013) 
Reverse ¶-ATGAACAGAAATGGCAGACATT 
PRLR1 Forward ¶-CTCCACCCACCATGACTGAT Developed in house 
Reverse ¶-CAGCGAATCTGCACAAGGTA 
DIO2 Forward AGCCGCTCCAAGTCCACTC Developed in house 
Reverse TTCCACTGGTGTCACCTCCT 
PRDM16 Forward GACGACCAGAACCTCACCAT Developed in house 
Reverse TCTTTCACATGGACCAGCAG 
KCNK3 Forward CCTTCTACTTCGCCATCACC Developed in house 
Reverse GTGCAGCAGGTACTTCACGA 
TGM2 Forward TTTCATGCTGGGTCAGTTCA Developed in house 
Reverse AACTTGGGGTTGACATCCAG
  
Abbreviations: UCP, Uncoupling protein; BMP, Bone Morphogenetic Protein; PPAR, 
peroxisome proliferator-DFWLYDWHGUHFHSWRU3*&33$5ȖFR-activator; TGM, Transglutaminase; 
KCNK3, potassium channel, subfamily K, membrane 3; PRDM16, PR (PRD1-BF1-RIZ1 
homologous)-domain-containing protein; HoX, Homobox; C/EBP, CCAAT-enhancer binding 
protein; DIO2, type 2 iodothronine deiodinase; ADRP, Adipose Differentiation Related Protein; 
ADR, adrenergic receptor; GR, glucocorticoid receptor; PRLR, prolactin receptor; RIP, 
Receptor interacting protein 
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2.4.1.4 Quantitative Polymerase Chain Reaction - procedure 
2.4.1.4.1 Hot start PCR procedure 
Conventional or classical PCR (cPCR) was performed for primer 
optimisation and creation of cDNA Q-PCR standards. Eppendorf tubes 
(200µl) were appropriately labelled and the reaction mixture was added 
per tube as given in Table 2.2. 
Table 2.2. Reaction mixture for classical PCR 
Step Volume per tube 
Random cDNA template or Nuclease-free water for 
negative control 
2 µl 
1:40 dilution of forward primer 4 µl 
1:40 dilution of reverse primer 4 µl 
PCR master mix (One TaqTM Hot Start Quick 
Load® 2X Master Mix with standard buffer (New 
England BioLabs inc. USA)) 
10 µl 
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Tubes were centrifuged for one minute at 10,000g and loaded in to the 
Techne thermal cycler and run at a 60°C hot start PCR programme 
(Table 2.3). The second phase repeats for 35 cycles. 
Table 2.3. Hot Start PCR programme. 
Process Temperature (°C) Duration (minutes) 
Initiation 105 4 
Enzyme activation 96 15 
Repeated for 35 cycles: 
  
Denaturing of cDNA strands 94 0.5 
Primer annealing 60 0.5 
Primer extension 72 1 
   
Final extension 72 7 
Hold 4  
The second phase of cDNA denaturation, primer annealing and 
extension is repeated for 35 cycles. 
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2.4.1.4.1.1 Agarose gel electrophoresis and DNA extraction 
Products of PCR can be analysed by separating them on an agarose 
matrix. The phosphate backbone of the DNA molecules makes them 
negatively charged. The fragments can thus be separated according to 
their size by the application of an electric field. Addition of an 
intercalating DNA dye such as ethidium bromide, which fluoresces 
when exposed to ultra-violet light, enables visualisation of the DNA 
EDQGVZLWKLQWKHPDWUL[3RVLWLYHFRQWURO'1$FDOOHG³'1$ODGGHU´LV
run simultaneously to identify the size of the unknown bands. 
The gel matrix was prepared by dissolving 2% w/v of agarose 
(electrophoresis grade) (Invitrogen Life Technologies) in TAE buffer 
(made from a stock solution of tris (hydroxymethy aminomethane base 
(tris), glacial acetic acid (Fischer Scientific), EDTA buffer), heated and 
mixed with 7µl of 10mg/ml ethidium bromide for visualisation, and 
cooled to form a gel. PCR products and DNA marker (ladder) (100bp 
Blue eXtendec Bioron, Ludwigshafen, Germany) were passed through 
the gel at 100V for 60 minutes. Ladder and PCR products were 
visualised under an ultraviolet (UV) trans-illuminator charged coupled 
device (CCD) camera (Fuji film luminescent image analyser LAS-1000 
v1.01). 
The fluorescent bands were cut out and cPCR products extracted and 
purified using the QIAquick Gel Extraction Kit (Qiagen, West Sussex, 
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UK). The gel bands were weighed and dissolved in Buffer QG by 
heating at 50°C for 10 minutes. Three volumes of Buffer QG were used 
for one volume of gel (assuming 100mg of gel ~ 100µl). One gel volume 
of isopropanol was added to the dissolved gel and mixed by vortex. The 
sample was then applied to the QIAquick column placed in a 2ml 
collection tube and centrifuged at 10,000g for 1 minute. The flow 
through was discarded and 0.5ml of Buffer QG was added to the spin 
column, centrifuged at 10,000g for 1 min and flow through discarded 
again. Following this, 0.75ml of Buffer PE was added to the spin column 
which was again centrifuged for 1 minute and the flow through 
discarded. The spin column was again centrifuged and any remaining 
flow through was discarded to remove any residual ethanol. To elute 
the PCR product, the QIAquick column was then placed in a clean 
1.5ml eppendorf tube and 30µl of Buffer EB was directly added on to 
the membrane. The column was allowed to rest for 1 minute and then 
centrifuged for 1 minute at 10,000g.  
Integrity and concentration of the PCR product was analysed using the 
Nanodrop®ND-1000 (Nanodrop Technologies, Wilmington, USA) 
spectrophotometer. All the extracted cDNA samples were diluted to 
1ng/µl and stores at -20°C until needed. 
Samples from newly designed primer products were sent for DNA 
VHTXHQFLQJZLWKLQWKH8QLYHUVLW\RI1RWWLQJKDP¶V&HQWUHIRU*HQHWLFV
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DQG*HQRPLFV4XHHQ¶V0HGLFDO&HQWUH1RWWLQJKDP8. and cross-
referenced against the NCBI online database. 
2.4.1.4.1.2 Q-PCR procedure 
2.4.1.4.1.2.1 Standard curve 
For each gene analysed, serial 1:10 dilutions were prepared from the 
1ng/µl template cDNA obtained from cPCR and gel electrophoresis. 
Dilutions up to and including 1X10-8 were prepared. These were run, in 
duplicate, with a negative (nuclease-free water) and positive control 
(random c-DNA sample) on a Q-PCR plate to verify the efficiency of the 
experiment. 
2.4.1.4.1.2.2 Q-PCR of unknown samples 
Samples and standards with a negative control were run in duplicate on 
a 96-well Q-PCR plate (Abgene, Thermo Fisher Scientific Inc. UK) in 
10µl aliquots. The reaction mixture was as given in Table 2.4. 
The PCR plates were sealed with an Abgene plate sealer and thermal 
seals (Alpha Laboratories, Hampshire, UK) and placed in the StepOne 
Plus Real Time PCR System (Applied Biosystems, Warrington, UK) and 
the Q-PCR run as per the protocol in Table 2.5. 
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Table 2.4. Q-PCR reaction mixture 
Reagent Volume per reaction 
SYBR® Green (Applied Biosystems, 
Warrington, UK) 5 µl 
1:40 dilution of forward primer 1 µl 
1:40 dilution of reverse primer 1 µl 
cDNA  3 µl 
 
Table 2.5. Q-PCR programme conditions 
Process Temperature Duration 
Initial denaturing of the 
cDNA strand  
95 °C 15 minutes 
 
Denaturing of cDNA strands 95 °C 15 seconds 
Annealing of the primers 58-62 °C 30 seconds 
(Above steps repeated for 45 cycles) 
Melt curve analysis 65 to 95 °C in 1 °C 
increments 
15 minutes 
(Above step repeated for 31 cycles) 
Hold 95 °C 10 minutes 
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2.4.1.5 Microarray analysis 
2.4.1.5.1 Principles of microarray analysis 
Microarray is an orderly arrangement of thousands of identified 
sequenced genes printed on an impermeable solid support, usually 
glass or silicon chip. Each sequenced gene corresponds to a fragment 
of genomic DNA, cDNA, PCR products or chemically synthesised 
oligonucleotides that represents a single gene. It is then used to run a 
high-throughput and versatile technology used for parallel gene 
expression analysis for thousands of genes of known and unknown 
function. 
RNA extracted from biological sample of interest is labelled to generate 
the target for the microarray. The mRNA extracted from the biological 
sample of interest and the reference is separately converted into cDNA 
using a reverse-transcriptase enzyme. This step also requires a short 
primer to initiate cDNA synthesis. Next, each cDNA is labelled with a 
different tracking molecule, often fluorescent cyanine dyes. The product 
is then purified to remove contaminants such as extra primers, proteins 
and unincorporated nucleotides.  
The microarray slides are incubated at high temperature with solutions 
of saline-sodium buffer, sodium dodecyl sulphate and bovine serum 
albumin to reduce non-specific binding. The labelled and purified cDNA 
is then competitively hybridised against the oligonucleotides on the 
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immobalised array and ideally, each molecule in the labelled cDNA will 
bind only to its appropriate complementary target sequence on the 
microarray chip.  
Un-hybridised cDNA fragments are removed by washing; slide is dried 
and placed in a scanner to determine how much labelled cDNA is 
bound to each target spot. The photo-excitation of each spot is then 
measured using a fluorescent microscope. This information is captured 
digitally and subjected to various analyses to extract the relevant 
biological information. Thus microarrays provide a powerful tool with 
which to screen biological specimens for alteration in the expression of 
mRNAs that accompany and may regulate physiological and 
pathological changes.  
2.4.1.5.2 Procedure: microarray analysis using GeneChip®  
mRNA extracted from epicardial adipose tissue samples were tested for 
integrity using the Agilent 2100 bioanalyzer (Agilent Technologies, 
Santa Clara, USA) and subsequent mRNA processing was completed 
using the GeneChip® ¶,97([SUHVVNLW$II\PHWUL[+LJK:\FRPEH
UK).  
Poly-A RNA controls were diluted and spiked into mRNA samples prior 
to cDNA synthesis as positive controls to assess the labelling. First and 
second strand cDNA synthesis was performed using the first and 
second strand master mixes provided in the kit. cDNA was then 
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transcribed in vitro to synthesise biotin labelled array RNA (aRNA) 
using the IVT kit with incubation for 16 hours at 40oC. aRNA purification 
was completed with RNA binding beads followed by elution with aRNA 
elution solution for each sample.  After elution, the yield of purified 
aRNA was determined through a Nanodrop spectrophotometer at 260 
nm wavelength absorbance. The aRNA samples were then fragmented 
using fragmentation buffer provided in the kit with incubation at 94 oC for 
35 min. To assess fragmentation, samples were run on an Agilent 2100 
bioanalyzer and demonstrated peak sizes of approximately 100-120 nt. 
Samples were hybridised to an Affymetrix® Human Genome U133 plus 
2.0 array (Affymetrix, High Wycombe, UK) with one cartridge per 
sample in a hybridisation oven for 16 hours at 45 0C. Following 
hybridisation, the samples were washed using a 450/250 Fluidics 
Station. Streptavidin Phycoerythrin was used for staining; this binds to 
biotinylated aRNA. Each GeneChip® was loaded into Affymetrix® 
Genechip® Scanner 3000 for analysis of fluorescence.  
Quality control of labelling and hybridisation, as well as data analysis 
was conducted using Partek (Partek Inc., St. Louis, USA). 
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2.4.2 Protein analysis 
2.4.3 Preparation of mitochondrial extracts 
Mitochondrial preparations were made from the tissue samples using 
the method described by Symonds et al. (Symonds et al. 1992). Ten 
millilitres of [hydroxymethyl] amino methane (tris) ± sucrose 
homogenisation buffer (10mM tris, 250mM sucrose and 1mM 
ethylenediaminetetraacetic acid (EDTA)) were added to approximately 
1 g of frozen pericardial adipose tissue which was then allowed to thaw 
on ice. The thawed tissue was homogenised using an Ultra Turrax 
homogeniser for 2X 30 seconds until no clumps of tissue were visible. 
The homogenate was transferred to a glass homogenisation tube and 
further homogenised with 10 strokes in the Potter-Elvehjem 
homogeniser. This homogenate was transferred into a centrifuge tube 
and volume made up to 20ml with the tris-sucrose homogenisation 
EXIIHU$ȝODOLTXRWZDVFROOHFWHGIURPHDFKVDPSOHIRUWRWDOSURWHLQ
concentration analysis. The remainder was centrifuged at 1000rpm for 
10 PLQXWHVDWÛ&7KHVXSHUQDWDQWZDVSDVVHGWKURXJKOD\HUVRI
gauze to remove the excess lipid tissue. The filtered supernatant was 
FHQWULIXJHGDWUSPIRUPLQXWHVDWÛ&$PODOLTXRWRIWKH
supernatant was collected for cytochrome c analysis and the rest 
discarded. The remaining mitochondrial pellet was re-suspended in the 
tris-VXFURVHEXIIHUE\DGGLQJȝODWDWLPH7KHYROXPHRIWKH
106 
 
resulting sample was noted and the mitochondrial preparations stored 
at -Û&XQWLOIXUWKHUDQDO\VLV 
In the human studies, due to limited sample size, the above method 
was modified to prepare mitochondria from 100-200mg of sample. The 
second homogenisation was performed by a hand-held mini-Potter-
Elvehjem homogeniser and only one layer of gauze used to remove 
excess lipids. 
2.4.3.1 Assessment of protein concentration 
Total protein concentrations and protein concentrations of the 
mitochondrial homogenates were measured using Bicinchoninic acid 
(BCA) assay or the Bradford assay. 
2.4.3.1.1 Bicinchoninic acid total protein determination 
2.4.3.1.1.1 Principle of BCA assay 
This assay depends on two reactions. In the first reaction, the protein 
peptide bonds from a tetradentate-Cu+ complex with copper (II) ions 
(Cu++) followed by this complex combining with BCA to form a BCA-Cu+ 
complex (purple in colour) in the second reaction. The interaction of 
Cu++ with peptide bonds occurs in an alkaline environment and thus 
Cu++ is reduced to Cu+. BCA acts as a detection agent for this reduced 
copper ion. In this reaction, two molecules of BCA chelate with one 
cuprous ion (Cu+). The resulting complex absorbs light at 562nm 
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making the solution purple in colour. As the amount of this complex 
formed depends on the concentration of the protein in the solution, the 
intensity of light absorption at 570nm wavelength is proportional to the 
concentration of protein in the sample.  
2.4.3.1.1.2 BCA assay procedure 
BCA reagent was prepared by mixing two reagents ± Reagent A (1% 
bicinchoninic acid + 2% sodium carbonate + 0.16% sodium tartarate + 
0.4% sodium hydroxide made to a volume of 500ml with distilled water 
and pH corrected to 11.25) and Reagent B (containing 4% cupric 
sulphate made to a volume of 25ml in distilled water). Protein samples 
ZHUHILUVWGLOXWHGWRDQGPDGHXSWRDWRWDOYROXPHRIȝOZLWK
normal saline. Normal saline was used as control and standard dilutions 
of Bovine Serum Albumin (BSA) were used to prepare the standard 
FXUYH)RUWKHUHDFWLRQȝORIVDPSOHFRQWURORUVWDQGDUGZDVSLSHWWHG
in duplicate to each well of a 96 well plate (PS-Microplates-flat bottom, 
Greiner Bio-2QH*PE+)ULFNHQKDXVHQ*HUPDQ\DQGȝ/RIWKH
BCA reagent added to each. The plate was incubated while shaking at 
Û&IRUPLQXWHVWKHQSODFHGLQWRDSODWHUHDGHU%LR-Teck uQuant, 
ReTiSoft Inc. Ontario, Canada) and absorbance measured at 562nm. 
Results that were within 10% of each other are considered suitable for 
analysis. 
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The standard curve (Figure 2.6) was generated by plotting the 
concentration of BSA with the measured absorbance at 562nm. Protein 
concentrations in the samples were calculated by linear regression 
analysis of the standard curve and corrected for initial dilution. 
2.4.3.1.2 Bradford assay 
2.4.3.1.2.1 Principle of the Bradford assay 
The Bradford Reagent (Sigma-Aldrich, Saint-Louise, Missouri, USA) 
consists of Brilliant Blue G in phosphoric acid and methanol. The 
procedure is based on the binding of Coomassie Brilliant Blue G-250 to 
protein in the sample. The binding of the dye to protein causes a shift in 
the absorption maximum of the dye from 465 to 595 nm, and it is the 
increase in absorption at 595 nm. The magnitude of the shift in 
absorption is proportional to the quantity of protein present and can be 
measured by a Spectrophotometer capable of measuring absorbance in 
the 595 nm range.  
2.4.3.1.2.2 Bradford assay procedure 
The Bradford assay was performed at room temperature by mixing 1 
part of the protein sample to 30 parts of the Bradford Reagent. A serial 
dilution of protein standards and blank samples (no protein) were 
included in the assay to produce a standard curve. Colour development 
begins almost immediately and protein concentration was determined 
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by measuring the absorbance at 595 nm and comparison to the 
standard curve.  
The assay was performed in a 96 well plate. The Bradford Reagent was 
gently mixed and allowed to reach room temperature. Protein standards 
were prepared with serial dilutions of known concentration of bovine 
serum albumin to produce a series of standards ranging from 0.1- 1.4 
mg/ml.  
Five microliters of protein standard, sample or blank solution (nuclease 
free water) was pipetted in to each well of the 96 well plate and 250 ȝO
of Bradford Reagent was added to each well. The 96 well plate was put 
on a shaker for 30 seconds to allow for the samples and reagent to mix 
and incubated at room temperature for 5 minutes. The absorbance was 
measured at 595 nm using a plate reader (Bio-Teck uQuant, RETiSoft 
Inc. Ontario, Canada). Three repeat measurements were taken at 5, 10 
and 20 minutes. 
The net absorbance vs. protein concentration of each standard was 
plotted to generate a standard curve and protein concentration of the 
unknown samples were calculated by comparing the net absorbance at 
595 nm of the sample against the standard curve (Figure 2.6). 
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Figure 2.6. Standard curve for estimation of protein content in 
mitochondrial extract 
The absorbance at 570 nm is plotted against the concentration of 
standard dilutions of bovine serum albumin to generate a linear graph 
that is then used to calculate the protein content of the experimental 
samples. 
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2.4.3.2  Western Blotting 
Western Blotting, as described by Burnette (Burnette 1981), is used to 
measure the abundance of selected proteins. This is achieved by 
sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) and each Western blot is performed in duplicate. 
2.4.3.2.1 Principle of Western Blotting 
Sodium dodecyl sulphate (SDS) is an anionic compound that can wrap 
around the polypeptide background of proteins. It binds in a specific 
mass ratio of 1.4g SDS to 1g protein and confers a negative charge to 
the resultant SDS-protein complex. This negative charge is proportional 
to the peptide length i.e. each denatured polypeptide strand from a 
particular protein has equal charge or charge density per unit length 
and the amount of charge on the polypeptide is proportional to its size. 
Thus, the SDS-protein complexes can be separated depending on their 
size by electrophoresis through a polyacrylamide gel. During 
electrophoresis, the negatively charged SDS-protein complexes move 
towards the anode at a rate that is inversely proportional to their size.  
To enable the separation by size, the polypeptide chains have to adopt 
a random coil configuration. The disulphide bridges in proteins have to 
be broken before this can happen. This is done during preparation of 
the protein sample by adding 2-mercaptoethanol or dithiothreitiol (DTT) 
and incubating at 100Û&IRUPLQXWHV 
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The size of the pores in the polyacrylamide gel depends on the 
concentration of the acrylamide and the bis-acrylamide that is used for 
cross-linking. This produces a sieving effect so that the migration of the 
polypeptide during SDS-PAGE is determined by its molecular weight 
and not the electrical charge it is carrying.  
After the polypeptides have been separated on the gel by SDS-PAGE, 
they are transferred on to nitrocellulose membrane for immunoblot 
analysis. This is done by applying an electric current to the gel and the 
nitrocellulose membrane so that the negatively charged polypeptides 
move from the gel on to the membrane in exactly the same 
configuration as they separated by SDS-PAGE.  
The areas on the nitrocellulose membrane that are not occupied by the 
SRO\SHSWLGHVEORWWHGIURPWKHJHODUH³EORFNHG´E\LQFXEDWLQJZLWKQRQ-
specific proteins so that the primary antibody does not bind to them. 
The nitrocellulose membrane is then incubated in an appropriate 
dilution of the primary antibody. If the membrane contains the antigen 
(i.e. appropriate polypeptide) corresponding to the primary antibody, it 
will bind to it and the excess primary antibody is washed at the end of 
the incubation.  
To enable visualisation of the bound primary antibody, the membrane is 
LQFXEDWHGZLWKD³VHFRQGDU\DQWLERG\´ZKLFKLVDQDQWL-immunoglobulin 
antibody coupled to a reporter group such as horseradish peroxidise 
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(HRP) enzyme. After incubation, the excess secondary antibody is 
washed off and the nitrocellulose membrane is incubated with a 
substrate which emits light upon reaction with the polypeptide-primary 
antibody- secondary antibody complex.  The membrane is visualised in 
a Charge Coupled Device (CCD) camera where the complex shows as 
a visible band. The concentration of the band is then measured by 
densitometry which gives a semi-quantitative estimate of the protein 
concentration. 
2.4.3.2.2 Western Blotting procedure 
2.4.3.2.2.1 Gel preparation and electrophoresis assembly 
Glass plates and combs supplied in the Mini-PROTEAN 3 cell (Bio-Rad, 
Ontario, Canada) were used to cast polyacrylamide gels. The resolving 
gel (12%) was prepared (4ml 30% acrylamide/8% bisacrylamide 
(37:5:1) solution, 3.3ml distilled water, 2.5ml 1.5M Tris (pH 8.8), 100ȝO
VRGLXPGRGHF\OVXOSKDWHȝODPPRQLXPSHUVXOSKDWHȝO
111¶1¶WHWUDPHWK\OHWK\OHQHGLDPLQHDQGSRXUHGEHWZHHQWKHVSDFHU
and short glass plates (a thickness of 1.5mm) and allowed to set for 1 
hour. A small amount of water saturated butanol was poured on top of 
the gel to prevent desiccation during polymerisation.  
Stacking gel was prepared (1.7ml 30% acrylamide/8% bisacrylamide 
VROXWLRQPOGLVWLOOHGZDWHUPO07ULVS+ȝO
VRGLXPGRGHF\OVXOSKDWHȝODPPRQLXPSHUVXOSKDWHȝO
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111¶1¶WHWUDPHWK\OHWK\OHQHGLDPLQHDQGSRXUHGRQWRSRIWKH
resolving gel and combs inserted to create wells. The gel was allowed 
to polymerise for 30 minutes and the combs then removed.  
The gels (within the glass sandwich) were transferred into the Electrode 
assembly and placed into the inner chamber of the vertical slab 
electrophoresis unit (part of the Mini-PROTEAN cell 3 systems). The 
inner chamber was placed into the Mini Tank (outer chamber). The 
inner chamber was filled with diluted (5X) Tris-Glycine Electrophoresis 
buffer (25mM Tris Base (151.0g), 250mM Glycine (940g) 10% sodium 
dodecyl sulphate (500ml) and made up to 10L with distilled water) such 
that the wells were filled with it and its level was between the tops of the 
two glass plates of the gel sandwich. The lower chamber was also filled 
with the same solution.  
2.4.3.2.2.2 Protein sample preparation for loading 
The protein samples (mitochondrial extract) were prepared on ice by 
diluting the mitochondrial extracts with [hydroxymethyl] amino methane 
(tris) ± sucrose homogenisation buffer (the buffer that was initially used 
for preparation of mitochondria) to a protein concentration of 4.2ȝJO
7KLVZDVSHUIRUPHGVRWKDWWKHILQDOSUHSDUDWLRQFRQWDLQHGȝJȝORI
SURWHLQ7KHGLOXWHGPLWRFKRQGULDOH[WUDFWZDVPL[HGZLWKȝORI
SURWHLQGLVVRFLDWLRQEXIIHUPOP07ULVS+FRQWDLQLQJPOȕ-
mercaptoethanol (5%),  20ml 10% sodium dodecyl sulphate (2%) and 
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POJOXFHURODQGȝORIJO\FHURO-bromophenol blue (0.01g 
bromophenol blue, 14.9ml 0.01M sodium hydroxide, 23.5ml distilled 
ZDWHU7KHVDPSOHVZHUHGHQDWXUHGDWÛ&IRUPLQXWHVDQG
immediately placed on ice.  
2.4.3.2.2.3 Gel loading 
(DFKZHOOZDVORDGHGZLWKȝOFRQWDLQLQJȝJRISURWHLQRIWKH
prepared protein sample. Precision Plus ProteinTM standards (All Blue) 
(Bio-Rad, Ontario, Canada) was used as the protein molecular weight 
marker (Figure 2.7). Ten microlitres of this was loaded into at least one 
well in each gel. Any potentially empty wells were filled with 
bromophenol blue to ensure even electrophoresis. One sample known 
to contain the protein of interest and one which did not (i.e. positive and 
one negative control samples) were run on each gel to allow 
comparison of abundance.  
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Figure 2.7. Representative of All blue prestained Precision Plus 
Protein standards on a 4-20% Tris-HCl CriterionTM Gel  
(From Instruction Manual, Precision Plus ProteinTM Standards, Catalog 
#161-0373, (Bio-Rad, Ontario, Canada)) 
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2.4.3.2.2.4 Electrophoresis 
The proteins were separated by electrophoresis at a constant voltage of 
200V for approximately 35 minutes (until the colour in the protein 
preparation reached the bottom of the resolving gel). 
2.4.3.2.2.5 Electroblotting 
The gel was extracted from between the glass plates and the separated 
protein transferred on to a nitrocellulose membrane (AmershamTM 
HybondTM-ECL membrane, GE Healthcare, Little Chalfont, U.K.) by 
electroblotting in the Bio-Rad Mini-PROTEAN 3 electroblotting 
apparatus (Bio-Rad, Ontario, Canada). The gel and nitrocellulose 
membrane were placed between 2 Scotch-BriteTM (3M Company, 
U.S.A) in to a cassette and inserted in to the electroblotter in the 
configuration shown in Figure 2.8. The proteins were blotted at a 
constant voltage of 60V for 1 hour. 
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Figure 2.8. Configuration of the polyacrylamide gel and 
nitrocellulose membrane in relation to the electrodes during 
electroblotting 
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The nitrocellulose membrane was stained by Ponceau S stain ((2g 
(2%(w/v)) Ponceau S, 30g (30%(w/v)) trichloroacetic acid, 30g 
(30%(w/v) sulphosalicylic acid in 100ml of distilled water; diluted 1:10 
with distilled water prior to use) for visualisation of the proteins on the 
membrane and verification of even blotting. An example of a membrane 
stained with Ponceau S is given in Figure 2.9. At this point, the 
positions of the molecular weight markers were noted and marked with 
PEN-R1 (Antigen-Antibody pen for Rabbit Primary Antibody, Alpha 
Diagnostics, San Antonio. U.S.A). 
 
Figure 2.9. Ponceau S staining of nitrocellulose membrane 
showing the electroblotting of protein on to the membrane and 
molecular weight markers on either side  
The grey areas visible on the membrane represent air bubbles between 
membrane and plastic wrapper trapped in the process of encasing the 
membrane in plastic. They are not integral to the membrane. 
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2.4.3.2.2.6 Immunodetection 
7KHQLWURFHOOXORVHPHPEUDQHZDVLQFXEDWHGRYHUQLJKWDWÛ&LQD
blocking solution (10% (w/v) non-fat milk (Marvel, Premier Bands UK 
Ltd.) in TTBS (Tris-sodium chloride (20mM (24.22g) Tris Base and 
500mM (292.2g) sodium chloride in distilled water) with pH corrected to 
7.5 with concentrated HCl made up to 10l volume with distilled water) 
mixed with 0.2% Tween 20) in order to block any remaining binding 
sites on the membrane. The membrane was further incubated in this 
solution for 30min, with shaking at room temperature, to ensure even 
blocking before the blocking solution was discarded and the membrane 
washed twice with TTBS. The membrane was then incubated whilst 
shaking at room temperature, with the primary antibody in appropriate 
dilution in normal rabbit serum to establish non-specific binding. The 
primary antibody was diluted in 3% (w/v) dried non-fat milk solution 
made with Marvel and TTBS. The membrane was then washed again in 
TTBS for 3X10 minutes, whilst shaking before adding the secondary 
antibody (HRP conjugated swine anti-rabbit immunoglobulin (PO217; 
Dako Ltd.) diluted 1:1000 in 3% (w/v) Marvel in TTBS). The incubation 
with the secondary antibody was performed for 1 hour, whilst shaking at 
room temperature. The secondary antibody solution was discarded, the 
membrane washed whilst shaking at room temperature for 4X 15 
minutes and then with TBS for 30min whilst shaking at room 
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temperature. The final step was incubation in TBS for 45min, at room 
temperature without shaking. 
2.4.3.2.2.7 Detection of Chemiluminescence 
The membrane was incubated in working HRP substrate prepared by 
mixing equal volumes of Luminol reagents and Peroxide solution 
(Reagents A and B of Chemiluminescent HRP substrate ImmunobilonTM 
Western (Millipore Corporation, Billerica, U.S.A)). The HRP substrate 
was left to reach room temperature for 10min and then the membrane 
was incubated with it for 5 minutes. The excess substrate was drained 
off and the membrane covered in clean plastic wrap.  
The membrane was exposed in a CCD camera (Fuji, Luminescent 
Image Analyser LAS-1000) for 5minutes. Longer exposure time was 
used, if required to visualise the bands. Approximate sizes of the 
visualised bands were calculated using regression analysis of the 
molecular weight markers. Densitometry was performed on the 
visualised bands using Aida software (Aida Image Analyzer version 
4.15.025 (Raytest Isotopenmessgeräte GmbH, Straubenhardt, 
Germany) to estimate the relative abundance of the proteins studied. 
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2.4.3.3 Immunohistochemistry 
Histology is the study of structure of cells and their formation into 
tissues and organs. Immunohistochemistry (IHC) is a combination of 
anatomical, immunological and biochemical techniques for detection of 
specific antigens (e.g. proteins) in cells of a tissue section. It enables 
visualisation of the distribution of specific antigens in the proper tissue 
context. 
2.4.3.3.1 Sample preparation for IHC 
2.4.3.3.1.1 Principles of IHC sample preparation 
2.4.3.3.1.1.1 Tissue fixation 
Tissue samples for IHC must be rapidly preserved to prevent 
breakdown of the cellular proteins and tissue architecture. Neutral 
buffered formalin (10%) which contains 4% formaldehyde induces 
cross-links between proteins, or between proteins and nucleic acids, 
involving hydroxymethylene bridges. This enables the proteins to retain 
their secondary structures (Werner et al. 2000). 
2.4.3.3.1.1.2 Tissue embedding 
To maintain the natural shape and architecture of the tissue sample 
during long term storage and sectioning, the formalin fixed samples are 
embedded in paraffin. The tissue is first dehydrated by graded alcohol 
solutions, washed with a clearing agent such as xylene and then 
embedded in warm paraffin. 
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2.4.3.3.1.1.3 Sectioning and Mounting 
Formalin fixed-paraffin embedded tissue samples need to be sectioned 
into 5-8µm and mounted onto glass slides. Pre-treatment of the slides 
with adhesives such as 3-aminopropyltriethoysilane (APTS) or poly-L-
lysine allows the tissue to couple and adhere to the slide surface 
especially dried in an oven. 
2.4.3.3.1.2 Procedure of IHC sample preparation 
Tissue samples from each human participant was removed during 
cardiac surgery and immediately immersed in 10% formalin (10% v/v 
formaldehyde in 0.9% w/v sodium chloride (Fischer Scientific) solution). 
Samples from sheep were also preserved similarly. The samples were 
allowed to remain immersed in this solution for at least 48 hours to 
enable appropriate tissue fixation. Samples were trimmed and loaded 
into a Histosette II (Simport, Quebec, Canada) 30mm X 20mm X 5mm 
cassettes and processed through six stages of ethanol dehydration 
followed by three stages of xylene for ethanol removal. The samples 
were then embedded in paraffin wax at 60°C by the Shandon 
ExcelsiorTM tissue wax processor (Thermo Scientific). The wax was 
allowed to set overnight. 
Tissue sections of 5µm were cut from the formalin-fixed, paraffin 
embedded samples using a sledge microtome (Anglia Scientific, 
Cambridge, UK). The sections were rinsed in 70% ethanol, de-wrinkled 
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by floating in warm water (45°C) and mounted on to SuperfrostTM Plus 
slides (Menzel-Gläser Inc, Braunchweig, Germany). The slides were 
dried on a heat rack for 15 minutes and incubated at 37°C in a drying 
oven for 24 hours. 
2.4.3.3.2 IHC staining 
2.4.3.3.2.1 Principles of IHC staining 
2.4.3.3.2.1.1 Epitope (Antigen) recovery 
The paraffin must be completely removed from the sections to allow the 
antibodies to reach the antigen. Organic solvents such as xylene can 
dissolve and remove the paraffin. Further to this, methylene bridges 
produced during formaldehyde fixation can also mask antigen 
presentation and interrupt antibody binding. These can be removed by 
heat treatment (heat-induced epitope retrieval (HEIR)). 
2.4.3.3.2.1.2 Quenching 
Staining procedures depend on biotin, peroxidises and/or phosphatases 
and hence these proteins have to be masked (or quenched) to prevent 
false positive or high background detection. This can be achieved by 
chemically inhibiting all enzymatic activity. 
2.4.3.3.2.1.3 Blocking nonspecific sites 
Nonspecific binding to antibody to random proteins in the sample 
causes high background staining and masks target antigen detection. 
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Blocking of reactive sites to which primary and secondary antibodies 
may otherwise bind by incubating the tissue sections in buffer solutions 
such as normal serum, non-fat dry milk or bovine serum albumen can 
prevent non-specific antibody binding. 
2.4.3.3.2.1.4 Immunodetection 
Antibody-mediated antigen detection can be direct or indirect. In the 
direct method, the antibody specific to the target antigen is conjugated 
with signalling markers such as fluorescent dyes or enzymes which 
then signal the binding of the labelled antibody to specific tissue sites. 
In the indirect method, the target antigen specific primary antibody first 
binds to the protein on the tissue section. The section is then washed 
and treated with a labelled secondary antibody such as one conjugated 
with horseradish peroxidise (HRP) enzyme which develops a brown 
precipitate in the presence of 3,3 diaminobenzidine (DAB), a 
chromogenic substance, through catalytic conversion. 
2.4.3.3.2.1.5 Counterstaining 
In the final step, the tissue section is counterstained to provide contrast 
to the primary stain and allow easier visualisation of the tissue 
architecture and antibody uptake. 
2.4.3.3.2.2 Procedure for IHC staining 
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Two slides per participant and a negative control were labelled with a 
random identifier and loaded into the Lecia BondMaxTM IHC slide 
processor (Leica Microsystem, Wetzlar, Germany) and run on the 
automated software programme (Vision Biosystems Bond Version 3.4A) 
using bond polymer refine detection reagents (Leica Microsystem, 
Wetzlar, Germany). 
In this protocol, slides were first treated with xylene for one minute 
followed by a one minute ethanol wash, incubation at 95°C with an 
epitope retrieval solution and treatment with peroxide block for 5 
minutes at room temperature. All the samples (excluding the negative 
controls) were then treated with 150µl of pre-optimised primary rabbit 
polyclonal antibody to UCP1 (ab10983, Abcam, Cambridge, UK) diluted 
to 1:500 for 30 minutes. The sections were then exposed to 150µl of 
HRP conjugated secondary anti-mouse and anti-rabbit antibody for 
eight minutes followed by treatment with 3,3 DAB for 10 minutes to 
allow for brown precipitation to develop. The sections were then 
FRXQWHUVWDLQHGZLWK+DUULV¶KDHPDWR[\OLQIRUPLQXWHV%HWween each 
of the above mentioned steps, the sections were washed with 
Bondwash buffer and distilled water. Tissue sections were mounted 
with coverslips using DPX mounting medium and dried overnight.  
Immunostaining was detected using the EnVision+ System (HRP-DAB-
rabbit) (Dako, Ely, UK) with appropriate controls undertaken in the 
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absence of the primary antibody. Sections were imaged using a Nikon 
Eclipse 90i microscope with charge - coupled device high-speed colour 
camera (Micropublisher 3.3RTV; QImaging, Surrey, BC, Canada) using 
Velocity 5 software (Improvision, Coventy, UK). Sections were 
visualised at 10X, 20X and 40X magnifications and photographed at 
20X and 40X magnifications for analysis of 10 random areas. A 
previously manually validated technique on Volocity imaging software 
was used to calculate the positive stained cell percentage, normalised 
against total cell number. 
2.4.3.3.3 Antibodies used for immunohistochemistry  
Immunohistochemistry for ovine tissue was performed using a UCP1 
primary antibody raised against ovine UCP1 at a dilution of 1:750 as 
described by Pope et al. (Pope et al. 2014).  
All human adipose tissue samples for immunohistochemistry (excluding 
the negative controls) were treated 1:500 dilution of pre-optimised 
primary rabbit polyclonal antibody to UCP1 (ab10983, Abcam, 
Cambridge, UK). 
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2.4.4 Statistical analysis 
Each individual sample was run in duplicate and, before any statistical 
analysis, coefficient of variance between the duplicates was calculated 
using Microsoft Office Excel 2010 (Microsoft Corporation, Berkshire, 
UK). A coefficient of variation of <5% was accepted as supporting the 
reproducibility of the respective assay and data points that were within 
this limit of variability were accepted for further statistical analysis. 
Statistical analysis was performed using IBM SPSS Statistics v.22.0 
statistical software for Windows package (IBM Corporation, NY, USA). 
All data were subjected to the Kolmogorov-Smirnov normality test for 
determining if their distribution was parametric or non-parametric. In this 
WHVWDSYDOXHRI0.05 indicates that the data are normally distributed. 
Comparisons between comparable groups were made using the 
analysis of variance (ANOVA) for data that were normally distributed or 
Kruskal-Wallis one-way analysis of variance for non-parametric data, 
with multiple group post hoc  %RQIHUURQLRU'XQQ¶VFRUUHFWLRQWHVWV
applied respectively. Correlation between gene expression and protein 
concentration for UCP1 and gene expression, UCP1 abundance and 
other biological parameters were determined by calculating the 
correlation coefficients and linear regression analysis. 
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The software GraphPad Prism v 5.00 (GraphPad Software, California, 
USA) is used to produce all statistical graphs and data are presented as 
mean ± standard error of mean (SEM).  
The anthropometric assessments of participants was performed using 
the Emergency Nutrition Assessment Tool (Erhardt and Pollgorm 2011) 
and the World Health Organisation (WHO) Anthro (version 3.2.2, 
January 2011).  
Statistical analysis for initial quality control of labelling and hybridisation, 
as well as data analysis of the microarray results were conducted using 
the Partek software (Partek Inc., St. Louis, USA). 
Further details of statistical analysis will be included in the individual 
sections, where relevant.
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3 Effect of maternal nutrient restriction on UCP1 
and other BAT associated genes in pericardial 
adipose tissue of newborn sheep 
The work described in this chapter has been published (Ojha et al. 
2013). The article is included in Appendix 10.4.1. 
3.1 Introduction 
In the newborn, BAT is essential for thermoregulation and its function is 
critical for survival. In a post-mortem study of 20 infants with gestation 
age between 28 to 42 weeks, Aherne and Hull described the anatomical 
distribution of BAT in newborn infants. They found BAT depots on the 
back, between the scapulae, in the posterior triangle of the neck and 
around the neck muscles extending under the clavicle into the axillae, in 
islands around the trachea, oesophagus and the large vessels in the 
mediastinum and around the suprarenal glands and the kidneys in the 
abdomen (Aherne and Hull 1964). In addition to these classically 
described depots, it has recently been recognised that BAT is also 
present in other locations.  
The presence of BAT around the heart of human adults has been 
suggested by the presence of BAT-specific UCP1 gene expression in 
epicardial fat (Sacks et al. 2009). Cardiac natriuretic peptides increase 
the expression of UCP1 and the transcription co-regulator PGCĮDQG
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induce mitochondriogenesis in adipocytes (Bordicchia et al. 2012). It 
has been postulated that brown adipocytes present in the vicinity of the 
heart may protect it from hypothermia (Sacks et al. 2009) and metabolic 
stresses (Festuccia et al. 2011). The exact role of BAT around the heart 
is unclear and there are currently no studies of BAT in pericardial depot 
of newborn infants or of BAT development in this depot in the perinatal 
period.  
In the sheep, in perirenal adipose tissue, UCP1 appears around mid-
gestation (Clarke et al. 1997) and, thereafter, its expression increases 
up to term gestation before rapidly declining after birth so that it is 
undetectable by the end of the first month of life (Finn et al. 1998). 
Maternal nutrition affects both gene expression and abundance of 
uncoupling protein in the offspring. Late gestation maternal nutrient 
restriction downregulates UCP1 gene expression but protein 
abundance in the perirenal depot is not affected (Budge et al. 2004). 
Increase in abundance of UCP1 in the near term fetus in response to 
increased maternal nutrition provides further evidence of nutritional 
regulation of UCP1 (Budge et al. 2003). Other mitochondrial membrane 
proteins such as voltage dependent anion channels (VDAC) and 
cytochrome c, important for energy metabolism within the adipocytes, 
are also altered in response to changes in maternal nutrition (Mostyn et 
al. 2003). 
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In addition to UCP1, BAT and WAT differ in expression of several other 
genes such as transglutaminase 2 (TGM2) and the potassium channel, 
subfamily K, membrane 3 (KCNK3) which are nearly 4 times higher in 
human BAT than in WAT (Svensson et al. 2011). Other transcription 
factors such as PGC1ĮDUHVSHFLILFDOO\LQYROYHGLQEURZQDGLSRJHQHVLV
(Puigserver et al. 1998) whilst others such as adipose differentiation 
related protein (ADRP) and leptin are predominantly expressed in WAT 
(Pope et al. 2013). Type 3 ȕDGUHQHUJLFUHFHSWRUVȕ$'5) are the 
predominant adrenergic receptor involved in the process of NST in 
brown adipocytes (Festuccia et al. 2009). In conjunction with 
sympathetic stimuli, thyroid hormones are a major regulator of brown 
adipocyte function. The enzyme type 2 iodothyronine deiodinase (DIO2) 
catalyses the conversion of T4 to T3; T3 is ten times more active than 
T4 and the intracellular conversion of T4 into T3 within brown 
adipocytes produces high intracellular T3 levels which saturate thyroid 
hormone receptors and induce a rapid increase in UCP1 gene 
expression and protein synthesis (Bianco and Silva 1987). 
3.1.1 Hypothesis and aim 
As described in Section 1.12.1, the hypothesis for this study is: given 
that UCP1 gene is expressed in epicardial depot of adult humans 
(Sacks et al. 2009), I hypothesised that BAT is present in pericardial 
adipose tissue in newborn sheep.  
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3.2 Methods 
This study was undertaken at the University of Nottingham, United 
Kingdom. Animal procedures were performed by Dr Sarah Pearce. 
Animal study protocols were designed in accordance with the Animals 
(Scientific Procedures) Act, 1986 under Home Office supervision. 
Tissue analysis was performed in the laboratories of Academic Child 
Health, University of Nottingham. 
3.2.1 Experimental design 
The experimental design for this study (as described in Chapter 2, 
(Section 2.2.1)) is summarised in Figure 3.1. 
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Figure 3.1. Experimental study design for Chapter 3  
C: control (100% of normal energy requirements); NR: nutrient 
restricted (60% of normal energy requirements); Day 0: samples taken 
at 6 hours of age; Day 30: samples taken at 30 days of age. Three 
animals between C0 and NR0 groups expired during the experimental 
procedure. 
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3.2.2 Laboratory procedures 
A complete description of the methods used in this study is located in 
Chapter 2 (Section 2.4). 
The Q-PCR for PGC1ĮDQGDGLSRQHFWLQZHUHLQLWLDOO\SHUIRUPHGE\0LVV
Momina Yazdani (Medical Student, University of Nottingham) under my 
supervision and were later repeated by myself, confirming Miss 
<D]GDQL¶VILQGLQJV7KH4-PCR for PRDM16 and DIO2 was performed 
by Dr Lindsay Robinson. 
3.2.2.1 mRNA detection 
Total RNA was extracted from 500 mg of sheep pericardial adipose 
tissue using Tri-Reagent (Sigma Chemical Co, Poole, UK) followed by 
purification with an RNeasy Plus kit (Qiagen, West Sussex, UK). To 
verify the quantity and quality of total RNA extracted, 
spectrophotometric analysis (Nanodrop; Thermo Scientific, Wilmington, 
DE) was performed. For each sample, 2 ȝJRI51$ZDVUHYHUVH
transcribed (RT) using reverse transcriptase and a Touchgene 
thermocycler (Techne; Barloworld Scientific, Stone UK). cDNA was 
V\QWKHVL]HGIURPȝJRI51$E\UHYHUVHWUDQVFULSWLRQLQDFFRUGDQFH
ZLWKWKHPDQXIDFWXUHU¶VSURWRFRO+LJKCapacity RNA to cDNA kit, 
Applied Biosystems, Warrington, UK). For each RT analysis, 
appropriate negative controls were included to ensure there was no 
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JHQRPLF'1$FRQWDPLQDWLRQ$OOF'1$ZDVVWRUHGDWí&XQWLO
further analysis.  
For each gene, a standard curve was generated to ensure uniformity, 
efficiency, and accuracy for each 96-well plate. DNA for the standard 
curve was made after DNA extraction (QIA quick gel extraction kit 
28704; Quigen, Crawley, UK) of the final product of PCR and run with 
2% agarose gel electrophoresis. In addition, correct product validation 
of all primers was confirmed by product size on gel electrophoresis and, 
when necessary, gene sequencing was performed with the results 
checked against known sequences on the GenBank Database.  
To establish mRNA abundance, qPCR was performed using a 10-ȝO
UHDFWLRQFRQVLVWLQJRIȝORIF'1$ȝORI)DVW6<%5*UHHQ0DVWHU
0L[$SSOLHG%LRV\VWHPVDQGȝORIIRUZDUGDQGUHYHUVHRYLQH-
specific oligonucleotide primers (Sigma±Aldrich, Gillingham, UK). The 
primer sequences are given in Table 2.1. The samples were run in 
duplicate and included a negative control and 10-fold dilution standard 
curve for standardization. qPCR was performed using the Step One 
Plus real-time PCR thermocycler (Applied Biosystems). Results were 
excluded and experimental analysis was repeated if the standard curve 
analysis demonstrated an efficiency of <90%. Data were analysed using 
18S mRNA as a housekeeping gene for the normalization of mRNA 
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expression and the 2íǻCt method and expressed as a ratio of the mean 
gene expression of day 0 control animals. 
3.2.2.2 Protein Analysis 
Mitochondria were prepared from 1 g of pericardial adipose tissue from 
each animal as described in Chapter 2, Section 2.4.3 and protein 
content was determined by bicinchoninic acid assay. The abundances 
of UCP1, VDAC, and cytochrome c were determined by western 
blotting using UCP1 and VDAC antibodies and cytochrome c antibody 
((H-104); SC-7159 (Santa Cruz Biotechnology,Santa Cruz, CA)) at a 
dilution of 1 to 1,000. Specificity of the detection was confirmed using 
nonimmune rabbit serum and a range of molecular weight markers was 
included on all gels. Densitometry analysis was performed on all 
membranes following image detection using a Fujifilm LAS-1000 cooled 
CCD camera (Fuji Photo Film, Tokyo, Japan) and results were 
expressed in arbitrary units. All gels were run in duplicate and a 
reference sample and negative control (from either hepatic or adipose 
tissue of the same 6-h-old control lamb) was included on each gel to 
allow comparison between groups. The membrane was exposed in a 
CCD camera (Fuji Luminescent Image Analyser LAS-1000). 
Densitometry was performed on the visualized bands using Aida 
software (Aida Image Analyzer version 4.15.025 (Raytest 
Isotopenmessgerate GmbH, Straubenhardt, Germany) to determine the 
relative abundance of the proteins studied. Data were analyzed 
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following densitometry and expressed as a ratio of the mean gene 
expression of day 0 control animals. 
3.2.3 Statistical Analysis 
All data are presented as means ± SEM and statistical significance was 
set at p <0.05. Data were assessed for normality using the 
Kolmogorov±Smirnov test followed by appropriate parametric or 
QRQSDUDPHWULFDQDO\VHV$QLQGHSHQGHQW6WXGHQW¶VWHVWRU0DQQ±
Whitney test was used to assess both the effect of age and the 
maternal diet as appropriate. All data were analysed using PASW 
software (version 22; IBM, Chicago, IL). 
139 
 
3.3 Results 
3.3.1 Whole body, heart and adipose tissue weights and 
adipose tissue composition  
There was a significant increase in total body weight, heart weight and 
absolute and relative pericardial adipose tissue weights between day 0 
and 30. However, there was no difference between offspring of control 
and nutrient restricted mothers at either age (Table 3.1). A significant 
reduction in total protein and mitochondrial protein content occurred 
between day 0 and 30 but there was no effect of maternal diet in late 
gestation at either age. 
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Table 3.1. Mean total body weight, pericardial adipose tissue and heart weights and total protein and total mitochondrial 
protein contents of pericardial adipose tissue (relative to protein content of control group) in offspring of control and 
nutrient restricted mothers at Day 0 and Day 30 life. 
 C0 (n=7) NR0 (n=7) C30 (n=8) NR30 (n=9) 
Body Weight (kg) 4.46±0.34a 4.26±0.16b 15.59±0.77c 14.84±0.55d 
Total pericardial adipose tissue weight (g) 4.61±0.43e 4.01±0.33f 97.28±11.93g 98.56±3.17h 
Pericardial adipose tissue weight relative 
to total body weight (g/kg) 1.05±0.94
i 0.96±0.11j 6.46±0.86k 6.69±0.25l 
Heart weight (g) 33.37±2.16 30.60±1.06 62.88±1.19 60.69±2.09 
Total protein (units) 1.00r0.08 0.8r0.14 0.23r0.04 0.28r0.04 
Total mitochondrial protein (units)          1.00r0.20 0.79r0.09 0.11r0.02 0.13r0.01 
Pericardial adipose tissue was sampled from 6 hour (0) and 30 day (30) old lambs born to sheep that 
consumed either 100% (C) or 60% (NR) of total metabolisable energy requirements to maintain maternal 
metabolism and fetal growth between 110 days of gestation and term. Values are means ± SEM. 
Comparisons a versus c, b versus d, e versus g, f versus h, i versus k and j versus l, p<0.05. 
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3.3.2 Mitochondrial proteins in the newborn and effect of 
maternal nutrient restriction 
Both UCP1 and cytochrome c were significantly reduced in offspring 
born to nutrient restricted mothers at day 0, but not day 30, as the 
abundance of both these proteins declined with postnatal age to basal 
values irrespective of maternal diet in pregnancy. In contrast, the 
abundance of VDAC was unaffected by either postnatal age and/or 
maternal diet (Figure 3.2). 
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Figure 3.2 A: UCP1, B: cytochrome c and C: VDAC protein 
abundance in pericardial adipose tissue of sheep in early 
postnatal life and the effect of maternal nutrient restriction in late 
gestation 
Pericardial adipose tissue was sampled from newborn, 0 (0) and 30 day 
old (30) lambs born to sheep that consumed either 100% (C) or 60% 
(NR) of total metabolisable energy requirements to maintain maternal 
metabolism and fetal growth between 110 days of gestation and term. 
UCP1 was not detected at 30 days in either nutritional group. 
UCP1 was not detectable in the pericardial adipose tissue of offspring 
of control and nutrient restricted sheep at day 30 (C30 and NR30 in A). 
Values are means ± SEM; n=7-9 per group. *p<0.05 
UCP1: uncoupling protein 1; VDAC: voltage dependent anion channel 
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3.3.3  Effect of maternal nutrient restriction on BAT related 
genes 
Gene expression of UCP1 declined with age but was unaffected by 
maternal diet (Figure 3.3) Genes that are known to be highly expressed 
in human BAT, TGM2 and KCNK3, mRNA expression was significantly 
reduced in offspring born to nutrient restricted mothers on day 0 and 
was further reduced with age, irrespective of maternal diet (Figure 3.3). 
Gene expression for the prolactin receptor (PRLR) decreased with age 
but was also unaffected by maternal diet (Figure 3.3) similar to the 
expression of the UCP1 gene. 
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Figure 3.3. Gene expression of A: UCP1, B: KCNK3, C: TGM2 and 
D: prolactin receptor (PRLR) in pericardial adipose tissue of sheep 
in early postnatal life and the effect of maternal nutrient restriction 
in late gestation 
Pericardial adipose tissue was sampled from 6 hours (0) and 30 day 
(30) old lambs born to sheep that consumed either 100% (C) or 60% 
(NR) of total metabolisable energy requirements to maintain maternal 
metabolism and fetal growth between 110 days of gestation and term. 
UCP1 gene expression was very low at 30 days in both nutritional 
groups.  
UCP1 gene expression was detectable but extremely low in the 
pericardial adipose tissue of offspring of control and nutrient restricted 
sheep at day 30 (C30 and NR30 in A). 
Values are means ± SEM; n=7-9 per grouSSS
p<0.001 
UCP1: uncoupling protein 1; KCNK3: potassium channel, subfamily K, 
member 3; TGM2: transglutaminase 2; PRLR: prolactin receptor 
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3.3.4 Effect of maternal nutrient restriction on BAT related 
transcription factors 
There was no change in the expression of bone morphogenetic protein 
(BMP)35'0DQG33$5ȖZKLOHWKHWUDQVFULSWLRQIDFWRU3*&Į
reduced with age but was unaffected by maternal nutrition (Figure 3.4).  
The gene expression of BMP7 (Figure 3.4) showed a trend of being 
downregulated by maternal nutrient restriction, but the differences were 
not significant statistically as the Kruskal-Wallis one-way analysis of 
variance produced a p value of 0.35.  
,QWKHDQDO\VLVRIWKHUHVXOWVIRUWKHJHQH3*&ĮRQHVDPSOHZDV
excluded. The Q-PCR efficiency for this reaction was 98% and the R2 
was 0.99. The maximum coefficient of variation for any sample on the 
plate was 2.7%. Despite these, one sample appeared anomalous with 
Ct value much higher than two standard deviations over the mean for 
the group. This sample was, therefore, considered to be an outlier and 
not included in the statistical analysis. 
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Figure 3.4. Gene expression of A: BMP7, B: PPARȖ&3*&ĮDQG
D: PRDM16 receptor in pericardial adipose tissue of sheep in early 
postnatal life and the effect of maternal nutrient restriction in late 
gestation  
Pericardial adipose tissue was sampled from 6 hours (0) and 30 day 
(30) old lambs born to sheep that consumed either 100% (C) or 60% 
(NR) of total metabolisable energy requirements to maintain maternal 
metabolism and fetal growth between 110 days of gestation and term. 
Values are means ± SEM; n=7-9 per group. *p<0.05, **p<0.01, 
p<0.001 
BMP: bone morphogenetic protein; PPAR: peroxisome proliferator-
activated receptor; PGC: PPAR co-activator; PRDM: PR (PRD1-BF1-
RIZ1 homologous)-domain containing protein 
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3.3.5 Effect of maternal nutrient restriction on WAT related 
genes and adipokines 
The gene expression of HOXc9 was not affected by maternal nutrient 
restriction and did not change with age (Figure 3.5). The expression 
demonstrated a tendency to be increased with maternal nutrient 
restriction at both Day 0 and Day 30 but the differences were not 
significant statistically (p value for Kruskal-Wallis one-way analysis of 
variance was 0.319). In this analysis, one sample was excluded. The Q-
PCR efficiency for this reaction was 99% and the R2 was 1. The 
maximum coefficient of variation for any sample on the plate was 4.4%. 
Despite these, the Ct value for one sample was higher than two 
standard deviations over the mean of its group. This sample was, 
therefore, considered to be an outlier and excluded from the analysis. 
The statistical analysis was repeated including this sample and this did 
not change the significance of the differences between the groups. 
Gene expression of the co-repressor Receptor Interacting Protein (RIP) 
140 was also unaffected by maternal nutrition. Further, the expression 
of this gene did not change significantly with age in the offspring of 
control mothers; however, in the offspring of nutrient restricted mothers, 
the expression of RIP140 was significantly higher at 30 days than at 6 
hours of age (Figure 3.5). 
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Leptin expression increased with age in offspring of both control and 
nutrient restricted mothers but was not affected by nutrient restriction. 
Gene expression of adiponectin did not change with age. In offspring of 
nutrient restricted mothers, mRNA expression for adiponectin was 
significantly higher at Day 0 but at Day 30 this difference did not reach 
statistical significance among the offspring of control mothers. 
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Figure 3.5. Gene expression of A: HOXc9, B: RIP140, C: leptin and 
D: adiponectin in pericardial adipose tissue of sheep in early 
postnatal life and the effect of maternal nutrient restriction in late 
gestation  
Pericardial adipose tissue was sampled from 6 hours (0) and 30 day 
(30) old lambs born to sheep that consumed either 100% (C) or 60% 
(NR) of total metabolisable energy requirements to maintain maternal 
metabolism and fetal growth between 110 days of gestation and term. 
Values are means ± SEM; n=7-9 per group. *p<0.05, **p<0.01, 
S 
HoX: homobox; RIP: receptor interacting protein 
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3.3.6 Effect of maternal nutrient restriction on ȕ adrenergic 
receptors and type 2 iodothyronine deiodenase gene 
*HQHH[SUHVVLRQRIW\SHȕDGUHQHUJLFUHFHSWRUVȕ$'5ZDVQRW
affected by age or maternal nutrient restriction (Figure 3.6). Gene 
expression of typHȕDGUHQHUJLFUHFHSWRUȕ$'5LQFUHDVHG
significantly with age in offspring of both control and nutrient restricted 
mothers (Figure 3.6). In contrast, gene expression of ȕ3ADR was 
downregulated in offspring of nutrient restricted mothers both at Day 0 
and at Day 30 (Figure 3.6). 
The gene expression of type 2 iodothronine deiodenase (DIO2) which 
converts T4 to T3 was also affected by maternal nutrition as it was 
lower in offspring of nutrient restricted mothers at Day 0 but not at Day 
30 (Figure 3.6). 
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Figure 3.6. Gene expression of A: ȕ$'5 %ȕ$'5&ȕ$'5
and D: DIO2 in pericardial adipose tissue of sheep in early 
postnatal life and the effect of maternal nutrient restriction in late 
gestation  
Pericardial adipose tissue was sampled from 6 hours (0) and 30 day 
(30) old lambs born to sheep that consumed either 100% (C) or 60% 
(NR) of total metabolisable energy requirements to maintain maternal 
metabolism and fetal growth between 110 days of gestation and term. 
Values are means ± SEM; n=7-9 per group. *p<0.05, **p<0.01, 
p<0.001 
ȕ$'5W\SHȕDGUHQHUJLFUHFHSWRUȕ$'5W\SHȕDGUHQHUJLF
UHFHSWRUȕ$'5W\SHȕDGUHQHUJLFUHFHSWRU',27\SH
iodothyronine deiodenase 
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3.3.7 Effect of maternal nutrient restriction on genes involved 
in glucose metabolism 
The gene expression for insulin receptor (IR) was reduced in offspring 
of nutrient restricted mothers in the newborn offspring but not at 30 
days of age (Figure 3.7). Neither the type 4 glucose transporter gene 
(GLUT4) nor the gene for glucocorticoid receptor (GR) was affected by 
maternal nutrition. In offspring of control mothers, the GR gene was 
increased significantly from Day 0 to Day 30 but this change did not 
reach statistical significance in offspring of nutrient restricted mothers 
(Figure 3.7). 
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Figure 3.7 Gene expression of A: Insulin receptor, B: Glucose 
transporter type 4 (GLUT4), C: Glucocorticoid receptor (GR) in 
pericardial adipose tissue of sheep in early postnatal life and the 
effect of maternal nutrient restriction in late gestation 
Pericardial adipose tissue was sampled from 6 hours (0) and 30 day 
(30) old lambs born to sheep that consumed either 100% (C) or 60% 
(NR) of total metabolisable energy requirements to maintain maternal 
metabolism and fetal growth between 110 days of gestation and term. 
Values are means ± SEM; n=7-9 per group. *p<0.05, **p<0.01, 
S 
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3.3.8 Relationship between UCP1 gene expression and 
protein abundance 
There was no significant correlation between UCP1 gene expression 
and protein abundance at Day 0. The relationship was not tested at Day 
30 due to absence of any detectable UCP1 in the older lambs Figure 
3.8). 
 
Figure 3.8 UCP1 gene expression is not correlated to protein 
abundance in pericardial adipose tissue of newborn lambs 
Pericardial adipose tissue was sampled from 6 hour old lambs born to 
sheep that consumed either 100% or 60% of total metabolisable energy 
requirements to maintain maternal metabolism and fetal growth 
between 110 days of gestation and term. 
UCP1: uncoupling protein1 
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3.4 Discussion 
This study has shown, for the first time, that pericardial fat is a depot of 
BAT in postnatal sheep by determining the presence of mRNA and 
protein for the BAT-specific UCP1 (Ojha et al. 2013). 
3.4.1 Pericardial adipose tissue changes from BAT to WAT in 
infancy 
Similar to other adipose depots such as perirenal fat (Budge et al. 
2004), pericardial adipose tissue changes from predominantly BAT to 
WAT in the early postnatal period. There is loss of UCP1 mRNA and 
protein and decrease in expression of BAT related genes with an 
increase in WAT related genes in this period.  
Gene expression for UCP1 declines significantly from day 0 to day 30 
and the protein is undetectable by Western blotting at 30 days. Genes 
such as TGM3 and KCNK3 which are known to have 4 times higher 
expression in human BAT than in WAT (Svensson et al. 2011) are 
highly expressed in sheep and their mRNA expression declines by 30 
GD\VRIDJHSDUDOOHOWRWKHGHFOLQHLQ8&33*&ĮDOVRGHFOLQHV
parallel to UCP1 but other transcription factors which regulate brown 
DGLSRJHQHVLVVXFKDV%0335'0DQG33$5Ȗdo not change over 
the first 30 days after birth. This suggests that, although brown 
adipocytes disappear, preadipocytes retain the potential to develop into 
brown adipocytes, a proposal supported by the discovery of BAT in 
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human adults (Cypess et al. 2009, van Marken Lichtenbelt et al. 2009, 
Virtanen et al. 2009) and the isolation of progenitor cells from human 
adult supraclavicular adipose tissue which can develop into mature 
brown adipocytes (Lee et al. 2011). 
Gene expression of leptin, a marker of white adipocytes (Cinti et al. 
1997), increases in the first 30 days of life. RIP140, a global regulator of 
energy balance, is highly expressed in WAT. It represses multiple 
metabolic pathways to reduce energy expenditure and functions as a 
coactivator of proinflammatory genes and macrophages (Rosell et al. 
2011). In offspring of nutrient restricted mothers, RIP140 increases 
between day 0 and 30 while the gene expression of HOXc9 does not 
change in this period.  
3.4.2 BAT development is modulated by maternal nutrient 
restriction in late gestation 
In the newborn, UCP1 abundance decreases as a consequence of 
maternal nutrient restriction in late gestation. This is accompanied by a 
decline in cytochrome c but the abundance of VDAC remains stable. 
BAT has a high concentration of cytochrome c, a protein in the inner 
mitochondrial membrane which is part of the electron transport chain, 
and the cytochrome c content of BAT correlates with the high oxygen 
consumption in this tissue (Joel and Ball 1962). In perirenal adipose 
tissue and the lung, VDAC and cytochrome c are upregulated by 
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maternal nutrient restriction (Mostyn et al. 2003) and these current 
findings represent depot specific responses to alterations in the in utero 
environment. 
3.4.3 Total amount of UCP1 in the pericardial depot 
From a functional point of view, the truly relevant measure of the 
animal¶s thermogenic capacity is the total amount of UCP1 present in 
the whole animal or at least in one particular depot (Nedergaard and 
Cannon 2013). As changes in thermogenic capacity are not solely due 
to an  increase or decrease in the amount of protein in the individual 
brown adipocyte or even per gram of BAT, but due to changes in the 
total amount of UCP1 in the whole BAT depot, the comparison between 
total UCP1 in the entire pericardial depot is the most relevant 
physiological parameter (Nedergaard and Cannon 2013). To calculate 
this, the entire depot has to be dissected and the total amount of UCP1 
in it should be measured. Therefore, I have measured UCP1 in a small, 
randomly selected, sample taken from the dissected depot and 
calculated the total UCP1 by multiplying the measured value by the total 
amount of fat in the depot. In this study, we found that, at 6 hours of 
age, the total amount of UCP1 in the pericardial depot is significantly 
reduced in offspring of nutrient restricted mothers when compared to 
offspring of control mothers. This finding indicates that maternal nutrient 
restriction in late gestation reduces the thermogenic capacity of 
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3.4.4 Correlation between UCP1 abundance and gene 
expression 
As mRNA eventually translates into protein, it can be postulated that 
there should be some correlation between mRNA levels and protein 
abundance. However, in the newborn animals, UCP1 gene expression 
does not correlate with protein abundance. Lack of a correlation could 
be due to one or more reasons (Greenbaum et al. 2003). Several post-
transcriptional mechanisms are involved in turning gene expression into 
protein abundance. These intermediary steps are not yet sufficiently 
understood to allow the simple computation of protein concentrations 
from mRNA expression. In addition, protein and mRNA have different 
half-lives and dramatic changes in UCP1 mRNA expression can be 
seen over short periods of time (Nedergaard and Cannon 2013). UCP1 
mRNA has a half-life of a few hours whilst the half-life of the protein is 
3-6 days (Puigserver et al. 1992). Therefore, lack of correlation between 
mRNA expression and protein abundance is biologically plausible even 
if perfect transcription to translation efficiency was present.  
3.4.5 Maternal nutrient restriction affects genes controlling 
non-shivering thermogenesis 
Importantly, this study has also demonstrated that maternal nutrient 
restriction in late gestation downregulates genes that control non-
shivering thermogenesis, although the physiological significance of this 
change (i.e. the effect of altered gene expression on the thermogenic 
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capacity of the animal) remains to be confirmed in vivo. Offspring of 
QXWULHQWUHVWULFWHGPRWKHUVKDYHUHGXFHGH[SUHVVLRQRIȕ$'5DWELUWK
and one month of age, whilst gene expression of DIO2 is significantly 
UHGXFHGLQWKHQHZERUQ7KHȕ$'5UHFHSWRUSURPRWHVSUROLIHUDWLRQ
and differentiation of brown adipocytes, inhibits apoptosis and controls 
the process of non-shivering thermogenesis by upregulating fatty acid 
oxidation and activating DIO2 (de Jesus et al. 2001). The enzyme DIO2 
is essential for optimal thermogenesis in brown adipocytes (Bianco and 
Silva 1987) and in its absence in mice basal UCP1 mRNA expression 
does not change, but the animals fail to increase their temperature on 
norepinephrine infusion when there is a 50% reduction in UCP1 
expression (de Jesus et al. 2001). High local concentrations of T3 are 
essential for mitochondrial biogenesis (Klingenspor et al. 1996) and 
UCP1 gene expression and lipolysis are impaired in its absence (de 
Jesus et al. 2001),QWKLVVWXG\',2DQGȕ$'5ZHUHGRZQUHJXODWHG
with maternal nutrient restriction in late gestation. These, along with 
reduced UCP1, may be mechanisms which make the newborn less 
capable of modulating body temperature when challenged with cold 
stress, making the offspring of nutrient restricted mothers more 
susceptible to hypothermia. 
'DWDIURPWKH'XWFK³+XQJHU:LQWHU´WKH)DPLQHRI-45) has 
shown that the timing of maternal nutrient restriction impacts upon the 
metabolic outcomes in the offspring (Roseboom et al. 2001). In guinea 
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pigs, maternal undernutrition increases the relative adiposity of the fetus 
and appears to preserve WAT at the expense of BAT in the 
interscapular depots (Kind et al. 2005). In sheep, maternal nutrient 
restriction in late gestation results in a 2.5 fold decrease in the 
abundance of UCP1 mRNA in near-term fetal adipose tissue but there 
is no effect on protein abundance at this stage (Budge et al. 2005). On 
the other hand, longer periods of nutrient restriction, extending 
throughout pregnancy, increase UCP1 expression in both sheep 
(Budge et al. 2005) and rats (Souza et al. 2012). Reduction in UCP1 
when nutrition is restricted only in the late gestation may be an 
adaptation to conserve energy for the growth of other vital organs. This 
study has demonstrated that UCP1 and expression of BAT related 
genes are significantly reduced by maternal nutrition restriction in this 
period of maximal fetal growth. These changes occur in the absence of 
effect on birth weight, a finding that is in concordance with other studies 
using a similar degree of maternal nutrient restriction (Edwards and 
McMillen 2001). These changes in BAT related proteins and genes 
signify that subtle, but vital, changes in adipose tissue development can 
occur even when body weight is not obviously affected.  
3.4.6 BAT in the pericardial depot 
BAT has recently been shown to be present in pericardial adipose 
tissue of human adults (Sacks et al. 2009). The function of BAT around 
the heart in mammals is unclear, although it has been suggested that it 
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may serve to protect the myocardium from severe hypothermia which 
can precipitate potentially fatal arrhythmias (Sacks et al. 2009), have 
paracrine effects on cardiovascular function and act as a plasma lipid-
clearing organ protecting the heart from hypertriglyceridemia (Festuccia 
et al. 2009). Although BAT development in pericardial adipose tissue of 
newborn animals is effected by maternal nutrition in late gestation, 
these changes do not persist as the animal grows and are not 
accompanied by alteration of genes predominantly expressed in WAT, 
indicating that the effect may be restricted to the newborn period. 
However, alteration of pericardial adipose tissue in older animals and 
humans and any long term outcomes remain to be investigated.  
3.5 Conclusion 
In summary, pericardial adipose tissue is a nutritionally regulated depot 
of BAT in newborn sheep. The depot changes from predominantly 
brown to white adipose tissue in the newborn period. Maternal nutrient 
restriction in late gestation reduces the abundance of UCP1 and 
downregulates other BAT related genes. Importantly, this nutritional 
LQWHUYHQWLRQUHGXFHVWKHH[SUHVVLRQRIȕ$'5DQG',2ZKLFKDUHNH\
regulators of brown adipocyte development and non-shivering 
thermogenesis. BAT is present in the adipose tissue depots around the 
heart in human adults and I have shown that its development in early 
life is a target of nutritional programming.  
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4 Suboptimal maternal nutrition during early-to-
mid gestation followed by ad libtum feeding in 
the sheep enhances pericardial adiposity in the 
near-term fetus 
The work described in this chapter has been published (Ojha et al. 
2014). The article is included in Appendix 10.4.3.  
4.1 Introduction 
Obesity, cardiovascular disease and type 2 diabetes are linked to 
inadequate fetal nutrition (Barker 1995). As discussed in Section 1.2, 
the link between early life environment and health in later life is 
GHVFULEHGDV³GHYHORSPHQWDOSURJUDPPLQJ´(Lucas 1991) which 
suggests that adverse environmental influences, such as inadequate 
nutrition, during these critical periods can permanently alter the 
structure and function of tissues and organs and these early life 
changes can subsequently render affected individuals more susceptible 
to disease in later life. Nutrition in fetal life is a central stimulus of 
programming for susceptibility to diseases in later life, a hypothesis that 
is supported by epidemiological evidence from long-term follow up of 
the offspring of pregnant women who suffered undernutrition during the 
Dutch famine of 1944-45. 
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The biogenesis of adipocytes comprises the differentiation of 
mesenchymal stem cells to committed precursor cells called 
preadipocytes, followed by terminal differentiation into mature 
adipocytes (Rosen and Spiegelman 2000). White and brown 
adipogenesis occur along two parallel pathways with distinct sets of 
transcription factors governing each process (Kajimura et al. 2010) 
(Figure 1.3). Genes such as bone morphogenetic protein (BMP) 7 
(Tseng et al. 2008), PR (PRD1-BF1-RIZ1 homologous)-domain-
containing protein (PRDM16) (Seale et al. 2007), CCAAT-enhancer 
binding protein (C/EBP) ȕ(Kajimura et al. 2009), peroxisome 
proliferator-DFWLYDWHGUHFHSWRUȖ33$5ȖDQG33$5ȖFR-activator 
3*&Į(Fruhbeck et al. 2009) are expressed along the brown 
adipogenic pathway whilst another set of transcription factors including 
BMP4 (Schulz and Tseng 2009), adipose differentiation related protein 
(ADRP) and homobox (Hox) C9 (Cantile et al. 2003) are specific to 
white adipogenesis. The extent to which these separate processes can 
be reset in utero has not yet been established. 
4.1.1 Hypothesis and aim 
As described in Section 1.12.2, the hypothesis for this study is: in fetal 
sheep, suboptimal maternal nutrition between early-to-mid gestation 
followed by ad libitum feeding until term will increase fetal adiposity and 
upregulate the expression of genes which control adipogenesis. 
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4.2 Methods 
4.2.1 Animal and diet 
Animal procedures were performed by Dr Lindsay Heasman and 
Professor Michael Symonds. Animal protocols were designed in 
accordance with the Animals (Scientific Procedure) Act, 1986 under 
Home Office supervision as described in Chapter 2 (Section 2.1.1).  
The details of the animal experiments and diet are given in Chapter 2 
(Section 2.2.2) and summarised in Figure 4.1. 
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Figure 4.1 Experimental study design for Chapter 4 
Filled bars represent the phases of nutritional intervention in control (C 
(fed 100% of total metabolisable energy requirement followed by ad 
libitum feeding after 80 d of gestation)) and nutrient restricted (NR 
(restricted to 60% of total metabolisable requirement between 28 and 
80 days of gestation followed by ad libitum feeding until term 
gestation)). The graph depicts the growth of the fetus and the placenta 
from the point of placental attachment to term gestation.  
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4.2.2 Laboratory procedures  
4.2.2.1 Histology  
Adipose tissue samples were fixed in formalin and embedded in 
paraffin. Sections were cut at 5 µm and processed as described in 
Chapter 2 (Section 2.4.3.3).  
4.2.2.2 Gene expression  
Total RNA was extracted from 500mg of pericardial adipose tissue and 
processed as described in Chapter 2 (Section 2.4.1.1). 
Primer sequences were designed as described in Chapter 2 (Section 
2.4.1.3.3) and are given in Table 2.1.  
mRNA abundance was determined by Q-PCR as described in Chapter 
2 (Section 2.4.1.3). Multiple reference genes were analysed for each 
set and the crossing threshold values for each reference gene were 
processed through the geNorm software v3.5 (Primer Deisgn, Ltd, 
Southampton, UK). IPO8 had the most stable expression and data were 
analysed using IPO8 as a housekeeping gene for the normalisation of 
mRNA expression. The 2-¨Ct method was used (Schmittgen and Livak 
2008) and relative gene expression was calculated as a ratio of the 
mean gene expression of offspring of C mothers. 
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4.2.2.3 Mitochondrial protein analysis  
Mitochondria were prepared from 1g of pericardial adipose tissue from 
each animal and processed as described in Chapter 2 (Section 2.4.1.5).  
Total and mitochondrial protein content of the tissue was determined by 
the Bradford assay as given in Chapter 2 (Section 2.4.3.1.2). The 
abundance of UCP1, voltage dependent anion channel-1 (VDAC), and 
cytochrome c were determined by Western blotting using antibodies 
and procedures described in Chapter 2 (Section 2.4.3.2). Data were 
analysed following densitometry and expressed as a ratio of the mean 
protein abundance of offspring born to C animals. 
4.2.3 Statistical analysis  
All data are presented as means ± standard error of mean (SEM) and 
statistical significance was set at p < 0.05. Data were assessed for 
normality using the Kolmogorov-Smirnov test followed by appropriate 
SDUDPHWULFRUQRQSDUDPHWULFDQDO\VHV$QLQGHSHQGHQW6WXGHQW¶V7-test 
or Mann-Whitney test was used to assess the effect of the maternal diet 
as appropriate. Multiple linear regression analyses were performed to 
assess the associations of UCP1 gene expression and relative protein 
FRQWHQWZLWKPRWKHU¶VZHLJKWIHWDOZHLJKWDQGZHLJKWRISHULFDUGLDO
adipose tissue. All data were analysed using PASW software (version 
21; IBM, Chicago, IL). 
168 
 
4.3 Results 
4.3.1 Whole body and adipose tissue weights and pericardial 
adipose tissue composition 
There was no effect of the maternal dietary regime on her body weight 
near to term (control (C): 43.40 ± 1.24 kg; nutrient-restricted (NR): 
43.37 ± 1.02 kg) or on the body weight of the fetus, although NR 
mothers weighed less at 80 days gestation, immediately after the period 
of nutritional intervention (C: 40.1 ± 1.03: NR: 36.4 ± 0.81 kg (P<0.01)). 
However, the nutritionally manipulated fetuses possessed more total 
and pericardial fat, in both absolute and relative terms (Table 4.1). 
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Table 4.1. Mean total body weight, visceral and pericardial adipose tissue weights, and total protein and total 
mitochondrial protein contents of pericardial adipose tissue in near term fetuses born to control and nutrient-restricted 
mothers at 140 days of gestation. 
 C (n=5) NR (n=7) 
Effect of suboptimal 
maternal nutrition 
(p-value) 
Body weight (kg) 4.85 ± 0.28 4.80 ± 0.28 NS 
Total visceral adipose tissue weight (g) 18 ± 0.51 22 ± 0.32 0.038 
Total pericardial adipose tissue weight (g) 3.86 ± 0.38 4.95 ± 0.46 0.041 
Pericardial adipose tissue weight relative to total 
body weight (g/kg) 0.79 ± 0.06
 1.04 ± 0.10 0.040 
Total protein in pericardial adipose tissue (mg/g) 3.46 ± 0.26 5.46 ± 0.80 0.067 
Total mitochondrial protein in pericardial adipose 
tissue (mg/g) 7.90 ± 1.01
 13.00 ± 1.48 0.021 
Pericardial adipose tissue was sampled from 140 day gestation sheep fetuses that consumed either 100% (control, C) or 60% 
(nutrient-restricted, NR) of total metabolisable energy requirements to maintain metabolism and fetal growth between 28 days 
and 80 days of gestation. Values are means ± SEM 
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4.3.2 Presence of UCP1 in pericardial adipose tissue of 
sheep at 140 d gestation  
At 140 days gestation, in pericardial adipose tissue sections, both white 
and brown adipocytes are clearly visible with large white adipocytes 
with single lipid droplets interspersed between multilocular, smaller 
brown adipocytes that strongly stain with UCP1 (Figure 4.2). This 
pericardial adipose tissue exhibited raised gene expression for UCP1, a 
difference that was translated into protein (as measured by Western 
Blotting) (Figure 4.3) and was accompanied with more mitochondrial 
protein (Table 4.10XOWLSOHUHJUHVVLRQDQDO\VHVLQFRUSRUDWLQJPRWKHU¶V
body weight, fetal weight and pericardial adipose tissue weight also 
identified maternal nutrition group as the only significant predictor of 
both UCP1 gene expression and relative protein content (Table 4.2). 
The abundance of the outer mitochondrial protein VDAC (C: 0.94 ± 
0.04; NR: 0.97± 0.04 arbitrary units (a.u.)) and cytochrome c (C: 0.92 ± 
0.04; NR: 1.02 ± 0.08 a.u.) were both unaffected by maternal diet.  
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Figure 4.2 Representative images of pericardial adipose tissue structure at 140 day gestation in fetal sheep 
Histological sections stained for immunohistochemical detection of uncoupling protein 1(UCP1):  antibody negative (A) and antibody 
positive (B) showing the presence of small multilocular adipocytes (indicated by white arrows). These multilocular adipocytes 
stained positive for UCP1 (B) demonstrating that these are brown adipocytes and the depot is brown fat 
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Figure 4.3 Effect of suboptimal maternal nutrition in early-to-mid gestation on (A) uncoupling protein 1 (UCP1) mRNA 
expression and (B) UCP1 protein abundance in pericardial adipose tissue of 140 day gestation sheep fetus 
Pericardial adipose tissue was sampled from 140 day gestation fetuses delivered to sheep that consumed either 100% (control(C)) 
or 60% (nutrient restricted (NR)) of total metabolisable energy requirements to maintain maternal metabolism and fetal growth 
between 30 d and 80 d of gestation followed by ad libitum feeding until delivery. Values are means ± SEM; n = 5-7 per group.  
*p <0.05. 
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Table 4.2. Multiple regression analyses for uncoupling protein 1 (UCP1) gene expression and relative protein content as 
dependent variable and mRWKHU¶VQXWULWLRQJURXSPRWKHU¶VZHLJKWIHWDOZHLJKWDQGSHULFDUGLDODGLSRVHWLVVXHZHLJKWDV
independent variables (n=12) 
UCP1 Gene expression  Relative protein content 
 B SEM ȕ p  B SEM ȕ p 
Constant -8.01 20.33 - 0.70  0.32 1.22 - 0.80 
0RWKHU¶VQXWUitional 
group* 1.86 0.70 0.74 0.04 
 0.46 0.14 0.84 0.01 
0RWKHU¶VZHLJKW -0.14 -0.14 -0.88 0.34  0.03 0.03 0.24 0.35 
Fetal weight -1.88 -2.80 -0.88 0.526  0.07 0.10 0.16 0.52 
Pericardial adipose 
tissue weight 13.69 14.01 2.40 0.37 
 0.02 0.08 0.07 0.83 
Pericardial adipose tissue was sampled from 140 day gestation fetuses RIVKHHS7KHPRWKHU¶VQXWULWLRQDOJURXSV
were control group (fed 100% of total metabolisable energy (ME) requirements) or nutrient-restricted group (fed 60% 
of total ME requirements) between 28 days and 80 days of gestation.  
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4.3.3 Effect of maternal nutrient restriction on genes involved 
in adipogenesis  
Gene expression for Ki-67, a gene involved in adipocyte proliferation, 
together with the brown adipogeneic gene BMP7 were upregulated in 
fetal pericardial adipose tissue of mothers nutrient restricted between 
early-to-mid gestation (Table 4.3), whereas mRNA abundance for 
PGCĮDQG35'0ZHUHXQDIIHFWHG$QXPEHURIJHQHVWKDWFRQWURO
adipogenesis in white adipocytes exhibited a two to three fold increase 
in mRNA expression in the fetus delivered to nutritionally manipulated 
PRWKHUVLQFOXGLQJ%03+R[&&(%3ĮDQGȕZKHUHDV33$5Ȗ
ADRP and RIP140 were unaffected, as were the adipokines, leptin and 
adiponectin*HQHH[SUHVVLRQVIRUȕDQGȕEXWQRWȕ$'5, were 
also raised in pericardial fat, whereas insulin receptor gene expression 
was reduced without changes in gene expression of the glucocorticoid 
receptor (Table 4.4). 
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Table 4.3. Effect of suboptimal maternal nutrition in early-to-mid 
gestation on genes expression of adipogenic transcription factors 
in pericardial adipose tissue of fetus at 140 days of gestation 
Pathway 
gene C (n=5) NR (n=7) 
Effect of suboptimal 
maternal nutrition 
(p-value) 
Brown adipogenesis 
BMP7 1 ± 0.26 1.87 ± 0.18 0.016 
3*&Į 1 ± 0.42 1.95 ± 0.35 0.088 
PRDM16 1 ± 0.26 1.30 ± 0.30 0.219 
White adipogenesis 
BMP4 1 ± 0.27 2.06 ± 0.43 0.048 
HoxC9 1 ± 0.37 3.67 ± 0.30 0.004 
&(%3Į  1 ± 0.20 2.02 ± 0.36 0.023 
ADRP 1 ± 0.21 0.91 ± 0.34 0.878 
Brown and white adipogenesis 
Ki67 1 ± 0.29 1.93 ± 0.29 0.033 
&(%3ȕ 1 ± 0.20 2.02 ± 0.36 0.024 
33$5Ȗ 1 ± 0.21 0.93 ± 0.21 0.811 
RIP140 1 ± 0.21 0.87 ± 0.40 0.760 
Abbreviations: C, control; NR, Nutrient Restricted; BMP, Bone Morphogenetic 
Protein; PPAR, peroxisome proliferator-activDWHGUHFHSWRU3*&33$5ȖFR-
activator; PRDM16, PR (PRD1-BF1-RIZ1 homologous)-domain-containing 
protein; HoX, Homobox; C/EBP, CCAAT-enhancer binding protein; ADRP, 
Adipose Differentiation Related Protein; ADR, adrenergic receptor; GR, 
glucocorticoid receptor.  Values are means ± SEM.  
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Table 4.4. Effect of suboptimal maternal nutrition in early-to-mid 
gestation on genes expression of ȕ-adrenergic receptors, genes 
involved in adipocyte metabolism and adipokines in pericardial 
adipose tissue of fetus at 140 days of gestation 
Pathway gene C (n=5) NR (n=7) 
Effect of 
suboptimal 
maternal nutrition 
(p-value) 
ȕ-adrenergic receptors 
ȕ$'5 1 ± 0.27 1.86 ± 0.23 0.035 
ȕ$'5 1 ± 0.17 1.2 ± 0.30 0.089 
ȕ$'5 1 ± 0.36 2.56 ± 0.71 0.036 
Adipocyte metabolism 
Insulin receptor 1 ± 0.34 0.45 ± 0.15 0.015 
GR 1 ± 0.35 1.03 ± 0.25 0.944 
Adipokines 
Leptin 1 ± 0.37 0.82 ± 0.33 0.723 
Adiponectin 1 ± 0.36 1.19 ± 0.30 0.690 
Abbreviations: C, control; NR, Nutrient Restricted; BMP, Bone 
Morphogenetic Protein; PPAR, peroxisome proliferator-activated 
UHFHSWRU3*&33$5ȖFR-activator; PRDM16, PR (PRD1-BF1-RIZ1 
homologous)-domain-containing protein; HoX, Homobox; C/EBP, 
CCAAT-enhancer binding protein; ADRP, Adipose Differentiation 
Related Protein; ADR, adrenergic receptor; GR, glucocorticoid receptor.  
Values are means ± SEM.  
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4.4 Discussion 
This study demonstrates that suboptimal maternal nutrition between 
early-to-mid gestation, followed by restoration of feeding to appetite up 
to term, enhances both adiposity and adipogenic potential in the near-
term fetus (Ojha et al. 2013).  
4.4.1 Suboptimal maternal nutrition in early-to-mid gestation 
followed by ad libitum feeding enhances fetal 
adiposity 
Although maternal and fetal total body weights were unaffected at term, 
fetal adiposity, including pericardial adipose tissue deposition, was 
raised. Human infants born with growth restriction exhibit increased 
visceral adiposity (Harrington et al. 2004) and, in ovine models, when 
suboptimal maternal nutrition during early-to-mid gestation (Bispham et 
al. 2003) is followed by rearing in an obesogenic environment, ectopic 
lipid accumulation is enhanced in the liver, kidney and heart (Chan et al. 
2009, Hyatt et al. 2011, Fainberg et al. 2013). Increased visceral 
adiposity is an established risk factor for cardiovascular disease and, in 
particular, raised pericardial adiposity is closely associated with 
coronary vascular pathologies (Taguchi et al. 2001). The greater total 
visceral and pericardial adiposity observed in this study are, therefore, 
consistent with studies showing that offspring of mothers who were 
subjected to suboptimal nutrition during embryonic and placental 
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development have higher blood pressure and compromised 
cardiovascular physiology in later life even in the absence of changes in 
birth weight (Gopalakrishnan et al. 2004). These findings further support 
the view that development of the fetus, particularly of adipose tissue, 
can be programmed by changes in maternal nutrition even in the 
absence of alterations in overall fetal growth. 
4.4.2 Suboptimal maternal nutrition in early-to-mid gestation 
followed by ad libitum feeding enhances adipogenic 
potential in the fetal pericardial depot 
Importantly, this study demonstrates that gene expression of several 
adipogenic transcription factors were upregulated in the pericardial 
depot of the nutritionally manipulated foetuses (Figure 4.4). BMP7 
promotes differentiation of brown preadipocytes and can activate the full 
programme of brown adipogenesis (Tseng et al. 2008). It induces 
robust expression of UCP1 mRNA as well as the expression of several 
EURZQDGLSRJHQLFIDFWRUVLQFOXGLQJ33$5ȖDQG&(%3ȕ(Tseng et al. 
2008),DOVRIRXQGDVLJQLILFDQWLQFUHDVHLQ&(%3ȕP51$H[SUHVVLRQ
whiFKFRXOGEHLPSRUWDQWDVWKH&(%3ȕ±PRDM16 complex is essential 
for the switch of cells from a myogenic to brown adipogenic lineage 
(Kajimura et al. 2009). C/EB3ȕDOVRLQGXFHVWKH&(%3Į-33$5Ȗ
complex which promotes adipogenesis along the white adipocyte 
lineage in parallel to increased brown adipogenic transcription factors.  
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I have also demonstrated enhancement of gene expression of several 
factors involved in ZKLWHDGLSRJHQHVLVLQFOXGLQJ&(%3Į%03DQG
HoxC9, which were all upregulated after suboptimal nutrition between 
early-to-mid gestation followed by ad libitum feeding. BMP4 triggers the 
commitment of pluripotent cells to the white adipocyte lineage (Tang et 
al. 2004). Like HoxC9, BMP4 expression is present in ovine adipose 
tissue from mid-gestation, peaks after birth (Pope et al. 2014) and is 
highly expressed in white adipose tissue in both mice and humans 
(Billon and Dani 2012).  
Enhanced cell proliferation in the pericardial depot is also suggested by 
the upregulation of Ki-67 mRNA, a protein associated with cell 
proliferation and is present in all active phases of the cell cycle 
(Scholzen and Gerdes 2000). I found that the gene expression of white 
adipogenic transcription factors was increased more than that of the 
brown adipogenic genes. For example, gene expression of BMP4 and 
&(%3Įwas increased two fold and expression of HoxC9 increased 
nearly four times in the offspring of mothers subjected to suboptimal 
nutrition. Upregulation of all these key transcription factors suggests 
that both brown and white adipogenesis are enhanced when the fetus is 
subjected to suboptimal maternal nutrition in early-to-mid gestation 
followed by the restoration of ad libitum feeding. 
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4.4.3 Suboptimal maternal nutrition in early-to-mid gestation 
followed by ad libitum feeding increases thermogenic 
potential of the fetal pericardial depot 
In these near-term fetuses, sampled from nutritionally manipulated 
mothers, I found that enhanced adipogenesis was accompanied by 
increases in pericardial adipose tissue UCP1 abundance and gene 
expression. Moreover, the effect of maternal nutrition on UCP1 gene 
expression and protein abundance was independent of maternal and 
fetal weights, and the amount of pericardial adipose tissue present in 
the near-term fetus.  
Along with the increase in UCP1, gene expression IRUȕDQGȕ$'5V 
were also enhanced in the fetus of the nutritionally manipulated 
mothers. Proliferation, differentiation and metabolism of mature brown 
DGLSRF\WHVDUHJRYHUQHGE\DGUHQHUJLFVWLPXODWLRQIURPWKHȕ$'5DQG
this would, therefore, be predicted to facilitate an enhanced 
thermogenic potential (Cannon and Nedergaard 2004). Mature brown 
DGLSRF\WHVDOVRSRVVHVVȕ$'5VDOWKRXJKWKH\DUHXVXDOO\PRUH
prominent in preadipocytes where their activation is coupled to cAMP 
production (Bronnikov et al. 1999). Increased gene expression of 
ȕ$'5PD\, therefore, be due to increased proliferation of 
preadipocytes.  
In contrast, insulin receptor gene expression was downregulated 
despite the restoration of maternal nutrition from mid gestation. Insulin 
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signalling is mediated by a series of pathways activated by insulin 
acting on its cytoplasmic receptor and reduced stimulation of this 
pathway leads to systemic insulin resistance (Wellen and Hotamisligil 
2005). Reduced insulin receptor gene expression could be a precursor 
of insulin resistance that accompanies obesity and ectopic lipid 
accumulation (DeFronzo and Ferrannini 1991). Indeed, this 
maladaptation is found when the offspring are reared in an obesogenic 
environment and exposed to juvenile onset obesity (Chan et al. 2009). 
Enhanced fetal pericardial adiposity, including raised brown and white 
adipogenesis and greater UCP1 abundance could provide the formerly 
nutritionally compromised fetus with a survival advantage by increasing 
its metabolic response to cold exposure at birth. The greater adiposity 
may further enable the offspring to withstand a period of suboptimal 
nutrition in later life. However, when this fetus is delivered into an 
environment of nutrient sufficiency or excess, the enhanced adipogenic 
potential, particularly in the white adipogenic lineage, is likely to be 
detrimental to long term metabolic health (Symonds et al. 2012). 
Increased pericardial adipose tissue volume is associated with several 
cardio-metabolic pathologies (Ding et al. 2008) and regulates the 
presence (Liu et al. 2010) and severity of coronary artery disease in 
adult humans (Taguchi et al. 2001). The findings of this study suggest 
that the origins of excess pericardial adiposity may lie in early fetal 
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development and suboptimal maternal nutrition can programme 
increased pericardial adiposity and enhance adipogenesis in this depot.  
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Figure 4.4. Effect of suboptimal maternal nutrition in early-to-mid gestation on adipogenesis  
Suboptimal maternal nutrition in early-to-mid gestation increases gene expression of transcription factors involved in both brown and white adipogenesis. 
UCP: uncoupling protein; BMP: bone morphogenetic protein; ADRP: adipose differentiation related protein; Hox: homobox; RIP: receptor interacting protein; 
PRDM: PR (PRD1-BF1-RIz1 homologous)-domain-containing protein; C/EBP: CCAAT enhancer binding protein 
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4.5 Conclusion 
The development of adipose tissue in offspring subjected to suboptimal 
maternal nutrition now needs to be further studied in order to elucidate 
the precise mechanisms underlying the progression from excess 
adipogenic potential in the pericardial depot to cardiovascular illness in 
adulthood. Previously, in the study in Chapter 3, I have shown that 
pericardial adipose tissue is a primary target of nutritional programming 
(Ojha et al. 2013) and, in the present study, I have demonstrated further 
that suboptimal maternal nutrition followed by ad libitum feeding in late 
gestation produces changes in pericardial adipose tissue, which may be 
the beginning of excess pericardial adiposity and cardiovascular illness 
in later life.  
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5 Epicardial fat is a depot of brown adipose 
tissue in adult humans 
The work described in this chapter has been published (Sacks et al. 
2013). The article is included in Appendix 10.4.2.  
5.1 Introduction 
Epicardial adipose tissue (EAT) is the fat present between the heart and 
the visceral layer of the pericardium i.e. in direct contact with the 
myocardium (Figure 1.9). EAT is anatomically and clinically related to 
cardiac morphology and function and is believed to be a metabolically 
active organ that generates several bioactive molecules, which may 
affect cardiac function and the evolution of cardiac pathologies 
(Iacobellis et al. 2005). Although EAT has the gross appearance of 
white fat in human adults, it evolves from brown adipose tissue (BAT) 
and has recently been shown to express high levels of uncoupling 
protein (UCP) 1 mRNA (Sacks et al. 2009).  
In adipose tissue samples collected from 28 patients undergoing 
coronary artery bypass grafting (CABG) for critical coronary 
atherosclerosis, Sacks et al. found that UCP1 gene expression was 5-
fold higher in EAT when compared to substernal fat. UCP1 gene 
expression was even lower (barely detectable) in samples taken from 
subcutaneous adipose tissue from the sternum, abdomen and leg 
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(Sacks et al. 2009). The gene expression of other BAT related genes, 
35'0DQG3*&ĮZHUHDOVRKLJKHULQ($7ZKHQFRPSDUHGWR
subcutaneous fat (Sacks et al. 2009). These findings raised the 
possibility that EAT functions as a depot of BAT. However, gene 
expression of UCP1 is not definite evidence of the existence of BAT. 
Presence of the protein is required to conclusively demonstrate that 
EAT is a depot of brown fat.  
5.1.1 Hypothesis and aim 
The hypothesis for this study, as mentioned in Chapter 1 (Section 
1.12.3), is given that in adult humans, relatively high levels of UCP1 
gene expression is present in EAT, I hypothesised that UCP1 is 
significantly more abundant in EAT when compared to other adipose 
tissue depots thus confirming that epicardial fat is a depot of BAT in 
adult humans. 
5.2 Methods 
5.2.1 Ethical approval 
Details of ethical approval and other procedural and legislative 
declarations are explained in Chapter 2 (Section 2.1.2.1). 
5.2.2 Adipose tissue samples 
The adipose tissue samples for this study were provided by Professor 
Harold Sacks and were collected from patients undergoing cardiac 
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surgery at The Baptist Heart, Baptist Memorial Hospital, Memphis, 
Tennessee. The details of sample collection, transfer and storage are 
given in Chapter 2 (Section 2.3.1).  
5.2.3 Preparation of mitochondrial extract 
Mitochondria were prepared from 7 EAT samples (range, 79-411 mg), 3 
paracardial fat samples (196-346 mg), 4 sternal fat samples (196-346 
mg), 3 upper abdominal subcutaneous adipose tissue samples (258-
568 mg) and 2 lower extremity subcutaneous adipose tissue samples 
(365-324 mg) as described in Chapter 2 (Section 2.4.1.5). 
5.2.3.1 Assessment of protein concentration  
Protein concentration of the mitochondrial extract was determined by 
the Bradford method (Bradford 1976) (Chapter 2 (Section 2.4.3.1.2)). 
5.2.3.2 Western Blotting Procedure  
Abundance of UCP1 was determined by Western Blotting using the 
procedure described in Chapter 2 (Section 2.4.3.2). Western Blotting 
was performed using rabbit polyclonal antibody to human UCP1 (ab 
10983; Abcam) at a dilution of 1:1000, together with cytochrome c as a 
reference protein using sc-7159 (Santa Cruz Biotechnology), also at a 
dilution of 1:1000. Specificity of the detection was confirmed using 
nonimmune rabbit serum and a range of molecular weight markers was 
included on all gels. Densitometric analysis was performed on all 
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membranes after image detection using a Fujifilm LAS-1000 cooled 
charge-coupled device camera (Fuji Photo Film Co. Ltd) and results 
were expressed in arbitrary unit. All gels were run in duplicate and 
reference samples (i.e. from either hepatic or pericardial adipose tissue 
of the same 6-h-old sheep) were included on each gel.  
5.2.4 Statistical analysis 
Statistical analysis was performed using IBM SPSS Statistics v.21.0 
statistical software for Windows package (IBM Corporation, NT, USA). 
Kolmogorov-Smirnov normality test was applied to each set of data to 
test whether the distribution was parametric or non-parametric. As data 
were not distributed normally, Kruskall-Wallis one-way analysis of 
YDULDQFHWHVWZLWKSRVWKRF'XQQ¶VFRUUHFWLRQZDVXVHGWRGHWHUPLQH
differences between the groups. GraphPad Prism v 5.00 (GraphPad 
Software, California, USA) software was used to produce all statistical 
graphs. All values are expressed as mean ± SEM.  
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5.3 Results 
There were 2 male and 6 female participants. The details of the 
participants and the types of samples obtained from them are described 
in Table 5.1. The mean (± SEM) age of the subjects was 65.6 (± 1.7) 
years and body mass index was 29.7 (± 1.8) kg/m2. 
5.3.1.1 Mitochondrial protein in adult human adipose tissue  
The mitochondrial protein yield from adult EAT was more than 3-fold 
less than the yield from pericardial fat from 6 hour old sheep (91.6 ± 3.3 
vs. 27.7 ± 3.6 mg/g) however the quantity of protein in adult EAT was 
higher than that in other adipose depots. 
5.3.2 UCP1 in epicardial, visceral paracardial, and 
subcutaneous fat 
UCP1 was highly abundant in each of the EAT samples analysed and 
the amounts were comparable with the UCP1 content of the positive 
control (4-fold dilution of mitochondrial extract prepared from pericardial 
adipose tissue of 6 hour old lamb) (Figure 5.1). 
UCP1 was not detected by Western Blotting in sternal, paracardial, and 
upper abdominal and leg subcutaneous adipose tissue despite similar 
amounts of the reference protein, cytochrome c, being present in all 
samples (Figure 5.1). 
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5.3.3 Correlation between relative protein abundance and 
fold change in gene expression 
Gene expression of UCP1 in the EAT samples analysed in this study 
was measured by Q-PCR by Dr John Fain and Dr Paramjeet Cheema 
and values were provided for statistical analysis. 
There was no correlation between relative protein abundance and fold 
change of gene expression of UCP1 in the 7 EAT samples analysed in 
this study (Figure 5.2). 
5.3.4 Correlation between relative UCP1 abundance and age 
and body mass index  
There was no significant correlation between age and body mass index 
and the relative protein abundance of UCP1 in epicardial adipose tissue 
of the seven subjects included in this study (Figure 5.3).
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Table 5.1. Characteristics of patients 
 
Age 
(years) 
Gender Weight 
(kg) 
Height 
(cm) 
Body mass 
index 
(kg/m2) 
Race Samples 
1 74 Female 63.6 160 24.8 Caucasian Epicardial 
2 65 Female 78.0 154.9 32.5 Caucasian Epicardial, Abdominal, Sternal 
3 61 Female 104.5 165.1 38.3 Caucasian Epicardial 
4 69 Female 85.4 177.8 27.0 Caucasian Epicardial 
5 65 Female 75 157.5 30.2 Caucasian Epicardial, Sternal, Leg, Paracardial 
6 66 Female 61.3 160.0 23.9 Asian Epicardial, Abdominal, Sternal, Leg, Paracardial 
7 67 Male 108.9 177.8 34.4 Caucasian Epicardial, Sternal 
8 58 Male 84.8 178.4 26.6 Caucasian Abdominal, Paracardial 
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Table 5.2. Total mitochondrial protein content of adipose tissue in 
different depots 
Adipose tissue Total mitochondrial protein (mg/g) 
Epicardial fat 27.7 ± 3.6 
Paracardial fat 5.9 ± 0.7 
Sternal fat 12.23 ± 3.6 
Abdominal fat 9.23 ± 3.07 
Leg subcutaneous fat 7.2 ± 3.09 
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Figure 5.1. Relative protein abundance of UCP1 in fat samples 
Optical densities (ordinate) are shown as black bars of Western Blots 
for uncoupling protein 1 (UCP1) from extracts of epicardial, paracardial, 
sterna, abdominal, and lower extremity subcutaneous fat. The number 
of separate patients is shown below each bracket designating the fat 
depot. Individual bands of UCP1 and their corresponding cytochrome c 
as a loading control are seen above the bars. The end bar with a darker 
background was from another membrane (marked with *). The figure 
represents the data from 1 of 5 experiments repeated on different days. 
P: positive control of brown fat mitochondrial protein; N: negative control 
of hepatic mitochondrial protein, both prepared from a 6 hour old lamb. 
No immunoreactive UCP1 was detected in paracardial, sternal and 
subcutaneous depots. 
* 
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Figure 5.2 Correlation between relative protein abundance and fold 
change in gene expression of UCP1 in human epicardial adipose 
tissue 
Adipose tissue samples were obtained from 7 adults undergoing 
cardiac surgery. Protein abundance of uncoupling protein 1 (UCP1) was 
estimated by Western Bolt and fold change in gene expression was 
calculated by quantitative polymerase chain reaction.  
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Figure 5.3. Correlation between relative protein abundance of uncoupling protein 1 (UCP1) in epicardial 
adipose tissue and age and body mass index (BMI) of adult humans  
Adipose tissue samples were obtained from 7 adults undergoing cardiac surgery. Protein abundance was estimated 
by Western Bolt. 
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5.4 Discussion 
The major finding of this study is that UCP1 is present in EAT of adult 
humans (Sacks et al. 2013). Sack et al. have previously shown that 
EAT has a significantly higher expression of UCP1 gene when 
compared to fat from other depots (Sacks et al. 2009). This study 
demonstrated that the protein itself is present in EAT in quantities that 
are comparable to the amount of UCP1 in pericardial adipose tissue of 
newborn lambs in which UCP1 is maximally expressed and activated 
(Ojha et al. 2013). 
Quantitative PCR is a very sensitive technique and measures mRNA 
expression highly efficiently. It can measure very low levels of gene 
expression. Quantitative physiological implications cannot be drawn 
from such measurements of gene expression alone, particularly when 
the crossing points on the Q-PCR are very high i.e. gene expression is 
very low. Changes in gene expression of UCP1 may be a marker of 
tissue response to a stimulus but are not valid parameters for 
estimating physiological function. The total amount of the protein, i.e. 
UCP1,  in the tissue is a better marker of functional capacity (Cannon et 
al. 1981). This study has, therefore, confirmed that human EAT is a 
repository of functional BAT by demonstrating significant levels UCP1 in 
fat samples obtained from this depot. 
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The Western Blots did not detect any UCP1 in paracardial or 
subcutaneous adipose tissue obtained from sternal, upper abdominal, 
and leg regions although Sacks et al. had demonstrated some degree 
of gene expression for UCP1 in these samples. This could be because 
such low levels of gene expression may not translate into protein 
abundance that are detectable by Western Blot. 
5.4.1 UCP1 gene expression does not correlate with protein 
abundance in human EAT 
There was no correlation between gene expression and relative protein 
abundance of UCP1 in EAT of adult humans. However, as this study 
was performed on the samples left over from a previous study (Sacks et 
al. 2009), I had only 8 participants and hence the power is not sufficient 
to detect a correlation, should there be one.  
Despite the lack of statistical power, it should be considered that this 
lack of correlation between gene expression and protein abundance is 
in keeping with the findings in newborn lambs (Chapter 3 (Section 
3.3.8) and could be due to differences in the half-life of proteins and 
mRNA and/or due to one of the many steps involved in translation of 
gene expression into protein abundance and/or several post-
translational mechanisms and regulatory processes that affect the 
turnover of proteins (Greenbaum et al. 2003).  
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The lack of correlation may be accentuated by the inaccuracies in the 
quantitative techniques used. Western Blotting is a quasi-quantitative 
method and there are many potential challenges in obtaining 
appropriate and reliable quantification when using this procedure. 
Studies suggest that up to 25% of quantitative data obtained from 
Western Blotting may be inappropriately interpreted (Taylor et al. 2013). 
Even with the use of innovative, highly precise technologies such as 
next-generation sequencing for quantification of RNA abundance and 
novel proteomics, squared Pearson correlation coefficient achieved 
between cellular concentrations of proteins with their corresponding 
mRNA abundance is ~0.4, suggesting that only 40% of variation in 
protein concentration can be explained by changes in mRNA 
expression (Vogel and Marcotte 2012).  
5.4.2 UCP abundance in human EAT does not correlate with 
BMI or age of the subjects 
There was no correlation between UCP1 abundance and age or body 
mass index (BMI) of the subjects studied. Other studies, with larger 
numbers of subjects, have reported that UCP1 positivity correlates with 
BMI and age. On examination of adipose tissue obtained from the neck 
of 35 adults, Zingaretti et al. reported that UCP1 positive (as measured 
by immunohistochemistry) subjects were mainly those who were 
younger and leaner (Zingaretti et al. 2009). The age range of the 
subjects studied by Zingaretti et al. was 18 to 82 years and the mean (± 
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SEM) age of the UCP1 positive subjects was 39 (± 5) years. The 7 
subjects in this study were older (range 58-74 years) and this may be 
the reason for the lack of correlation between age and UCP1 
abundance.  
BAT activity as measured by radioactive fluoride (18F) labelled 
fluorodeoxyglucose (FDG) positron emission tomography/computed 
tomography (PET-CT) has also been reported to correlate with age and 
BMI but some aspects of the reports are conflicting. Cypess et al. 
detected BAT most frequently in patients younger than 50 years and 
those who were the least obese among their cohort of 3640 subjects 
who underwent 18F-FDG PET-CT scanning but BMI was a significant 
predictor of presence of BAT only in the older subjects (Cypess et al. 
2009). In contrast, Pfannenberg et al. reported a significant negative 
correlation between BAT activity and BMI in younger male subjects 
while in females the strong negative correlation persisted at all ages 
(Pfannenberg et al. 2010). Six of the 7 subjects in this study were 
females but this study did not demonstrate any relationship between 
BMI and UCP1 abundance. This may be due to limited number of 
samples or because 18F-FDG PET-CT studies estimate BAT activity 
and have classified individuals as BAT positive or BAT negative while in 
this study, the correlation was measured between the relative quantity 
of UCP1 and BMI. The amount of protein may not be the same as 
200 
 
presence of concurrently active BAT especially in the absence of stimuli 
that activate UCP1. 
5.4.3 The limitations 
The samples analysed in this study were the tissue remaining from a 
previous study (Sacks et al. 2009) and the number of samples and the 
amount of tissue available for analysis were limited. Although the 
original study was prospectively conducted, this analysis was done in 
retrospect. 
The cohort had a mean age of 66 years and BMI of nearly 30 kg/m2. 
Studies investigating the presence of BAT in adult humans have 
generally shown that active BAT is more prevalent in younger and 
leaner individuals (Cypess et al. 2009, van Marken Lichtenbelt et al. 
2009, Pfannenberg et al. 2010) hence this cohort was not particularly 
appropriate group to measure BAT activity. In additions, due to ethical 
considerations, adipose tissue samples such as supraclavicular fat, 
which would be more suitable for comparing UCP1 presence, were not 
acquired. Comparison between depots was dependent on the sites that 
the surgeon would require to access in the normal course of the open 
heart surgery. 
5.4.4 Significance of UCP1 in human EAT 
Until very recently, interest in BAT was restricted to researchers in 
mitochondrial bioenergetics and hibernation and the only role of BAT in 
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humans was thought to be the maintenance of body temperature in 
newborn infants. The rediscovery of BAT in adult humans regenerated 
interest and recent studies have demonstrated that BAT may have a 
role in energy homeostasis and intermediary metabolism in human 
adults. The presence of BAT in EAT i.e. in close proximity and with 
intimate vascular connections with the myocardium and coronary 
vasculature raises the possibility that BAT may have a role in cardiac 
metabolism.  
Bartelt et al. demonstrated that activating BAT increases the turnover of 
triglyceride rich lipoproteins and clears triglycerides from the circulation 
(Bartelt et al. 2011). In a pathophysiological model of hyperlipidaemia 
(Apoa5-/- mice), they showed that BAT activation by cold exposure 
corrected plasma lipid concentrations within hours. In models of obesity, 
they also found that the clearance of triglyceride rich lipoproteins by 
brown adipocytes was independent of insulin concentrations and insulin 
resistance in the animal. This demonstrates that active BAT can 
improve deleterious effects of obesity and hyperlipidaemia, despite 
insulin resistance.  
In addition to its role in lipid metabolism, BAT is also a major organ of 
glucose disposal. Presence of active BAT in adult humans was 
rediscovered due to the highly active uptake of glucose by this tissue 
(Hany et al. 2002). BAT is highly sensitive to insulin action and insulin-
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stimulated glucose uptake by brown adipocytes is close to skeletal 
muscle uptake (Orava et al. 2011). In addition, stimulation of BAT such 
as by cold activation, results in rapid uptake of glucose, independent of 
insulin action.  
The above evidence indicates that BAT may have a beneficial effect on 
metabolic balance, both for lipid and glucose metabolism. Brown 
adipocytes in EAT may act as lipid and glucose clearing mechanisms 
prior to the blood reaching the coronary circulation and may have 
metabolic functions other than, or in addition to, its thermogenic role.  
5.5 Conclusion 
EAT from adult humans contains UCP1 confirming that EAT is a BAT 
depot. In view of the potential role of BAT in regulation of lipid and 
glucose metabolism, this may have therapeutic implications for 
treatment of cardiovascular complications of obesity. 
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6 Brown adipose tissue is present in epicardial 
fat of newborn infants, children and 
adolescents 
6.1 Introduction 
A plethora of recent imaging studies using positron emission 
tomography and computed tomography (PET/CT) (Drubach et al. 2011, 
Chalfant et al. 2012, Gilsanz et al. 2012) have demonstrated that brown 
adipose tissue (BAT) persists beyond infancy in children and 
adolescents and that the major depots of BAT correspond to those 
found in the early anatomical studies (Aherne and Hull 1966). 
Excess fat deposition around the heart has well established links with 
cardiovascular diseases in adults (Taguchi et al. 2001, Ding et al. 2009) 
and recent advances in obesity research have demonstrated links 
between paediatric obesity and metabolic and cardiovascular 
morbidities suggesting that a similar relationship exists in childhood 
(Cote et al. 2013). Although some earlier studies in children failed to 
demonstrate any link between epicardial fat thickness and markers of 
the metabolic syndrome such as insulin resistance (Mazur et al. 2010), 
increasing evidence suggests that fat deposition around the heart may 
be a useful tool in assessing cardiovascular risk in children (Cote et al. 
2013).  
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Among pre-pubertal and early pubertal obese children, those who are 
insulin resistant have higher volumes of epicardial fat as compared to 
those who are insulin sensitive (Manco et al. 2013). The process of 
atherosclerosis can start at an early age and epicardial fat in children 
and adolescents shows a positive and significant correlation with carotid 
intima-media thickness (Boyraz et al. 2013, Cabrera-Rego et al. 2014), 
a sensitive marker of atherosclerosis and cardiovascular morbidity and 
mortality in the adult population (Lorenz et al. 2007).  
In view of the potential importance of epicardial fat in the genesis of 
cardiovascular pathologies and the metabolic syndrome and my 
previous work demonstrating that BAT is present in the epicardial depot 
in adults (Chapter 5) (Sacks et al. 2013), I aimed to investigate that 
presence of BAT in fat depots around the heart in children.  
Children with congenital heart disease often require cardiac surgery 
during which a sample of epicardial adipose tissue may be collected for 
analysis. With appropriate ethical and regulatory approvals, and 
informed parental consent, I aimed to collect epicardial fat samples from 
children undergoing heart surgery at the Glenfield Hospital, Leicester. 
Due to the nature of their illness, children with congenital cardiac 
disease may have persistent hypoxia, co-morbidities, and may be on 
medications. As discussed in Chapter 1 (Section 1.6), hypoxia and 
medications such as ȕ-adrenergic blockers can affect BAT. Therefore, I 
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aimed to collect relevant clinical information (Section 6.2.4) about the 
children who participated in the study. I also collected information about 
the participDQW¶VHWKQLFRULJLQEHFDXVHYROXPHDQGDFWLYLW\RI%$7PD\
differ in individuals of different racial origins (Bakker et al. 2014, 
Robinson et al. 2014).  
6.1.1 Hypothesis 
As in Chapter 1 (Section 1.12.4), I hypothesised that BAT is present in 
epicardial depot in infants and children and, given that gene expression 
of the unique BAT protein, uncoupling protein 1 (UCP1), in human 
adults is inversely proportional to BMI and is higher in women than in 
men (Cypess et al. 2009), that the gene expression of UCP1 is 
correlated with age and weight for age and is higher in girls than in 
boys. I also hypothesised that UCP1 gene expression will be higher in 
children of Caucasian origin when compared to children of Asian (Indian 
sub-continent) origin.  
Propranolol is a non-VHOHFWLYHȕ-adrenergic antagonist. As discussed in 
Chapter 1 (Section 1.6.3), development and metabolism of brown fat as 
well as regulation of the UCP1 gene is under adrenergic control and is 
WKRXJKWWREHPDLQO\UHJXODWHGE\ȕ-adrenergic receptors (ȕADR) 
(Cannon and Nedergaard 2004). Therefore, I hypothesised that gene 
expression of UCP1 is downregulated in children receiving regular 
propranolol therapy. 
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6.2 Methods 
6.2.1 Ethical and Regulatory Approvals 
The study was approved by National Research Ethics Service 
Committee (NRES) East Midlands ± Nottingham 2 (REC reference 
number: 12/EM/0214). Further details of ethical and regulatory 
approvals obtained for this study are given in Chapter 2 (Section 
2.1.2.2). 
6.2.2 Adipose tissue samples 
Adipose tissue samples for this study were collected with informed 
parental consent, from children undergoing cardiac surgery at the East 
Midlands Congenial Heart Centre at the Glenfield Hospital, Leicester by 
the Paediatric Cardiothoracic Surgery team under the supervision of Mr 
Attilio Lotto (Paediatric Cardiothoracic Surgeon). All participants had 
congenital heart disease and the samples were taken at the time of the 
surgery immediately prior to the child being put onto cardio-pulmonary 
bypass. This ensured that all participants were normothermic in the 
hours before, and at the time of sample collection. 
Although, due to small volumes, it is difficult to consistently separate the 
fat present around the heart in infants and children into epicardial 
adipose tissue (i.e. fat present between the myocardium and visceral 
pericardium) and paracardial adipose tissue (i.e. fat present between 
the visceral and parietal layers of the pericardium) at dissection (Greif et 
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al. 2009, McAuley et al. 2011, Wong et al. 2011), fat for this study was 
taken from as close to the myocardium as possible and is, therefore, 
considered to be primarily epicardial adipose tissue.   
A sample of epicardial adipose tissue (approximately 5 grams) was 
collected during the dissection of the pericardium as a part of the 
standard process undertaken during cardiac surgery. Cardiac surgery is 
mostly performed through a median sternotomy. The pericardial sac is 
opened to reach the heart and great vessels and pericardiotomy is 
SHUIRUPHGDVDQLQYHUWHGµ7¶7KLVRSHQV the pericardium longitudinally 
with an extension transversally at the level of the diaphragm. Adipose 
tissue is present in this area. A small sample from this fat was removed 
taking care to obtain the sample from as close to the myocardium as 
possible. Approximately 3 grams of tissue were placed in a collection 
tube containing 20 ml of Allprotect Tissue Reagent® (Qiagen, West 
Sussex, UK) for RNA extraction and lipid analysis and another 2 grams 
were placed in a tube containing 3% formalin for immunohistochemistry 
and stored at room temperature.  
With appropriate ethical and regulatory approvals and in keeping with 
the Human Tissue Act 2004, samples were transferred to the Academic 
Division of Child Health, University of Nottingham. The samples 
preserved in Allprotect Tissue Reagent® were transferred at room 
temperature. In the laboratory, the sample was removed from the 
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solution, snap frozen in liquid nitrogen, and stored at -80°C until further 
analysis. The formalin-fixed samples were transferred and stored at 
room temperature until further analysis.  
Further details of sample collection, storage and transfer are given in 
Chapter 2 (Section 2.3.2).  
6.2.3 Laboratory analysis 
6.2.3.1 Analysis of gene expression 
RNA was extracted from the adipose tissue samples as described in 
Chapter 2 (Section 2.4.1.1). The extracted RNA was tested for purity 
and integrity by the Nanodrop®ND-1000 (Nanodrop Technologies, 
Wilmington, USA) and the Agilent 2100 Bioanalyzer (Agilent 
Technologies, USA) as described in Chapter 2 (Section 2.4.1.1.3). RNA 
was extracted from adipose tissue samples taken from all 63 children 
who participated in the study. On testing for purity and integrity, 57 out 
of the 63 RNA samples had RNA integrity number (RIN) >7 and intact 
18S and 28S fragments. These 57 samples were selected for further 
analysis as the quality of RNA extracted from the remaining 6 samples 
was unsuitable for gene expression analysis.  
Gene expression was analysed by microarray analysis. I choose to 
utilise microarray technology to measure gene expression in these 
samples rather than analyse individual gene expression by Q-PCR as in 
the previous studies because microarray technology is capable of 
209 
 
making thousands of gene expression measurements simultaneously 
and allows the quantification of a large number of transcripts in a single 
experiment (Stoughton 2005). This technology is ideally suited to the 
early phases of biological research and high throughput screening 
studies, where changes in expression of a large number of genes can 
be examined in relation to key biological characteristics or events 
(Blohm and Guiseppi-Elie 2001). As the human genome has been 
successfully sequenced (International Human Genome Sequencing 
2004), pre-prepared gene arrays are available to perform large scale 
microarray analyses on human samples. These gene arrays are DNA 
probes printed onto glass that are used to detect target complementary 
DNA in the sample. In addition, this technology is available in only a 
limited number of laboratories. For this study, the microarray assay was 
performed by Dr Marcos Castellanos and colleagues at the Nottingham 
Arabidopsis Stock Centre (University of Nottingham, Sutton Bonington 
Campus, Plant Science Building, School of Biosciences, Loughborough, 
UK) using the GeneChip® ¶,97([SUHVVkit (Affymetrix, High 
Wycombe, UK) as described in Chapter 2 (Section 2.4.1.5). As the 
sheep genome has not been completely sequenced yet, this technology 
could not be applied to samples in my studies in sheep.  
6.2.3.2 Immunohistochemistry  
As described in Chapter 2 (Section 2.4.3.3), the formalin fixed tissue 
samples were rehydrated, loaded into Histosette II (Simport, Quebec, 
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Canada) cassettes and processed by ethanol dehydration followed by 
xylene rinse. The samples were then embedded in paraffin wax by the 
Shandon ExcelsiorTM tissue wax processor (Thermo Scientific). Five 
micrometre tissue sections were cut from the samples using a sledge 
microtome (Anglia Scientific, Cambridge, UK) and mounted on to 
SuperfrostTM Plus slides (Menzel-Gläser Inc, Braunchweig, Germany). 
Two slides per participant and a negative control were labelled with a 
random identifier and loaded into the Lecia BondMaxTM IHC slide 
processor (Leica Microsystem, Wetzlar, Germany) and run on the 
automated software programme (Vision Biosystems Bond Version 3.4A) 
using bond polymer refine detection reagents (Leica Microsystem, 
Wetzlar, Germany) and 1:500 dilution of pre-optimised primary rabbit 
polyclonal antibody to UCP1 (ab10983, Abcam, Cambridge, UK) for the 
antibody positive samples. Full details of the procedure are given in 
Chapter 2 (Section 2.4.3.3.3). 
6.2.4 Data collection 
Each participant¶s date of birth and date of surgery were recorded. The 
age of the participant at sample collection was calculated from these 
two dates. In addition, information about gender and ethnic origin was 
collected. All the participants had some form of congenital heart disease 
and data about the cardiac and any other co-existing medical 
FRQGLWLRQVWKHLQGLYLGXDO¶VEDVHOLQHR[\JHQVDWXUDWLRQOHYHO
medications (particularly regular ȕ blocker), weight and height on the 
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day of admission were also collected. These data were collected using 
a standardised proforma (Appendix 10.2). 
6.2.5 Statistical analysis 
The anthropometric assessments of participants was performed using 
the Emergency Nutrition Assessment Tool (Erhardt and Pollgorm 2011) 
and the World Health Organisation (WHO) Anthro (version 3.2.2, 
January 2011). Statistical analysis for initial quality control of labelling 
and hybridisation, as well as data analysis of the microarray results 
were conducted using the Partek software (Partek Inc., St. Louis, USA). 
Multiple gene expression comparisons (Table 6.10 and Table 6.11) 
were performed using this software. The programme is automated such 
that it assigns statistical significance to a result only if the p value is 
<0.05 after correction for multiple testing and only if there is a 1.5 times 
fold change difference between the two groups (to ensure that the 
difference has some biological significance).  
Other statistical analyses were performed using IBM SPSS Statistics 
v.21.0 statistical software for Windows package (IBM Corporation, NT, 
USA). 
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6.3 Results 
With appropriate informed consent, adipose tissue samples were 
collected from 63 children undergoing cardiac surgery. There were 42 
boys and 20 girls. Congenital heart diseases present early in life and 
most children undergo cardiac surgery in the first two years of life. As a 
consequence, only 15 out of the 63 participants were over two years of 
age; the median age was 0.68 years (range 0.1-17.05). 
Further characteristics of the participants are given in Table 6.1. The 
cardiac and other diagnoses of the participants and their regular 
medications are given in Appendix 10.3 (Table 10.1). 
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Table 6.1 Basic characteristic of the participants 
  Total 
participants 
Gene Analysis 
participants 
 n = 63 n = 57 
Gender 
Male 42 38 
Female 20 18 
Information missing 1 1 
Ethnic 
origin 
Caucasian 51 45 
Asian 10 10 
Other 2 2 
Information missing 0 0 
ȕ blocker 
therapy 
Yes 8 7 
No 53 49 
Information missing 2 1 
Baseline 
oxygen 
saturation 
 37 33 
<92% 24 23 
Information missing 2 1 
Total participants: all the 0-18 year olds who participated in the study; 
Gene analysis participants: those 0-18 year olds whose samples had 
appropriate RNA integrity to be suitable for microarray analysis i.e. 6 
participants were excluded from analysis of gene expression as the 
RNA extracted from their epicardial adipose tissue sample was not 
suitable for further microarray analysis. 
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6.3.1 Anthropometric assessment of participants  
The anthropometric parameters of all 63 participants are described in 
Table 6.2. This table also contains information about the anthropometric 
assessments of the 57 children whose epicardial adipose tissue 
samples yielded RNA suitable for microarray analysis. The only reason 
6 participants were excluded from analysis of gene expression was that 
the RNA extracted from their epicardial adipose tissue sample was 
degraded (as indicated by RIN <7) and therefore, not suitable for further 
analysis. Low quality RNA compromises results derived from microarray 
analysis. If samples with low RIN are processed the Signal to Noise 
ratio used to create a background subtraction is too high and results in 
a variable extent of bias in quantification of different transcripts (Auer et 
al. 2003). It is recommended that samples with RIN <7 should not be 
used for analysis (Thompson et al. 2007). 
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Table 6.2 Anthropometric assessment of all participants and those 
included in gene analyses 
  Total 
participants 
Gene Analysis 
Participants 
 n = 63 n = 57 
WAZ 
Male -1.037 ± 0.25 -1.33 ± 0.23 
Female -1.36 ± 0.36 -1.09 ± 0.47 
HAZ 
Male -0.66 ± 0.27 -0.80 ± 0. 32 
Female -0.11 ± 0.38 -0.02 ± 0.44 
WHZ 
Male -0.96 ± 0.30 -1.36 ± 0.26 
Female -1.51 ± 0.41 -1.43 ± 0.51 
BMI z-score 
Male -0.63 ± 0.22 -0.66 ± 0.17 
Female 0.76 ± 0.27 -0.33 ± 0.27 
The values are mean ± standard error of mean (SEM). 
WAZ, weight for age z-score; HAZ, height for age z-score; WHZ, 
weight for height z-score; BMI, body mass index 
Total participants: all the 0-18 year olds who participated in the study; 
Gene analysis participants: those 0-18 year olds whose samples had 
appropriate RNA integrity to be suitable for microarray analysis i.e. 6 
participants were excluded from analysis of gene expression as the 
RNA extracted from their epicardial adipose tissue sample was not 
suitable for further microarray analysis.  
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6.3.1.1 Anthropometric measures of children 0-2 years of age 
As mentioned at the beginning of Section 6.3, most of the participants 
were \HDUVRIDJH$PRQJWKHFKLOGUHQZKRVHHSLFDUGLDODGLSRVH
WLVVXHVDPSOHV\LHOGHG51$RIVXLWDEOHLQWHJULW\FKLOGUHQZHUH
years in age. As I subsequently selected these for further analysis of 
variations in UCP1 gene expression (Section 6.3.2.2), I analysed their 
anthropometric measures separately. Of these 48 children in the 0-2 
year age group, anthropometric parameters could be computed for 47 
as the information about the gender of one participant was missing.  
The mean ± SEM weight for age z-score (WAZ) of children 0-2 years of 
age was -1.29 ± 0.22; the mean ± SEM height for age z-score (HAZ) 
was -0.52 ± 0.28; the mean ± SEM weight for height z-score was -1.36 
± 0.25; and the mean ± SEM body mass index z-score (BMI z-score) 
was -0.53 ± 0.15. In this cohort, there was no difference in the 
anthropometric parameters between boys and girls (Table 6.3) but the 
children of Asian/mixed ethnicity were lighter and shorter than the 
Caucasian children (Table 6.4). As they were proportionately lighter and 
shorter, there was no significant difference in the weight for height or 
BMI z-scores (Table 6.4). Despite the small number of Asian children in 
this study, it is important to note the significant differences in 
anthropometry as adipose tissue development in early life can be 
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affected by both growth and racial origin and the effect of one may be 
confounded by the other.  
Table 6.3. Weight for age, height for age and body mass index z-
scores of 0-2 year old children 
Anthropometric 
parameter 
Males 
(n = 33) 
Females 
(n = 14) p value 
WAZ -1.28 ± 0.24 -1.07 ± 0.51 0.14 
HAZ -0.72 ± 0.33 -0.01± 0.48 0.67 
BMI z-score -0.60 ± 0.18 0.21 ± 0.26 0.20 
WAZ, weight for age z-score; HAZ, height for age z-score; BMI, body 
mass index 
 
Table 6.4. Weight for age, height for age and body mass index z-
scores of 0-2 year old children classified according to ethnic origin 
Anthropometric 
parameter 
Asian/Mixed 
(n = 11) 
Caucasian 
(n = 36) p value 
WAZ -2.51 ± 0.40 -0.94 ± 0.23 0.004 
HAZ -1.57 ± 0.41 -0.18± 0.34 0.016 
BMI z-score -0.99 ± 0.43 0.45 ± 0.16 0.273 
WAZ, weight for age z-score; HAZ, height for age z-score; BMI, body 
mass index 
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Infants with congenital heart disease are generally of normal size at 
birth (Kramer et al. 1990) and suffer faltering growth later in infancy 
(Salzer et al. 1989). Therefore, to further analyse the growth of the 0-2 
year old participants, I performed sub-group analyses of growth in 
QHZERUQLQIDQWVGD\VRIDJHDQGWKRVHROGHUWKDQGD\VLH
29 days to 2 years of age) and reanalysed their anthropometric 
measures.  
6.3.1.1.1 Newborn infant anthropometric measures were normal 
but Asian infants were significantly lighter and shorter 
than Caucasian infants. 
7KHUHZHUHQHZERUQLQIDQWVGHILQHGDVGD\VRIDJH out of the 
48 infants in the 0-2 year age group. Mean anthropometric parameters 
of the newborn infants (n = 15) were within 1 SD of the normal (mean ± 
SEM WAZ, -0.39 ± 0.35; HAZ, -0.12 ± 0.51; WHZ, -0.81 ± 0.38; BMI z-
score, -0.49 ± 0.32) although the newborn infants of Asian origin were 
significantly lighter and shorter than the Caucasian newborn infants 
(Table 6.6). There was no difference in WAZ, HAZ or BMI z-score 
between newborn males and females (Table 6.5). 
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Table 6.5. Weight for age, height for age and body mass index z-
scores of newborn infants classified according to gender 
Anthropometric 
parameter 
Males 
(n = 12) 
Females 
(n = 3) p value 
WAZ -0.50 ± 0.40 -0.03 ± 1.05 0.56 
HAZ -0.02 ± 0.63 -0.44 ± 0.81 0.75 
BMI z-score -0.69 ± 0.29 0.17 ± 1.06 0.27 
WAZ, weight for age z-score; HAZ, height (length) for age z-score; BMI, 
body mass index 
 
 
Table 6.6 Weight for age, height for age and body mass index z-
scores of newborn infants classified according to ethnic origin 
Anthropometric 
parameter 
Asian 
(n = 4) 
Caucasian 
(n = 11) p value 
WAZ -1.32 ± 0.29 0.02 ± 0.43 0.026 
HAZ -1.50 ± 0.17 0.50 ± 0.63 0.013 
BMI z-score -0.76 ± 0.68 0.38 ± 0.38 0.646 
WAZ, weight for age z-score; HAZ, height for age z-score; WHZ, weight 
for height  z-score; BMI, body mass index 
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6.3.1.1.2 Wasting was present in one-third of children 
undergoing cardiac surgery between 29 days and 2 
years of age 
The group of children between 29 days and 2 years (n = 33) of age 
consisted of 11 females and 21 males (data missing for one child). 
Seven children were of Asian or mixed ethnic origin, 5 were on regular 
propranolol therapy and 12 were classified as having low baseline 
oxygen saturation levels. 
Eleven out of the 33 (33%) children between 29 days and 2 years of 
age had WAZ scores less than ±2 SD of that expected for their age and 
gender.  The mean ± SEM WAZ in this group was -1.66 ± 0.25. Height 
was less affected; 8 out of 33 (24%) children were stunted (HAZ <- 2 
SD) and the mean HAZ ± SEM was -0.69 ± 0.33. As a number of 
children were both wasted and stunted, BMI z-score was less affected 
(mean ± SEM, -0.55 ± 0.17). 
In this age group also, children of Asian/mixed ethnic origin were 
significantly lighter than the children of Caucasian origin (mean ± SEM 
WAZ Asian/mixed (n = 7), -3.02 ± 0.43; Caucasian (n = 26), 1.28 ± 
0.25; p = 0.005). However, the difference in HAZ was not significant 
statistically (mean ± SEM HAZ Asian/mixed, -1.49 ± 0.54; Caucasian, 
0.45 ± 0.39; p = 0.143) (Table 6.7). 
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These subgroup analyses (grouped into newborn infants and those 29 
days to 2 years of age) of anthropometric parameters of 0-2 years 
infants demonstrated that, as expected from the known growth pattern 
among children with congenital heart disease (Salzer et al. 1989), 
newborn infants included in this study were of normal size but the older 
children (29 days to 2 years of age) had poor growth as indicated by 
lower WAZ and HAZ. However, children of Asian/mixed ethnic origin 
were significantly lighter than children of Caucasian origin in both age 
groups suggesting that the smaller size of the Asian children may be 
due to genetic differences rather than nutritional in nature. Despite the 
small number of Asian participants in the study, this may be of 
significance as both genetic factors (determined by racial origin) and 
growth in early life (possibly due to nutritional factors) could affect the 
development of adipose tissue.  
Table 6.7. Weight for age and height for age z-scores of 29 days to 
2 year old children classified according to ethnic origin 
Anthropometric 
parameter 
Asian 
(n = 4) 
Caucasian 
(n = 11) p value 
WAZ -3.02 ± 0.43 1.28 ± 0.25 0.005 
HAZ -1.49 ± 0.54 0.45 ± 0.39 0.143 
WAZ, weight for age z-score; HAZ, height for age z-score; WHZ, weight 
for height  z-score 
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6.3.2 Analysis of gene expression 
After RNA extraction, as explained in Section 6.2.3.1, 6 RNA samples 
were excluded from further analysis due to low RNA integrity. 
Microarray analysis for gene expression was performed on 57 samples. 
The description of these participants is given in Table 6.1 and the 
anthropometric assessment is described in Table 6.2. 
6.3.2.1 UCP1 gene is expressed in epicardial fat in children  
As hypothesised, UCP1 gene was highly expressed in the epicardial fat 
of newborn infants. The UCP1 gene was also expressed in epicardial 
fat of older children and did not appear to change to significantly with 
age (Figure 6.1). 
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Figure 6.1. Uncoupling protein 1 (UCP1) gene expression in 
epicardial fat in children 
Epicardial adipose tissue was sampled from children undergoing 
cardiac surgery. Values are means ± SEM. (n, 0-28d = 15; 1-5mo = 12; 
6-11mo = 15; 12-17mo = 3; 18-24mo = 3; >2y = 9). 
mRNA expression is measured as a ratio of the signal intensity 
obtained from the sample relative to the signal intensity obtained from 
the positive control on the microarray gene chip.  
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6.3.2.2 UCP1 in children 0-2 years of age  
As discussed in Section 6.3, 14 out of the total 63 participants were 0-2 
years in age. Among the 57 children whose epicardial adipose tissue 
samples yielded RNA of suitable integrity, 48 children were 0-2 years in 
age. As the remaining 9 children were spread over a relatively much 
wider age range (>2 years to 18 years of age) and data on pubertal 
development of the older children was not available, I selected those 
from 0-2 years of age for further analysis of variations in UCP1 gene 
expression. 
This group of forty eight 0-2 year old children consisted of 33 males and 
14 females (1 information missing). Thirty seven children were of White 
British ethnic origin, 9 were of Asian (Indian sub-continent) origin and 2 
children of mixed ethnicity (both Asian-Caucasian). Six children were on 
regular propranolol treatment. The baseline oxygen saturation level in 
FKLOGUHQZDV92%, while 22 were relatively hypoxic due to cyanotic 
congenital heart disease (oxygen saturation levels ranging between 75-
91% in air). No participant was on regular home oxygen therapy or any 
assisted ventilation prior to admission for surgery. 
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6.3.2.2.1  Effect of gender on expression of UCP1 gene in 
epicardial adipose tissue of children 0-2 years of age 
There were 33 males and 14 females 0-2 year old group. The gene 
expression for UCP1 did not vary significantly with gender (UCP1 
mRNA: males, 9.46 ± 0.57; females, 9.37 ± 0.84 relative signal intensity 
in arbitrary units (mean ± SEM) p = 0.93). 
6.3.2.2.2 Effect of use of propranolol on expression of UCP1 gene 
in epicardial adipose tissue of children 0-2 years of age 
Among the children 0-2 years of age, 6 were receiving regular 
propranolol treatment for their underlying cardiac disease. I found that 
the gene expression for UCP1 did not differ in children on propranolol 
ZKHQFRPSDUHGWRWKRVHZKRZHUHQRWUHFHLYLQJDQ\ȕ-adrenergic 
blockers 8&3P51$QRȕ-blockers, 9.52 ± 0.49; on regular 
propranolol, 9.00 ± 1.38 relative signal intensity in arbitrary units (mean 
± SEM) p = 0.93). 
6.3.2.2.3  Effect of ethnic origin on expression of UCP1 gene in 
epicardial adipose tissue of children 0-2 years of age 
The expression of UCP1 was significantly higher in children of 
Caucasian origin as compared to children who were Asian or of mixed 
ethnicity (UCP1 mRNA: Caucasian, 10.02 ± 0.48; Asian/mixed, 7.61 ± 
0.99 relative signal intensity in arbitrary units (mean ± SEM)  p = 0.02) 
as demonstrated in (Figure 6.2). 
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Figure 6.2  Uncoupling protein 1 (UCP1) gene expression in 
epicardial adipose tissue of children 0-2 years of age 
Epicardial adipose tissue was sampled from children undergoing 
cardiac surgery. Values are means ± SEM; n= 37 Caucasians; 11 
Asian/mixed. *p<0.05 
mRNA expression is measured as a ratio of the signal intensity 
obtained from the sample relative to the signal intensity obtained from 
the positive control on the microarray gene chip.  
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6.3.2.2.4 There is no correlation between UCP1 gene expression 
in epicardial adipose tissue and age in children 0-2 
years of age 
The gene expression of UCP1 did not correlate with age of the 
participants (Figure 6.3). 
 
Figure 6.3  Uncoupling protein 1 (UCP1) gene expression in 
epicardial adipose tissue of children 0-2 years of age does not 
correlate with age 
Epicardial adipose tissue was sampled from children undergoing 
cardiac surgery. Each point represents a child (n = 48) 
mRNA expression of UCP1 is measured as a ratio of the signal intensity 
obtained from the sample relative to the signal intensity obtained from 
the positive control on the microarray gene chip.  
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6.3.2.2.5 UCP1 gene expression in epicardial adipose tissue is 
associated with weight for age z-score in children 0-2 
years of age 
A statistically significant correlation was present between UCP1 gene 
expression in epicardial fat and weight for age z-score of the children 
(Pearson correlation co-efficient = 0.30; r2 = 0.09 p <0.05) (Figure 6.4). 
Whilst this relationship was statistically significant only 9% of the 
variance in UCP1 gene expression could be explained by WAZ. 
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Figure 6.4 Uncoupling protein 1 (UCP1) gene expression in 
epicardial adipose tissue of children 0-2 years of age correlates 
with weight for age z-score 
Epicardial adipose tissue was sampled from children undergoing 
cardiac surgery. Each point represents a child (n = 47); r2 = 0.09; p 
<0.05. 
mRNA expression of UCP1 is measured as a ratio of the signal intensity 
obtained from the sample relative to the signal intensity obtained from 
the positive control on the microarray gene chip. 
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6.3.2.2.6 The correlation between UCP1 gene expression in 
epicardial adipose tissue and weight for age z-score is 
independent of age, gender, baseline oxygen 
saturations and use of propranolol 
On multiple regression analysis, the association between UCP1 gene 
expression in epicardial adipose tissue and weight for age z-score 
remained significant despite correcting for age, gender, baseline 
oxygen saturation levels and use of propranolol in children 0-2 years of 
age (Table 6.8). However, the relationship was no longer statistically 
significant when ethnic origin was added to the model (weight for age z-
VFRUH% 6(0 ȕ S  
Table 6.8 Multiple regression analysis of UCP1 gene expression in 
epicardial adipose tissue of 0-2 year old children. 
UCP1 Gene expression 
 B SEM ȕ p 
Constant 9.67 1.15 - 0.00 
Age (days) 0.00 0.00 0.05 0.76 
Gender 0.26 1.04 0.04 0.80 
WAZ 0.79 0.35 0.36 0.03 
Baseline SaO2 0.92 1.06 0.14 0.39 
Use of propranolol 0.91 1.43 0.15 0.47 
UCP1, uncoupling protein 1; WAZ, weight for age; SaO2, oxygen 
saturation 
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6.3.2.3 UCP1 in epicardial adipose tissue of newborn infants  
7KHUHZHUHSDUWLFLSDQWVGLQDJHPDOHVDQGIHPDOHV2I
these, 11 were Caucasian, 3 Asian and 1 of mixed racial origin. Ten 
had cyanotic congenital heart disease with baseline oxygen saturation 
levels < 92% while the rest were normoxic. Only one infant was 
receiving ȕ adrenergic blocker (propranolol). The anthropometric 
parameters of this group are described in Section 6.3.1.1.1. 
6.3.2.3.1 UCP1 gene expression in epicardial adipose tissue of 
newborn infants (0-28 days) is independent of  age, 
gender, ethnic origin, weight for age z-score or baseline 
oxygen saturations 
The UCP1 gene expression in epicardial fat in this age group was not 
associated with age, gender, ethnic origin, weight for age z-score, or 
baseline oxygen saturations (Table 6.9). Only one infant in the 0-28 
days age group was on propranolol hence this variable was not 
included in the analysis.  
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Table 6.9 Multiple regression analysis of UCP1 gene expression in 
epicardial adipose tissue of newborn infants. 
UCP1 Gene expression 
 B SEM ȕ p 
Constant -12.85 13.72 - 0.31 
Age (days) -0.8 0.14 0.16 0.57 
Gender 1.56 2.04 0.26 0.47 
Race -0.28 0.84 -0.10 0.75 
WAZ 0.66 0.67 0.28 0.36 
Baseline SaO2 0.26 0.15 0.50 0.12 
UCP1, uncoupling protein 1; WAZ, weight for age; SaO2, oxygen 
saturation 
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6.3.2.4 Epicardial fat mRNA expression of other genes involved 
in brown and white adipose tissue development and 
metabolism 
6.3.2.4.1 Effect of gender on gene expression 
The gene expression of leptin receptor and BMP4 was higher in 
females compared to males. There was no difference in the gene 
expression of the other genes between males and females (Table 6.10). 
6.3.2.4.2 Effect of ethnic origin on gene expression in epicardial fat  
On comparing the gene expression between children of Caucasian and 
Asian origin, I found that the leptin receptor gene was significantly less 
expressed in Asian children as compared to children of Caucasian 
origin but there was no difference in the expression of any of the other 
genes studied (Table 6.11). 
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Table 6.10 Comparison between gene expression in males vs. 
females in epicardial adipose tissue of 0-2 year old children. 
Pathway gene 
Male  
(n = 32) 
Female  
(n = 14) p-value 
Leptin 8.84 ± 0.26 8.80 ± 0.42 0.94 
Leptin receptor 5.01 ± 0.19 5.56 ± 0.18 0.04 
DIO2 3.26 ± 0.07 3.30 ± 0.17 0.85 
33$5Į 5.84 ± 0.16 6.07 ± 0.26 0.45 
BMP7 4.86 ± 0.06 4.87 ± 0.06 0.92 
BMP4 5.08 ± 0.13 5.70 ± 0.16 0.01 
Insulin receptor 5.45 ± 0.10 5.30 ± 0.17 0.40 
IGF1 9.55 ± 0.12 9.27 ± 0.12 0.10 
IGFBP1 5.14 ± 0.13 5.20 ± 0.21 0.82 
IGFBP2 5.64 ± 0.09 5.63 ± 0.08 0.98 
IGFBP3 4.10 ± 0.08 4.40 ± 0.13 0.06 
Ki67 5.49 ± 0.11 5.38 ± 0.19 0.64 
ȕ$'5 5.76 ± 0.19 5.94 ± 0.14 0.45 
ȕ$'5 5.32 ± 0.11 5.33 ± 0.15 0.97 
ȕ$'5 5.45 ± 0.15 5.26 ± 0.43 0.68 
GR 8.83 ± 0.12 8.89 ± 0.13 0.74 
Abbreviations: DIO2, type 2 iodothyronine deiodinase; PPAR, 
peroxisome proliferator-activated receptor; BMP, Bone Morphogenetic 
Protein; IGF, insulin-like growth factor; IGFBP, insulin-like growth factor 
binding protein; ADR, adrenergic receptor; GR, glucocorticoid receptor.  
Values are means ± SEM.  
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Table 6.11 Comparison between gene expression in Caucasian vs. 
Asians subjects in epicardial adipose tissue of 0-2 year old 
children. 
Pathway gene 
Caucasian  
(n = 36) 
Asian  
(n = 9) p-value 
Leptin 9.04 ± 0.22 8.44 ± 0.60 0.37 
Leptin receptor 5.30 ± 0.16 4.51 ± 0.32 0.04 
DIO2 3.32 ± 0.08 3.14 ± 0.07 0.12 
33$5Į 6.07 ± 0.14 5.55 ± 0.37 0.22 
BMP7 4.90 ± 0.05 4.72 ± 0.08 0.09 
BMP4 5.33 ± 0.13 5.05 ± 0.24 0.32 
Insulin receptor 5.34 ± 0.10 5.61 ± 0.21 0.62 
IGF1 9.48 ± 0.10 9.50 ± 0.30 0.95 
IGFBP1 5.28 ± 0.12 4.92 ± 0.23 0.18 
IGFBP2 5.65 ± 0.07 5.58 ± 0.16 0.71 
IGFBP3 4.26 ± 0.08 3.92 ± 0.13 0.04 
Ki67 5.35 ± 0.07 5.55 ± 0.26 0.48 
ȕ$'5 5.76 ±0.12 6.07 ±0.42 0.50 
ȕ$'5 5.39 ± 0.10 5.16 ± 0.17 0.27 
ȕ$'5 5.65 ± 0.12 5.12 ± 0.36 0.16 
GR 8.77 ±0.10 9.08 ± 0.23 0.52 
Abbreviations: DIO2, type 2 iodothyronine deiodinase; PPAR, 
peroxisome proliferator-activated receptor; BMP, Bone Morphogenetic 
Protein; IGF, insulin-like growth factor; IGFBP, insulin-like growth factor 
binding protein; ADR, adrenergic receptor; GR, glucocorticoid receptor. 
Values are means ± SEM.  
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6.3.2.5 Expression of leptin gene in epicardial fat is associated 
with weight for age z-score in 0-2 year old children 
As leptin is thought to be related to white fat mass, I further analysed 
WKHUHODWLRQVKLSEHWZHHQWKHFKLOG¶VQXWULWLRQDOVWDWXVDVPHDVXred by 
weight for age z-score) and gene expression of leptin in the epicardial 
adipose tissue and found there was a significant correlation between 
the gene expression of leptin and weight for age z-score (r2 = 0.13; p = 
0.02). Gene expression of leptin was upregulated with increase in 
weight for age z-score (Figure 6.5). 
6.3.2.6 Expression of leptin gene in epicardial fat is not associated 
with age in children 0-2 years of age 
There was no significant correlation between age and leptin gene 
expression in children (R2 = 0.01; p = 0.41). 
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Figure 6.5 Leptin gene expression in epicardial adipose tissue of 
children 0-2 year old correlates with weight for age z-score 
Epicardial adipose tissue was sampled from children undergoing 
cardiac surgery. Each point represents a child (n = 47); r2 = 0.13; p 
<0.05 
mRNA expression of leptin is measured as a ratio of the signal intensity 
obtained from the sample relative to the signal intensity obtained from 
the positive control on the microarray gene chip.  
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6.3.3 Gene expression in children with high vs. low UCP1 
gene expression 
UCP1 gene expression is a marker of presence of BAT (Nedergaard 
and Cannon 2013). The mean ± SEM relative expression of UCP1 
mRNA for the 15 newborn infants included in this study was 9.84 ± 
0.78. As it is well known, and accepted, that newborn infants have 
significant amounts of brown fat (Aherne and Hull 1966), I assumed that 
participants who have UCP1 gene expression comparable to that in 
newborn infants, are likely to have significant amounts of BAT. 
Therefore, to analyse the expression of other genes related to brown 
and white fat development and metabolism, I divided the 42 participants 
(out of 57 total participants (0-18 years old)) whose samples were 
analysed by microarray into those whose UCP1 relative gene 
expression was equal to, or higher than, the UCP1 gene expression in 
the newborn infants (high UCP1) and those whose relative UCP1 gene 
expression was lower than the mean of the newborn infants (low 
UCP1).  
The gene expression of glucocorticoid receptor (GR) was significantly 
downregulated and the expression of leptin, type 2 iodothyronine 
deiodinase (DIO2), peroxisome proliferator-activated receptor (PPAR) 
Įinsulin-like growth factor binding protein (IGFBP) ,*)%3ȕ 
adrenergic receptor (ADR)DQGȕ$'5ZHUHVLJQLILFDQWO\XSUHJXODWHG
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in children with high UCP1 gene expression when compared to those 
who had low UCP1 gene expression (Table 6.12). 
In addition, in children with high UCP1 gene expression, UCP1 
expression had a positive correlation with expression of the leptin gene 
(R2 = 0.53; p <0.001) and negative correlation with mRNA expression of 
the gene for glucocorticoid receptor (R2 = 0.51; p <0.001). 
Furthermore, in these children, gene expression of UCP1 also had a 
significant positive correlation with mRNA expression of BAT related 
genes: DIO2 (R2 = 0.26; p <0.001) and ȕ$'552 = 0.16; p = 0.005). 
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Table 6.12 Comparison between gene expression in children with 
high vs. low UCP1 gene expression. 
Pathway gene 
High UCP1  
(n = 22) 
Low UCP1 
(n = 20) p-value 
Leptin 9.52 ± 0.22 7.56 ± 0.31 <0.001 
Leptin receptor 5.04 ± 0.91 5.47 ± 1.05 0.161 
DIO2 3.38 ± 0.11 3.08 ± 0.05 0.019 
33$5Į 6.38 ± 0.15 5.31 ± 0.21 <0.001 
BMP7 4.98 ± 0.08 4.79 ± 0.07 0.090 
BMP4 5.31 ± 0.13 5.47 ± 0.14 0.431 
Insulin receptor 5.35 ± 0.11 5.55 ± 0.11 0.209 
IGF1 9.36 ± 0.15 9.70 ± 0.18 0.140 
IGFBP1 5.58 ± 0.12 4.77 ± 0.19 0.001 
IGFBP2 5.77 ± 0.08 5.44 ± 0.13 0.031 
IGFBP3 4.40 ± 0.12 4.08 ± 0.12 0.073 
Ki67 5.23 ± 0.11 5.50 ± 0.66 0.145 
ȕ$'5 5.94 ± 0.14 5.99 ± 0.25 0.869 
ȕ$'5 5.60 ± 0.09 5.07 ± 0.14 0.002 
ȕ$'5 5.93 ± 0.10 4.83 ± 0.31 0.001 
GR 8.59 ± 0.12 9.41 ± 0.09 <0.001 
Abbreviations: DIO2, type 2 iodothyronine deiodinase; PPAR, 
peroxisome proliferator-activated receptor; BMP, Bone Morphogenetic 
Protein; IGF, insulin-like growth factor; IGFBP, insulin-like growth factor 
binding protein; ADR, adrenergic receptor; GR, glucocorticoid receptor.  
Values are means ± SEM.  
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6.3.4 Uncoupling Protein 1 is present in epicardial adipose 
tissue  
6.3.4.1 Epicardial adipose tissue of newborn infants is 
predominantly brown fat 
Immuno-histochemical analysis of sections of epicardial adipose tissue 
from all 15 newborn infants included in the study demonstrated the 
presence of UCP1 in multilocular adipocytes with only occasional 
interspersed large unilocular adipocytes that did not stain for UCP1. An 
example of the images obtained from these participants is shown in 
Figure 6.6. 
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Figure 6.6 Representative images of epicardial adipose tissue from 
a 6 day old male infant  
Immunohistochemical detection of uncoupling protein 1 (UCP1): 
antibody negative (A and C) and antibody positive (B and D) showing 
the presence of small multilocular adipocytes (indicated by black 
arrows). These multilocular adipocytes stained positive for UCP1 (B and 
D) demonstrating that these are brown adipocytes and the depot is 
brown fat. 
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6.3.4.2 Islands of brown adipose tissue are present in epicardial 
fat of older infants and adolescents. 
Epicardial adipose tissue samples obtained from older infants (>28 days 
of age) were predominantly white. A representative sample from these 
participants showing large unilocular white adipocytes that did not stain 
with UCP1 is given in Figure 6.7. However, randomly selected 
histological sections taken from 9 out of 40 (22.5%) participants over 28 
days of age contained interspersed islands of small, multilocular 
adipocytes that stained positive with UCP1 antibody as demonstrated in 
the representative images in Figure 6.8. 
In addition, UCP1 positive multilocular adipocytes were also present in 
samples from all the three adolescents who participated in this study as 
shown in the representative images shown in Figure 6.9. 
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Figure 6.7 Representative images of epicardial adipose tissue from 
an 18 month old male child 
Immunohistochemical detection of uncoupling protein 1 (UCP1): 
antibody negative (A and C) and antibody positive (B and D) showing 
the presence of large unilocular adipocytes(indicated by blue arrows) 
that did not stain positive with UCP1 antibody demonstrating that these 
are white adipocytes and the depot is white fat 
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Figure 6.8 Representative images of epicardial adipose tissue from 
a 3 year old male child  
Immunohistochemical detection of uncoupling protein 1 (UCP1):  
antibody negative (A and C) and antibody positive (B and D) showing 
the presence of large unilocular adipocytes (indicated by blue arrows) 
with adjoining areas with small multilocular adipocytes (indicated by 
black arrows). The multilocular adipocytes stained positive for UCP1 (B 
and D) demonstrating that these are brown adipocytes and the depot a 
mixture of brown and white fat. 
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Figure 6.9 Representative images of epicardial adipose tissue from 
a 17 year old male 
Immunohistochemical detection of uncoupling protein 1 (UCP1):  
antibody negative (A and C) and antibody positive (B and D) showing 
the presence of large unilocular adipocytes (indicated by blue arrows) 
with adjoining areas with small multilocular adipocytes (indicated by 
black arrows). The multilocular adipocytes stained positive for UCP1 (B 
and D) demonstrating that these are brown adipocytes and the depot a 
mixture of brown and white fat. 
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6.4 Discussion 
6.4.1 Human epicardial adipose tissue is a depot of brown fat 
in newborn infants and children 
The most significant finding of this study is that epicardial adipose 
tissue is a depot of brown fat in newborn infants and older children. 
Sack et al. reported UCP1 gene expression in epicardial fat of adults 
and I have confirmed the presence of brown fat in the depot by 
demonstrating the presence of UCP1 by Western Blotting (Chapter 5). 
In this study, I found that UCP1 gene is expressed in epicardial fat 
throughout early childhood and in adolescence. Furthermore, it appears 
that the gene expression of UCP1 does not decline with age, at least up 
to 2 years of age, as there was no difference between gene expression 
in newborn infants and older children. Whilst this study had relatively 
few children older than 2 years of age, the 13 samples obtained from 
older children demonstrate that UCP1 gene expression is present in 
later childhood and adolescence. 
The presence of brown fat in the epicardial depot was confirmed by 
histology and immunohistochemistry. The histological sections taken 
from newborn infants were replete with multilocular, small adipocytes 
that stained strongly for UCP1, demonstrating that epicardial fat is 
brown at this age. In older children, the depot appears to be 
predominantly white, with large, unilocular adipocytes that do not stain 
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with UCP1 with islands of small, multilocular adipocytes that stained 
positive for UCP1. Samples taken from all the three adolescents 
included in this study demonstrated the presence of islands of UCP1 
positive, multilocular, smaller adipocytes interspersed between white 
adipocytes. These findings establish that, although epicardial fat is 
predominantly white after the newborn period, the depot contains 
FOXVWHUVRIEURZQRU³EURZQ-OLNH´DGLSRF\WHVWKURXJKRXWFKLOGKRRGDQG
adolescence.  
My finding that many children have high levels of UCP1 gene 
expression and demonstrable UCP1 on immunohistochemistry is in 
keeping with 18F-FDG PET-CT scan studies demonstrating that BAT is 
detected more frequently in children than in adults (Gelfand et al. 2005, 
Bar-Sever et al. 2007, Zukotynski et al. 2009, Drubach et al. 2011, 
Gilsanz et al. 2013)'HWHFWLRQRI³KRWVSRWV´XVLQJLQIUDUHG
thermography also suggests that BAT is present in all healthy children 
(Robinson et al. 2014).  
This study confirms that BAT is present in children and that epicardial 
fat is a depot of BAT in humans. The findings presented here 
demonstrate, for the first time, that the epicardial fat depot is BAT in 
newborn infants and UCP1 gene expression is present throughout 
childhood. Furthermore, the results reveal that, at least in some 
individuals, particularly iQDGROHVFHQFHSRFNHWVRIEURZQRU³EURZQ-OLNH´
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adipocytes persist within the predominantly white adipose tissue that 
makes up the epicardial fat mass. 
6.4.2 Caucasian children have a higher expression of UCP1 
gene when compared to children of South Asian and 
mixed ethnicity 
Further analysis of UCP1 gene expression in 0-2 year old children 
showed that children of Caucasian origin had a significantly higher 
expression of the UCP1 gene when compared to Asian/mixed ethnic 
children. Although mRNA expression of UCP1 gene is a good marker of 
presence of BAT, caution should be exercised when interpreting the 
results as UCP1 gene expression is not a measure of BAT function and 
such differences in mRNA expression may not signify differences in 
metabolic or other functional capacities of BAT in the individual.  
Asians originating from the Indian sub-continent are known to have a 
greater risk of cardiovascular and metabolic illnesses. In the UK, this 
sub-group of the population has a 3-4 times higher risk of developing 
Type 2 diabetes as compared to the general population, in parallel to a 
similar scale of increased risk for coronary heart disease and metabolic 
syndrome even at the same body mass index (HSE 2006).  The 
underlying cause of this risk is not completely understood but might 
involve genetic differences in metabolism and energy homeostasis (Hall 
et al. 2010).  
250 
 
It has been suggested that a reduced amount of BAT may be one of the 
factors contributing to the disadvantaged metabolic profile seen among 
Asians from the Indian sub-continent (Bakker et al. 2014).  
Bakker and colleagues demonstrated that healthy lean young men of 
South Asian descent had lower resting energy expenditure, lower BAT 
volumes and were more dependent on shivering thermogenesis to 
maintain body temperature during cold exposure when compared to 
white Caucasians of similar age and BMI (Bakker et al. 2014). In a 
similar study, Admiraal et al. could not find an ethnic difference in 
metabolic activity in BAT when comparing South Asians with 
Caucasians (Admiraal et al. 2013). The differences, however, may not 
have been apparent in the study of Admiraal et al. as the authors used 
a room with a fixed cool temperature (16-18°C) to activate BAT in the 
participants. There are inter-individual differences in the onset 
temperature of shivering and less intense cooling may have 
underestimated BAT volume and activity in some study participants. 
Indeed, Bakker et al. found that, despite an increased fat mass 
percentage, the temperature at which shivering started was higher in 
South Asians than in Caucasians (Bakker et al. 2014). In a previous 
smaller, retrospective review of PET-CT images, no difference in BAT 
volume was detected between African and Caucasian cancer patients 
but BAT was detectable in only a small number of Asian patients 
(Perkins et al. 2013).  
251 
 
Conversely, a study of assessment of BAT function by infrared 
thermography in 6-11 year old children indicated that those who were 
non-Caucasians (but born in the UK) had more active BAT that the 
Caucasian children (Robinson et al. 2014). The children included in the 
latter study were healthy and older and had a higher BMI (BMI centile 
58.8 ± 28.0 (mean ± SD)) than the cohort included in my study. The 
non-Caucasian children included in Robinson et al. study were of 
several different ethnic origins while the non-Caucasian children in my 
current study were all of South Asian (Indian subcontinent) origin. The 
two mixed ethnic origin children had one parent who was Asian.  
In the present study, I found that ethnic differences in molecular 
characteristics of BAT are present from early childhood. Given its high 
capacity to dissipate excess energy and its role in lipid and glucose 
metabolism, such differences in BAT may be a contributing factor to the 
disadvantageous metabolic phenotype that makes South Asians more 
susceptible to obesity and its adverse cardio-metabolic complications.  
6.4.3 There was no difference in UCP1 gene expression 
between boys and girls in early childhood 
I did not find any difference in UCP1 gene expression between boys 
and girls either in the newborn period (0-28 days of life) or up to 2 years 
of age. Due to limited number of participants over two years of age, I 
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was unable to analyse the relationship between gender and UCP1 gene 
expression in older children and adolescents.  
In adults, it is unclear whether there is a clear gender dimorphism in 
BAT deposition (Bloor and Symonds 2014). Men and women have a 
similar distribution of BAT although some studies have reported greater 
mass of BAT and higher 18F-FDG uptake in women as compared to 
men (Cypess et al. 2009), while others did not demonstrate any gender 
differences in 18F-FDG uptake (Saito et al. 2009). The difference in 18F-
FDG intake may be explained by greater cold sensitivity in females 
(Quevedo et al. 1998) although it does not explain the finding by 
Pfannenberg et al. that age related reduction in BAT activity and volume 
occurs more rapidly in men than in women (Pfannenberg et al. 2010).   
Studies in children have not reported differences in BAT detection rate 
between boys and girls (Drubach et al. 2011, Gilsanz et al. 2012). 
Some gender differences in BAT prevalence may depend on stage of 
pubertal development. Gilsanz et al. found no significant differences in 
the prevalence of PET-CT studies depicting BAT (20 of 35 girls and 23 
of 38 boys; p = 0.769) but as BAT volume increased with puberty, the 
volume became significantly greater in boys than in girls during Tanner 
stages 4 and 5 of pubertal development (Gilsanz et al. 2012). This 
supports my finding that, among children under 2 years of age, there is 
no difference in UCP1 gene expression. Differences in BAT volume and 
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characteristics may arise later in adolescence. Indeed, in the male 
adolescents included in this study, I found islands of UCP1 positive, 
multilocular adipocytes within the epicardial adipose sections studied. 
However, due to limitation of sample size and absence of female 
adolescent participants, no definite conclusions on post-pubertal gender 
dimorphism can be derived.  
6.4.4 UCP1 gene expression was not affected by treatment 
with propranolol  
The children who participated in this study had congenital heart disease 
and six participants were receiving regular treatment with propranolol, a 
ȕ-ADR blocker. I did not find any difference in UCP1 gene expression 
between children who were on regular propranolol when compared to 
FKLOGUHQZKRZHUHQRWUHFHLYLQJDQ\ȕ-adrenergic blockers. This is 
contrary to my hypothesis as ȕ adrenergic stimulation is the major 
stimulant for UCP1 gene expression and BAT development and activity, 
at least in rodents (Cannon and Nedergaard 2004).  
Brown adipose depots are richly innervated by sympathetic nerves and 
ȕ adrenergic stimulation is the major drive for proliferation, 
differentiation and metabolism in brown adipocytes including the 
expression and function of the UCP1 gene (Cannon and Nedergaard 
2004). In adults, there is some evidence that brown fat activation can be 
inhibited by a single dose of propranolol (Parysow et al. 2007, Agrawal 
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et al. 2009). Söderlund and colleagues studied eleven adults with 
strong brown fat uptake on 18F-FDG PET-CT scans; BAT activity almost 
completely disappeared on the repeat scan performed two hours after 
oral administration of 80 mg propranolol (Soderlund et al. 2007). 
Similarly, Parysow et al. found a significant reduction in BAT activity 
with a smaller dose (20 mg) (Parysow et al. 2007). The usual 
therapeutic dose of propranolol is 80-240 mg in a day in adults and 2-
5mg/kg/day in children.  
However, despite the above mentioned studies, there is contradictory 
evidence and it is unclear whether propranolol and other ȕ-adrenergic 
blockers affect BAT activity in humans. Wijers et al. conducted an 
elaborate experiment with ten lean male subjects in a respiration 
chamber and studied the effect of propranolol intake on energy 
expenditure and mitochondrial uncoupling in muscle biopsy samples 
after cold exposure (Wijers et al. 2011). They found that cold exposure 
increased energy expenditure and this response was decreased by 
intake of propranolol. However, despite efficient inhibition of the 
sympathetic nervous system (as indicated by significantly reduced heart 
rate and decrease in energy expenditure), cold-induced thermogenesis 
was not affected. This is supported by the finding that pharmacological 
VWLPXODWLRQRIWKHȕ-adrenergic sympathetic nervous system activity 
increases energy expenditure similar to that in response to cold 
exposure but, although BAT activity is increased in response to cold, 
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adrenergic stimulants such as ephedrine and isoprenaline do not 
increase BAT activity in humans (Cypess et al. 2012, Vosselman et al. 
2012). These findings suggest that additional mechanisms may be 
involved in regulation of BAT thermogenesis in humans.  
In this study, I have analysed the gene expression of UCP1 and found 
no effect of propranolol therapy. Epicardial adipose tissue sections 
taken from children on propranolol also stained positive for UCP1. It is 
possible that although there is no difference in gene expression and 
some UCP1 positive cells persist, children on regular propranolol may 
have reduced activation of brown fat in response to cold or other 
stimulation. This requires further investigation.  
Another explanation for the lack of an effect of propranolol on BAT may 
be that sympathetic stimulation of BAT is mainly governed by ȕ
adrenergic receptors, at least in rodents (Cannon and Nedergaard 
2004). Propranolol is more selective for ȕDQGȕDGUHQHUJLFUHFHSWRUV
and this may also explain why UCP1 gene expression was not 
downregulated by intake of propranolol. Although clinical trials of 
VHOHFWLYHȕUHFHSWRUDJRQLVWVGLGQRWGHPRQVWUDWHDQ\HIIHFWRQHQHUJ\
metabolism or weight loss (Larsen et al. 2002, Redman et al. 2007), 
QRYHOVHOHFWLYHȕUHFHSWRUDJRQLVWVKDYHUHFHQWO\EHHQVKRZQ
stimulate BAT thermogenesis in humans (Cypess et al. 2015) and as a  
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consequence are being investigated as a potential pharmacological 
strategy against obesity. 
6.4.5 In early childhood (0-2 years), gene expression of UCP1 
in epicardial fat is downregulated in children with 
lower weight for age z-scores 
The participants of this study were all patients with congenital heart 
disease, a group particularly vulnerable to poor nutrition and growth 
(Steltzer et al. 2005). The newborn infants included in the study were of 
normal weight and length but, beyond the newborn period (> 28 days of 
age), one third of children had WAZ less than ± 2 SD below the mean 
for their age and gender and one quarter had HAZ less than ± 2 SD 
below the mean. This is in keeping with the existing records of growth in 
children with congenital heart disease; most infants with these 
conditions have normal weight for gestational age at birth but develop 
nutritional and growth problems in early infancy (Bayer and Robinson 
1969, Salzer et al. 1989, Cameron et al. 1995, Daymont et al. 2013). 
Although growth deficits are global (Daymont et al. 2013), weight can 
be more affected than height (Thommessen et al. 1992). Energy 
imbalance as a consequence of reduced intake due to feeding 
problems and increased energy requirements due to hypermetabolic 
state are believed to be causes of faltering growth (Nydegger and Bines 
2006, Medoff-Cooper and Ravishankar 2013). Detailed data on 
nutritional intake and energy expenditure in the participants was not 
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available and I was unable to analyse the exact aetiology of the lower 
than expected weights and heights.  
WAZ reflects body mass relative to chronological age and is a marker of 
nutritional status of the child (WHO 1986). Changes in weight can be 
precipitated by inter-current illnesses and short periods of poor nutrition 
and, therefore, it may not be a good marker of long term nutrition 
(Gorstein et al. 1994). However, as weight increases more rapidly in 
infancy than height, WAZ can be a sensitive marker of nutrition in early 
life (WHO 1986).  
In this cohort, gene expression of UCP1 was downregulated with poor 
nutrition as indicated by a low WAZ. Rockstroh and colleagues recently 
published an analysis of UCP1 gene expression in adipose tissue 
samples from children and adults and did not find any correlation 
between anthropometric markers and UCP1 gene expression in 
subcutaneous adipose tissue (Rockstroh et al. 2015). Subcutaneous 
adipose tissue is not a typical depot of BAT and Rockstroh found that 
only 3 out of 80 subcutaneous adipose tissue samples were positive for 
UCP1 on immunohistochemistry. In the epicardial adipose tissue 
samples that I have analysed, UCP1 was present in a much higher 
proportion (23%) of children and adolescents. An association between 
anthropometry and gene expression of UCP1 may therefore be more 
demonstrable in this richer depot of BAT. 
258 
 
UCP1 gene expression in fetus and newborn is known to be nutritionally 
regulated, at least in sheep (Symonds et al. 2003, Budge et al. 2004, 
Mostyn et al. 2004). In the adipose depot present around the heart, I 
have previously shown that, in sheep, UCP1 gene expression is 
upregulated with suboptimal maternal nutrition in early-to-mid gestation 
followed by ad libitum feeding in later pregnancy (Chapter 4 (Ojha et al. 
2014)) while it is down regulated by reduced maternal nutrition in late 
gestation (Chapter 3 (Ojha et al. 2013)). The results of the current study 
indicate that UCP1 gene expression in humans is also nutritionally 
regulated in the early years of postnatal life; children with poorer 
nutritional states as indicated by low WAZ have less UCP1 gene 
H[SUHVVLRQ7KLVUHODWLRQVKLSZDVLQGHSHQGHQWRIWKHFKLOG¶VJHQGHU
postnatal age, base line oxygen saturation levels and whether the child 
was taking regular ȕ-blockers or not. However, the finding was 
FRQIRXQGHGE\WKHFKLOG¶VHWKQLFRULJLQ$VWKHFKLOGUHQRI$VLDQRULJLQ
had a significantly lower WAZ as compared to children of Caucasian 
origin, it is difficult to ascertain whether the downregulation in the UCP1 
gene is due to poor nutrition or genetic/phenotypic ethnic differences.  
In older children, it is unclear whether BAT volume and activity, as 
measured by 18F-FDG uptake on PET-CT scans, correlates with 
anthropometric measures. Gilsanz and colleagues did not find any 
difference in weight, BMI or measures of adiposity in children with or 
without BAT although muscle volume was greater in BAT positive 
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children (Gilsanz et al. 2011). Conversely, Durbach et al. found an 
inverse relation between BMI centile and BAT activity in a cohort of 
children; the patients in this study were older with age of 14.2 ± 3.7 
(mean ± SD) years and had higher BMI centiles (62.9 ± 31.5 (mean ± 
SD)) (Drubach et al. 2011) than the younger children with lower weights 
and BMI included in the current study. Similarly, measuring BAT activity 
by infrared thermography, Robinson et al. also found a negative 
relationship between BMI percentile and baseline supraclavicular region 
temperature, which may be a marker of baseline BAT activity (Robinson 
et al. 2014).  
All previous studies assessing BAT activity and BMI in children include 
older children who are relatively better nourished (including a proportion 
of overweight and obese children) (Drubach et al. 2011, Gilsanz et al. 
2011, Robinson et al. 2014) than those included in my study. The 
nutritional regulation of UCP1 may be age dependent and poor nutrition 
in early life may reduce BAT development to enable the rapidly growing 
child to conserve energy for growth.   
6.4.6 In early childhood (0-2 years), gene expression of leptin 
in epicardial fat is downregulated in children with 
lower weight for age z-scores 
In parallel to the positive linear relationship between WAZ and UCP1 in 
the 0-2 year old children, I also found a positive correlation between 
WAZ score and leptin gene expression. Leptin is a marker of white 
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adipose tissue and high serum leptin concentrations are associated with 
increasing fat mass in children (Johnson et al. 2001). Leptin mRNA 
expression increases with obesity in adults (Lonnqvist et al. 1995, 
Maffei et al. 1995) and in children (Hassink et al. 1996) and is higher in 
adipose tissue obtained from obese children when compared to 
samples from non-obese children (Lindgren et al. 1997). This is in 
keeping with my finding that leptin mRNA expression is downregulated 
with reduction in WAZ in children.   
There are depot specific differences in leptin gene expression and 
children with congenital heart disease have higher leptin gene 
expression in subcutaneous fat compared with intra-thoracic fat (Schoof 
et al. 2004). Some studies have reported increasing leptin mRNA 
expression with age at specific sites such as subcutaneous (Lindgren et 
al. 1997, Schoof et al. 2004), intrathoracic and omental fat but not in 
mesenteric fat (Schoof et al. 2004). I did not find a relationship between 
leptin gene expression and age in this cohort. This may be due to depot 
specific differences between fat in the epicardial and other sites.  
6.4.7 Children with high UCP1 gene expression have a 
different mRNA expression pattern as compared to 
children with low UCP1 gene expression 
It is now well recognised that BAT is present beyond the newborn 
period, at least in some individuals (Cypess et al. 2009, Gilsanz et al. 
2013, Rockstroh et al. 2015). In the cohort of children included in the 
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current study, 23% of those over 28 days of age had UCP1 present on 
immunohistochemical examination of their epicardial adipose tissue 
samples. More than half of the children over 28 days of age had UCP1 
gene expression equal to, or more than, the mean of the UCP1 gene 
expression found in newborn infants. Comparison between children with 
high vs. low UCP1 gene expression revealed differences in expression 
of other genes related to brown and white adipose tissue development 
and metabolism.  
Children with low UCP1 gene expression had low leptin mRNA 
expression and there was a positive correlation between the 
expressions of these two adipose tissue markers. Leptin is a marker of 
white adipose tissue (Margetic et al. 2002) and Rockstroh et al. found a 
reduction in leptin gene expression in the UCP1 positive adipose tissue 
samples (Rockstroh et al. 2015). The opposite finding in my study could 
be due to the relatively poor nutritional status of the participants. Both 
UCP1 and leptin gene expression correlated with WAZ and it is possible 
that the poor nutrition in these children suppressed both brown and 
white fat development as reflected by the concomitant reduction in 
UCP1 and leptin gene expression, respectively. This is supported by 
the finding that gene expression of peroxisome proliferator-activated 
UHFHSWRUDOSKD33$5ĮDOLJDQGDFWLYDWHGWUDQVFULSWLRQIDFWRUWKDWLVD
regulator of adipocyte differentiation and lipid metabolism (Ferre 2004), 
was also downregulated in children with low UCP1 gene expression. 
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Genes related to BAT were upregulated in those who had high UCP1 
gene expression and the mRNA concentrations of BAT related genes 
VXFKDV',2DQGȕ3ADR had a positive correlation with gene 
expression of UCP1. DIO2 is an enzyme that catalyses the conversion 
of thyroxine (T4) into triiodothyronine (T3). It is highly expressed in BAT 
(Silva and Larsen 1983), is an inducer of UCP1 gene expression and 
protein synthesis in brown adipocytes (Bianco and Silva 1987) and is 
essential for optimum thermogenesis (de Jesus et al. 2001).  
Sympathetic control of BAT development, activity and metabolism are 
believed to EHUHJXODWHGPDLQO\YLDȕ$'5V(Rohlfs et al. 1995) and the 
thermogenic response of brown adipocytes is predominantly mediated 
via these receptors (Zhao et al. 1994). Reduction of gene expression of 
',2DQGȕ$'5VXJJHVWWKDW%$7IXQFWLRQPD\DOVREHFRPSURPLVHG
in these children. 
The gene expression of GR was increased in children with low UCP1 
gene expression while genes for insulin like growth factor binding 
proteins 1 and 2 were reduced signifying that adipose tissue 
metabolism may have been affected in these children. Glucocorticoid 
action is dependent on the density of the intracellular receptors and the 
level of pre-receptor metabolism. Cortisol binds to GR within the 
cytoplasm and the cortisol-GR complex translocates to the nucleus 
where it regulates the transcription of target genes (Campbell et al. 
2011). Glucocorticoid action induces differentiation in preadipocytes, 
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thereby enhancing adipogenesis, whereas cortisol increases lipolysis in 
mature adipocytes. Normally the adipogenic action of glucocorticoids is 
more prominent than the lipolytic effect such that excessive 
glucocorticoids increase adipose tissue mass through hyperplasia 
rather than hypertrophy. In addition, glucocorticoids also modulate 
adipose tissue via effect on inflammation and low GR abundance can 
attenuate the immunomodulatory and other effects of glucocorticoids. 
Increased tissue cortisol concentration and increased tissue-specific 
glucocorticoid sensitivity have been implicated in the pathophysiology of 
the metabolic syndrome (Anagnostis et al. 2009). Glucocorticoid 
sensitivity is influenced by and directly related to the amount GR mRNA 
(Melo et al. 2004, Sousa e Silva et al. 2010) and elevated local increase 
in GR gene expression in visceral adipose tissue can increase the 
predisposition to metabolic abnormalities including insulin resistance  
(Vegiopoulos and Herzig 2007).  
6.4.8 Epicardial fat in children 
Epicardial fat, the fat deposited within the pericardial sac, is a 
metabolically active adipose tissue (Sacks and Fain 2007). Deposits of 
fat within the pericardium are present in the fetus and the newborn 
human (Fletcher et al. 1987) and other species (Marchington et al. 
1989). Primary epicardial cells grown from human embryonic heart 
tissue explants demonstrate prominent adipocyte differentiation both 
spontaneously and in response to exposure to adipogenesis-inducing 
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PL[WXUHVDSURFHVVWKDWLVGULYHQE\WKHH[SUHVVLRQRI33$5Ȗ in 
several cell types (Yamaguchi et al. 2015). This behaviour, when 
occurring in vivo, results in the presence of epicardial fat over the heart 
in newborn infants and thereafter throughout childhood and later life.  
Several studies in adults have demonstrated the relationship between 
epicardial fat accumulation and cardiovascular pathologies (as 
discussed in Chapter 1 (Section 1.10.3.1)). Although most studies have 
been performed in adults, emerging evidence suggests that epicardial 
fat could be equally important in children and accumulation of fat in this 
depot may be an early marker of adverse cardiovascular and metabolic 
outcomes.  
In a study of 46 obese subjects (10.2 ± 2.5 years of age, 25 boys) and 
30 age- and gender matched lean subjects (10.8 ± 3.1 years of age, 13 
boys), Abaci et al. demonstrated that accumulation of fat in the 
epicardial depot is correlated with BMI and, above a cut off value of 
4.1mm, thickness predicts insulin resistance in obese children (Abaci et 
al. 2009). This finding was reproduced in another study of peri-pubertal 
children (Manco et al. 2013). However, Mazur et al. found that although 
thickness of epicardial fat was a good indicator of visceral adiposity, it 
was not an independent predictor of metabolic syndrome or insulin 
resistance in children (Mazur et al. 2010). Schusterova et al. also found 
that epicardial fat thickness in children is associated with an 
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unfavourable cardio-metabolic risk profile but that body mass index was 
a stronger indicator (Schusterova et al. 2014).  
In addition, similar to the associations found in adults, epicardial fat 
thickness in children is significantly correlated with left atrial and left 
ventricular mass and has a significant and independent association with 
increased carotid intima-media thickness, a subclinical form of carotid 
atherosclerosis (Cabrera-Rego et al. 2014). In children with a family 
history of Type 2 diabetes, Mahfouz et al. found increased epicardial fat 
thickness with increased diastolic dysfunction as compared to age and 
BMI matched controls who did not have family history of type 2 diabetes 
(Mahfouz et al. 2015). 
Emerging evidence suggests that the epicardial depot in children, as in 
adults, may be an important repository of visceral fat and, due to its 
proximity to the heart, it is postulated that it could play a vital role in the 
evolution of cardio-metabolic pathologies.  BAT has a vital role in 
energy homeostasis and particularly in lipid (Bartelt et al. 2011) and 
glucose (Orava et al. 2011) metabolism. The novel finding here that 
epicardial fat is a depot of BAT in newborn infants and retains brown or 
brown-like adipocytes throughout childhood and adolescence raises the 
possibility that BAT could play a role in evolution of cardiovascular 
physiology and pathogenesis from early life and the potential of using 
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BAT activation as a therapeutic target for prevention and treatment of 
cardiovascular illnesses.  
6.4.9 Strengths of the study 
This is the first study looking at the presence of BAT in epicardial fat in 
children. The large number of participants included in the study enabled 
a detailed analysis of gene expression in early childhood. Availability of 
clinical data made it possible to further analyse gene expression in 
relation to age and anthropometric parameters. The population from 
which the patients were derived (in and around Leicester, U.K.) is such 
that the cohort contains adequate number of Asian patients from a 
similar ethnic background allowing analysis of UCP1 gene expression in 
relation to ethnic origin. As the participants were patients with 
congenital heart disease, effects of the XVHRIȕ-adrenergic blocker 
medication and of low oxygen saturation levels, both factors that may 
have affected UCP1 gene expression, these could be analysed without 
any additional intervention in the children.  
UCP1 gene expression, especially when measured by highly sensitive 
technologies such as microarray assay, does not prove the presence of 
BAT. The additional strength of this work is that the presence of BAT 
was confirmed by immunohistochemical demonstration of UCP1 in 
epicardial fat.  
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6.4.10 Limitations of the study 
The children who contributed to this study were not healthy volunteers. 
Their illness and poor nutritional status may have confounded the 
findings of the gene analysis. However, this was unavoidable as 
epicardial tissue samples can only be collected from individuals 
undergoing cardiac surgery, a population that is, by definition, unwell 
and is known to have poor nutrition (Salzer et al. 1989, Daymont et al. 
2013). Nevertheless, this is the first study to demonstrate the presence 
of BAT in epicardial fat in children and access to these numbers of 
epicardial tissue samples from living subjects could only be obtained  
from children undergoing cardiac surgery.  
Another limitation of this study is the skewed age distribution of the 
participants. Whilst 48 out of 57 adipose tissue samples suitable for 
gene analysis were from children less than or equal to two years of age 
making the study findings very strong in children in the 0-2 year age 
group, gene analysis results were available for only 12 children 
between 2 and 18 years of age. This is because most children with 
congenital heart disease require surgery in the first few years of life and 
the samples could only be collected at the time of the surgery. It is, 
therefore, difficult to make any firm conclusions about the gene 
expression results in later childhood and adolescence. However, 
children >2 years old had detectable levels of UCP1 gene expression 
that were comparable to the expression in the younger children. 
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Nevertheless, larger numbers of samples are required to study the 
changes in UCP1 and other gene expression over the childhood years 
and adolescence.  
Pubertal development may have a major impact on BAT development in 
children (Gilsanz et al. 2012); adipose tissue samples collected from a 
larger number of older pre- and post- pubertal children would allow a 
better analysis of changes in BAT during a childhood and puberty. 
Further details of pubertal development and data on nutritional intake 
and body composition of the participants would enable more 
sophisticated analyses. 
The results were affected by the finding that children of Asian ethnic 
origin had significantly lower WAZ at all ages; this makes it difficult to 
ascertain whether the differences in UCP1 gene expression are due to 
ethnic differences in BAT development or an effect of lower weight gain 
in early life.  
In the current work, I have presented gene expression measured by 
microarray analysis. Further confirmation of gene expression using Q-
PCR may be required, although gene expression levels obtained using 
microarray technology are highly correlated with results obtained from 
Q-PCR when identical transcripts are targeted by the two methods 
(Dallas et al. 2005, Allanach et al. 2008). It is also important to point out 
that gene expression levels are not a measure of function and detection 
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of UCP1 gene expression does not prove the presence of BAT. In 
addition, high or low UCP1 gene expression do not necessarily indicate 
more or less BAT activity (Nedergaard and Cannon 2013).  
However, in this study, demonstration of UCP1, the BAT specific 
protein, by immunohistochemistry confirms that BAT is present in 
epicardial fat in children but even this cannot quantify the functional 
capabilities of the tissue. To utilise physiological techniques designed to 
measure the thermogenic and other metabolic function of BAT can be 
measured by physiological techniques which may be logistically 
unfeasible to perform in epicardial fat in humans, especially in children 
where small volumes of epicardial fat are present.  
6.5 Conclusion 
Epicardial fat from newborn infants, children and adolescents contains 
UCP1 confirming that it is a BAT depot in humans. UCP1 gene 
expression in early years of life in humans is downregulated with poor 
nutrition. In view of the potential role of BAT in regulation of lipid and 
glucose metabolism, this may have therapeutic implications for 
prevention and treatment of cardiovascular complications of obesity. 
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7 Summary and conclusions 
7.1 Pericardial fat is a depot of brown adipose tissue 
The studies in this thesis categorically demonstrate, for the first time, 
that adipose tissue depots present around the heart are a repository of 
brown fat, at least in humans and sheep.  
Adipose tissue present around the heart, particularly epicardial fat, has 
unique anatomical and functional characteristics. Apart from forming a 
protective layer around the heart and great vessels, fat in this depot has 
unique metabolic and endocrine/paracrine properties (Iacobellis and 
Bianco 2011). Under physiological conditions, epicardial fat, due to high 
rates of FFA uptake and incorporation, acts as a buffering system 
against toxic levels of fatty acids between the myocardium and blood in 
the coronary circulation (Iacobellis and Bianco 2011). Presence of BAT 
in this location could further enhance this protective effect as brown 
adipocytes are particularly efficient in clearing lipoproteins and glucose, 
even in the presence of obesity and insulin resistance (Bartelt et al. 
2011, Orava et al. 2011).  
In sheep, I have demonstrated that UCP1 gene expression and protein 
are present in pericardial adipose tissue samples taken from late 
gestation fetus and newborn lambs. Sacks and colleagues 
demonstrated gene expression of UCP1 in epicardial fat from adult 
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humans and suggested that epicardial adipose tissue might function as 
brown fat (Sacks et al. 2009). UCP1 gene expression, however, is not 
definite evidence of presence of functional BAT (Nedergaard and 
Cannon 2013). In my thesis, I have presented results that, for the first 
time, confirm the suggestion made by Sacks et al. by demonstrating the 
presence of the unique BAT protein, UCP1, by Western Blot, in this 
location thus providing definite evidence that epicardial fat in adult 
humans is a depot of BAT.  
I have further demonstrated the novel finding that, in humans, BAT is 
present in epicardial fat throughout childhood and adolescence. The 
epicardial fat of newborn infants is almost entirely brown as evident by 
immunohistological staining with UCP1 antibody. Beyond the newborn 
period, histologically, epicardial fat appears to be predominantly white. 
However, islands of small, multilocular adipocytes that are positive for 
UCP1 are present in more than 20% of children and all the adolescents 
in my study, and UCP1 gene expression is present in epicardial fat 
throughout childhood establishing, for the first time, that epicardial fat 
contains at least some BAT throughout childhood and adolescence. 
7.2 Pericardial fat is a nutritionally regulated depot of 
brown adipose tissue 
Adipose tissue first appears in early to mid-gestation (Poissonnet et al. 
1984) and total adipose tissue mass increases through late gestation 
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and early childhood (Griffin and Cooke 2012). Experimental evidence 
from animal models and observational studies in humans suggest that 
early life experiences are important in setting later adiposity such as the 
effects of early life nutrition on adipose tissue mass, adipocyte numbers 
and relative distribution of brown and white fat in later life (Symonds et 
al. 2011). In my studies, I found that development of brown adipose 
tissue in the pericardial depot is affected by nutritional experiences in 
early life.  
In sheep, suboptimal maternal nutrition in early to mid-gestation 
followed by ad libitum feeding until term, enhances UCP1 gene 
expression and protein abundance along with increased pericardial and 
total body adiposity and augments the gene expression of key 
adipogenic genes involved in both brown and white adipogenic 
pathways. Such enhanced fetal fat stores and increased adipogenic 
potential may be beneficial in the short term but could subsequently 
result in excess fat deposition leading to obesity in later life. Excess 
adiposity in the pericardial depot may be particularly detrimental as 
increased pericardial fat deposition is associated with cardiovascular 
illness (Iacobellis and Bianco 2011).  In contrast, restricting maternal 
nutrition in late gestation reduces UCP1 gene expression and protein 
abundance and downregulates the expression of genes controlling non-
shivering thermogenesis suggesting compromised BAT development in 
the newborn animal. In children, I found that UCP1 gene expression 
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was downregulated in children with poorer nutrition as indicated by low 
weight for age z-scores (WAZ) suggesting that, even in postnatal life, 
BAT development continues to be affected by nutrition. These findings 
suggest that suboptimal nutrition in late gestation and early years of 
postnatal life can supress BAT development. 
Suboptimal nutrition in utero and during early life is compromises fetal 
and childhood development. Physiological and metabolic adaptations, 
including changes in adiposity, made by the individual to an inadequate, 
or excess nutritional environment, may promote immediate survival but 
are lasting, conferring significantly increased risks of ill health in 
childhood and adulthood. It is now accepted that BAT persists beyond 
the neonatal period in to adult life and, therefore, presents a potential 
target for long lasting nutritional manipulations (Ojha et al. 2013). How 
these changes in composition of adipose tissue affect long term 
adipose tissue function and propensity towards obesity remains to be 
elucidated. However, a reduction in thermogenesis presents a plausible 
mechanism for the increased metabolic efficiency associated with 
nutritional deprivation in early life.  
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8 Future research  
The pandemic of obesity and related non-communicable diseases 
continues unabated despite attempts at preventing and managing 
obesity via interventions ranging from community and family based 
approaches (Wang et al. 2013) to marketing strategies that may change 
food purchasing behaviours (Glanz et al. 2012). Approaches to weight 
loss by diet, exercise, behavioural modification, with or without 
pharmacological support, can be successful in the short term but the 
benefits do not last beyond a few years (Nguyen et al. 2012). This lack 
of success in finding the remedy for prevention or cure of obesity 
highlights the need to further investigate the avenues which make 
obesity and metabolic illness such difficult problems.  
*URZLQJHYLGHQFHVXJJHVWVWKDWPDWHUQDOKHDOWKDQGWKHRIIVSULQJ¶V
early childhood nutritional experience influence long term health 
outcomes. Both under and over nutrition in mothers and young children 
are linked to subsequent obesity and adult diseases.  Although the 
mechanisms behind these associations remain controversial and the 
developmental origins hypothesis faces several challenges (Horton 
2013), there is little doubt that whether it is via in utero programming or 
genetic, epigenetic and/or life style factors, the early years of life are 
key determinants of health. 
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8.1 Implications for future research  
The role of nutrition and environmental exposures in early life in the 
etiology of obesity and related metabolic diseases is supported by 
human observational and animal experimental studies, such as those 
described here, but there is a lack of randomised trials of interventions 
that may ameliorate the effects of, or prevent developmental 
programming. While animal studies provide proof of principle and 
suggest mechanisms, and epidemiological observational studies on 
human cohorts demonstrate associations and can provide some 
evidence to support the case for interventions, only randomised control 
trials will provide definite evidence to support any potential therapeutic 
intervention. 
However, in addition to the ethical difficulties of preforming experimental 
trials in pregnant women and young children, the numerous 
confounders which cannot be controlled in human populations and the 
temporal dissociation between the occurrence of the etiological insults 
and the ultimate emergence of the diseases pose challenges to the 
design of such trials. Despite these challenges, there have been some 
attempts at randomised control trials in this field. These have 
demonstrated that interventions such as dietary counselling, physical 
activity and supplementary weight monitoring can control gestational 
weight gain (Streuling et al. 2010) and treatment of mild gestational 
diabetes can reduce risk of fetal overgrowth (Landon et al. 2009). 
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Follow up of health outcomes in offspring of participants of such trials 
(Gillman et al. 2010) and other large human cohorts can provide direct 
evidence to support or refute the role of such interventions in reducing 
the risks of obesity and other illness in later life.  
Developmental origins of health is an interdisciplinary field involving a 
multi-directional interplay of basic sciences, genetics, epidemiology, 
behavioural sciences and various clinical disciplines ranging from 
obstetrics and child health to adolescent health and, adult cardiology, 
endocrinology and psychiatry (Ojha et al. 2015). A concerted approach 
to design and execution of research that test randomly assigned 
interventions in mothers and young children and study the long term 
effects may produce the vital evidence that could be instrumental in 
controlling the currently uncontainable intergeneration amplification of 
the global obesity crisis. If conducted properly, these ought to be multi-
centred and multi-disciplinary efforts which bring together the expertise 
and resources from all the above mentioned domains of science. 
8.2 Implications for public health 
The public health importance of this approach was highlighted in the 
&KLHI0HGLFDO2IILFHU¶VUHSRUWZKLFKLQFOXGHGDNH\PHVVDJHWKDW
³WKHSULPDU\SUHYHQWLRQRIREHVLW\VKRXOGEHJLQLQLQIDQF\ZLWKWKH
delivery of interventions aimed at improving the eating and activity 
SDWWHUQVRI\RXQJFKLOGUHQ´(CMO 2012).  
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Integrating interventions that improve maternal nutrition with other 
public health programmes aimed at young children should therefore be 
the priority of public health. Evidence to support this has been 
demonstrated in some regions such as in an undernourished population 
in India, where children whose mothers took nutritional supplements 
during pregnancy as part of an integrated child development 
programme had lower insulin resistance in adolescence (Kinra et al. 
2008).  
The evidence base clearly identifies that events that occur in early life 
affect health and wellbeing in later life. Optimal nutritional intake 
alongside the development of healthy eating and activity patterns have 
been identified as key to building resilience and protecting against later 
chronic diseases (CMO 2012). Public health interventions that target 
maternal and child health and wellbeing and those that support mothers 
during significant periods of child development such as before and 
during pregnancy, while breast feeding, and in managing nutrition in 
infancy will produce benefits with a positive impact on the health of the 
future adult population.  
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10 Appendices 
10.1 Ethical approvals for human studies 
10.1.1 Study of brown adipose tissue in epicardial fat of adult 
humans 
The samples for the study of brown adipose tissue in epicardial fat of 
human adults were obtained from the participants of the Human 
Epicardial Fat Adipokines and Coronary Atherosclerosis study. Ethical 
approval for this study was obtained from the Baptist Memorial Health 
Care Corporation Institutional Review Board. 
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10.1.2 Study of brown adipose tissue in pericardial fat of 
newborns, infants and children 
The sample collection for the study of pericardial adipose tissue in 
children was conducted with ethical approval from National Research 
Ethics Service Committee (NRES) East Midlands ± Nottingham 2 (REC 
reference number: 12/EM/0214). 
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10.2 Data collection proforma for the Study of brown 
adipose tissue in pericardial fat of newborns, 
infants and children 
For this study, each participant¶s date of birth and date of surgery were 
recorded. In addition, information about gender and ethnic origin, type 
of congenital heart disease and data about the cardiac and any other 
co-H[LVWLQJPHGLFDOFRQGLWLRQVWKHLQGLYLGXDO¶VEDVHOLQHR[\JHQ
saturation level, medications (particularly regular beta blocker), weight 
and height on the day of admission were also collected using a 
standardised proforma given in the next page. 
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Study Number: 
Patient Identification Number for this trial: 
Study of Presence of Brown Adipose Tissue in Pericardial Adipose 
Tissue in Newborn Infants and Children  
(A Study of Fat around the Heart of Newborn Infants and Children) 
(Analysis of Pericardial Adipose Tissue in Children (a-PAC) Study) 
Data Collection Proforma 
(Draft version 1.0: 03/07/2012) 
 
 
 
 
 
Primary cardiac diagnosis:  
 
 
Baseline oxygen saturations (%) ______________________ 
Other medical conditions 
 
 
Medications (in the period before and during surgery) 
Name of the drug  Dose 
  
  
  
  
  
  
Date of Birth (dd/mm/yyyy): ___/___/______ 
Sex:   Male/Female 
Weight (kg): ________ 
Height (cm): ________ 
Racial origin: ________ 
320 
 
10.3 Clinical characteristics of participants  
Table 10.1 Characteristics of participants: diagnosis and medications 
Study 
number 
Age 
(in years) Gender 
Primary Cardiac 
diagnosis 
Other medical 
conditions Regular medications 
1 0.46 Male 
Ventricular septal 
defect 
Right ventricular 
outflow tract 
obstruction 
none 
frusemide, 
spironolactone 
2 16.48 Male Atrial septal defect none atomoxetin prostaglandin E2 
3 0.02 Male Hypoplastic left heart 
syndrome none dobutamine 
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4 0.08 Male Hypoplastic left heart 
syndrome none none 
5 0.15 Male 
Ventricular septal 
defect 
Aortopulmonary valve 
dysplasia 
Tracheo-oesophageal 
fistula 
frusemide 
captopril 
ranitidine 
domperidone 
6 0.01 Female Hypoplastic left heart 
syndrome none 
prostaglandin E2 
dobutamine 
7 0.67 Female Ventricular septal defect none 
frusemide 
captopril 
8 0.68 Male Ventricular septal defect 
Trisomy 21 
Intrauterine growth 
restriction 
Infant of diabetic mother 
frusemide 
spironolactone 
9 0.31 Male Tetralogy of Fallot Prematurity (36 weeks gestation) propranolol 
10 0.12 Male Ventricular septal none frusemide 
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defect spironolactone 
11 17.05 Male 
Partial anomalous 
pulmonary venous 
drainage 
ostium primum atrial 
septal defect 
none none 
12 3.46 Male Atrial septal defect none none 
13 0.93 Male Pulmonary stenosis Noonan's syndrome none 
14 2.61 Male 
Ventricular septal 
defect 
Co-arctation of aorta 
Hypoplastic aortic 
arch 
none 
frusemide 
spironolactone 
15 0.47 Female 
Ventricular septal 
defect 
Atrial septal defect 
none 
frusemide 
spironolactone 
16 3.11 Female Ventricular septal 
defect 
none frusemide 
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Atrial septal defect spironolactone 
17 1.30 Male Absent pulmonary 
valve 
Prematurity (26 week 
gestation) 
Post-NEC ileostomy 
fentanyl 
midazolam 
spironolactone 
enoxaparin 
18 0.87 Male Tetralogy of Fallot none aspirin 
19 0.59 
 
Pulmonary atresia  
Ventricular septal 
defect 
Major aorto-
pulmonary collateral 
arteries 
22q deletion none 
20 6.38 Male Mixed aortic valve disease none amoxicillin 
21 0.58 Female 
Tetralogy of Fallot 
Left pulmonary artery 
stenosis 
none none 
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22 14.84 Male Mixed aortic valve disease none none 
23 0.64 Female Ventricular septal defect none 
frusemide 
captopril 
24 0.80 Female Ventricular septal defect 22q deletion 
frusemide 
captopril 
25 0.99 Male Pulmonary stenosis none none 
26 3.40 Female Atrial septal defect none none 
27 1.51 Female 
Atrio-ventricular 
septal defect 
 
none none 
28 6.69 Male Hypertrophic 
cardiomyopathy none propranolol 
29 0.96 Female Mild right pulmonary 
artery stenosis none none 
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30 0.50 Female Atrial septal defect none none 
31 3.36 Female Tumour extension  into IVC Wilm's tumor none 
32 0.90 Female ventricular septal defect none 
frusemide 
captopril 
33 7.15 Female severe RVOTO none none 
34 0.11 Male TA + VSD none none 
35 1.50 Male AS + AR Bronchial asthma 
frusemide, 
spironolactone 
inhaled steroids 
36 0.34 Male TOF none none 
37 4.47 Male ventricular septal defect none enalapril 
38 0.41 Male ventricular septal defect none none 
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39 0.01 Male TA + PA none prostaglandin 
40 0.01 Male TGA none  
41 0.02 Male TGA none 
frusemide 
spironolactone 
prostaglandin 
42 0.48 Male TOF none propranolol 
43 0.46 Male TOF none frusemide 
spironolactone 
44 3.61 Female Atrial septal defect none none 
45 0.82 Male Ventricular septal defect none 
frusemide 
captopril 
46 1.25 Female Ventricular septal defect none 
frusemide 
captopril 
47 0.03 Female Transposition of great 
arteries none 
frusemide 
spironolactone 
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prostaglandin 
48 0.71 Female Tetralogy of Fallot none propranolol 
49 1.66 Male Tetralogy of Fallot Prematurity none 
50 0.07 Male Truncus arteriosus Inversion of 
chromosome 8 
frusemide 
propranolol 
51 2.18 Male Atrial septal defect Prematurity 
frusemide 
spironolactone 
salbutamol 
betamethasone 
52 0.27 Female 
Corrected 
transposition of great 
arteries 
Atrio-ventricular block frusemide 
spironolactone 
53 0.05 Male 
Transposition of great 
arteries 
Ventricular septal 
defect 
Atrial septal defect 
Prematurity frusemide 
spironolactone 
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54 0.99 Male 
Ventricular septal 
defect 
Right ventricular 
outflow tract 
obstruction 
none 
frusemide 
propranolol 
55 0.25 Male 
Total anomalous 
pulmonary venous 
connections 
none frusemide 
propranolol 
56 0.02 Male Transposition of great 
arteries 
none prostaglandin 
57 0.41 Male Tetralogy of Fallot none propranolol 
58 1.80 Male Atrial septal defect Pulmonary stenosis 
none 
none 
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59 1.07 Male Tetralogy of Fallot none propranolol 
60 0.47 Male Atrioventricular septal defect Trisomy 21 
frusemide 
digoxin 
captopril 
domperidone 
61 0.03 Male Transposition of great 
arteries none prostaglandin 
62 0.03 Female Hypoplastic aortic 
arch none 
prostaglandin 
frusemide 
digoxin 
63 0.73 Male 
Ventricular septal 
defect 
Persistent foramen 
ovale 
Trisomy 21 movicol® 
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10.4 Abstracts of original peer reviewed publications 
and papers 
10.4.1 Brown adipose tissue genes in pericardial adipose 
tissue of newborn sheep are downregulated by 
maternal nutrient restriction in late gestation. 
Ojha, S., Robinson, L., Yazdani, M., Symonds, M. E. and Budge, H. 
(2013). Pediatr Res 74, 246-251. 
Background: Brown adipose tissue (BAT) thermogenesis is essential 
for newborn survival. Pericardial adipose tissue is a visceral depot that 
promotes metabolic and cardiovascular adaptations. We determined 
whether BAT is present in pericardial adipose tissue in newborns and 
whether maternal nutrition during late gestation compromises BAT in 
the postnatal period. 
Methods: We measured uncoupling protein 1 (UCP1) and other BAT-
VSHFLILFJHQHVHJȕ-DGUHQHUJLFUHFHSWRUȕ$'5 and deiodinase 
type 2 (DIO2)), together with markers of white adipose tissue (WAT) in 
sheep on either the first or 30th day after birth. These were twin 
offspring born to mothers fed with either 100% or nutrient restricted 
(NR) to 60% of their total metabolizable requirements from 110 d 
gestation to term. 
Results: Gene expression of UCP1 and other BAT-related genes 
decreased significantly with age. In newborns, maternal nutrient 
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restriction downregulated gene expression of DIO2aQGWKHȕ-
adrenergic receptor with reduced UCP1 but had no effect on genes 
predominantly expressed in WAT. 
Conclusion: BAT is present around the heart in newborns. Exposure to 
a suboptimal maternal diet in late gestation specifically compromises 
BAT development and has the potential to place these offspring at 
increased risk of hypothermia afterbirth without effects on the 
subsequent appearance of WAT. 
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10.4.2 Adult Epicardial Fat Exhibits Beige Features 
Sacks, H.S., Fain, J.N., Bahouth, S.W., Ojha, S. Frontini, A., Budge, H., 
Cinti, S., and Symonds, M.E. (2013).  J Clin Endocrinol Metab. 98, 
E1448-E1455  
Context: Human epicardial fat has been designated previously as 
brown-like fat. The supraclavicular fat depot in man has been defined 
as beige coexistent with classical brown based on its gene expression 
profile. 
Objective: The aim of the study was to establish the gene expression 
profile and morphology of human epicardial and visceral paracardial fat 
compared with sc fat. 
Setting: The study was conducted at a tertiary care hospital cardiac 
center. 
Patients: Epicardial, visceral paracardial, and sc fat samples had been 
taken from middle-aged patients with severe coronary atherosclerosis 
or valvular heart disease. 
Interventions: Gene expression was determined by reverse 
transcription- quantitative PCR and relative abundance of the 
mitochondrial uncoupling protein-1 (UCP-1) by Western blotting. 
Epicardial tissue sections from patients were examined by light 
microscopy, UCP-1 immunohistochemistry, and cell morphometry. 
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Main Outcome measures: We hypothesized that epicardial fat has a 
mixed phenotype with a gene expression profile similar to that 
described for beige cell lineage. 
Results: Immunoreactive UCP-1 was clearly measurable in each 
epicardial sample analyzed but was undetectable in each of the 4 other 
visceral and sc depots. Epicardial fat exhibited high expression of 
genes for UCP-1, PRDM16, PGC-1Į, PPARȖ, and the beige adipocyte-
specific marker CD137, which were also expressed in visceral 
paracardial fat but only weakly in sternal, upper abdominal, and lower 
extremity sc fat. Histology of epicardial fat showed small unilocular 
adipocytes without UCP-1 immunostaining. 
Conclusion: UCP-1 is relatively abundant in epicardial fat, and this 
depot possesses molecular features characteristic of those found in 
vitro in beige lineage adipocytes. 
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10.4.3 Suboptimal maternal nutrition during early-to-mid 
gestation in the sheep enhances pericardial adiposity 
in the near-term fetus 
Ojha, S., Symonds, M.E. and Budge, H. (2014) Reproduction, Fertility 
and Development 
Manipulation of the maternal diet at defined stages of gestation 
influences long-term health by inducing changes in fetal adipose tissue 
development, characterised as possessing brown and white adipocytes. 
We determined whether suboptimal maternal nutrition in early-to-mid 
gestation, followed by ad libitum feeding until term, increases adiposity 
in the pericardial depot of the sheep fetus. Pericardial adipose tissue 
was sampled from near-term (140 days) fetuses delivered to mothers 
fed either 100% (C) or 60% (i.e. nutrient restricted (NR)) of their total 
metabolisable requirements from 28 to 80 days gestation and then fed 
ad libitum. Adipose tissue mass, uncoupling protein (UCP) 1 and gene 
expression of brown and white adipogenic genes was measured. Total 
visceral and pericardial adiposity was increased in offspring born to NR 
mothers. The abundance of UCP1 was increased, together with those 
genes involved in brown (e.g. BMP7 and &(%3ȕ) and white (e.g. 
BMP4 and &(%3Į) adipogenesis, whereas insulin receptor gene 
expression was downregulated. In conclusion, suboptimal maternal 
nutrition between early-to-mid gestation followed by ad libitum feeding 
enhances pericardial adiposity near to term. A combination of raised 
335 
 
UCP1 and adipose tissue mass could improve survival following cold 
exposure at birth. In the longer term, this enhanced adipogenic potential 
could predispose to greater pericardial adiposity. 
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10.5 Details of suppliers 
Abcam®, 330 Cambridge Science Park, Cambridge, CB4 0FL, UK; 
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Bibby Scientific Ltd, Beacon Road, Stone, Staffordshire, ST15 0SA, 
UK; www.techne.com  
Biotek UK, 6 Bull Street, Potton, Befordshire, SG19 2NR, UK; 
www.biotek.com  
Bio-Rad Laboratories Ltd, Bio-Rad House, Maxted Road, Hemel 
Hempstead, Hertfordshire, HP2 7DX, UK; www.bio-rad.com   
Bioron, Rheingoenheimer Str. 36, D-67065, Ludwigshafen, Germany; 
www.bioron.net  
Cell Biolabs Inc., 7758 Arjons Drive, San Diego, California (CA), 
92126, USA; www.cellbiolabs.com  
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Ecolabs®, 370 Wabasha St N, Saint Paul, Minnesota (MN), 55102, 
USA; www.ecolab.com 
Fisher Scientific UK Ltd, Bishop Meadow Road, Loughborough, 
Leicestershire, LE11 5RG, UK; www.fisher.co.uk  
GE Healthcare Ltd, Amersham Place, Little Chalfont, 
Buckinghamshire, HP7 9NA, UK; www.gehealthcare.com  
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Genetex Inc., 2456 Alton Parkway, Irvine, California (CA), 92606, USA; 
www.genetex.com  
GraphPad Software Inc., 2236 Avenida de la Playa, La Jolla, 
California (CA), 92037, USA; www.graphpad.com  
Grenier Bio-One Ltd, Brunel Way, Stroudwater Business Park, 
Stonehouse, GL10 3SX, UK; www.greinerbioone.com  
Hoefer® Inc., 84 October Hill Road, Holliston, Massachusetts (MA), 
01746, USA; www.hoeferinc.com  
IBM UK Ltd, PO Box 41, North Harbour, Portsmouth, Hampshire, PO6 
3AU, UK; www.spss.com 
Invitrogen Ltd, 3 Fountain Drive, Inchinnan Business Park, Paisley, 
PA4 9RF, UK; www.invitrogen.com  
Leica Microsystems (UK) Ltd, Davy Avenue Knowlhill, Milton Keynes, 
Buckinghamshire, MK5 8LB, UK; www.leica-microsystems.com  
Linton Instrumentation, 1 Forge Business Centre, Upper Rose Lane, 
Palgrave, Diss, Norfolk, IP22 1AP, UK; www.lintoninst.co.uk  
Manor Farm Feeds Ltd, Owston, Oakham, Rutland, LE15 8DH, UK; 
www.manorfarmfeeds.co.uk  
Mercodia, Sylveniusgatan, 8A, SE-754 50, Uppsala, Sweden; 
www.mercodia.se  
Menzel-Gläser Inc., Glasbearbeitungswerk GmbH & Co., 
Saarbrückener Str. 248, D-38116, Braunschweig, Germany; 
www.menzel.de  
Microsoft Corporation, One Microsoft Way, Redmond, Washington 
(WA), 98052, USA; www.microsoft.com 
Millipore, 290 Concord Road, Billerica, Massachusetts (MA), 01821, 
USA; www.millipore.com 
Minitab Ltd, Brandon Court, Unit E1-E2, Progess Way, Coventry, CV3 
2TE, UK; www.minitab.com  
Partek Incorporated, 624 Trade Center Boulevard, St. Louis, Missouri 
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PerkinElmer, Saxon Way Bar Hill, Cambridge, Cambridgeshire, CB23 
8SL, UK; www.perkinelmer.co.uk  
Premier Biosoft International, 3786 Corina Way, Palo Alto, California 
(CA), 94303, USA; www.premierbiosoft.com  
Primer Design Ltd, Millbrook Technology Campus, Second Avenue, 
Southampton, Hampshire, SO15 0DJ, UK; www.primerdesign.co.uk  
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Qiagen UK Ltd, Qiagen House, Fleming Way, Crawley, West Sussex, 
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Randox Laboratories Ltd, 55 Diamond Road, Crumlin, County Antrim, 
BT29 4QY, UK; www.randox.com  
Raytek Corporation, 1201 Shaffer Road, Santa Cruz, California (CA), 
95061, USA; www.raytek.com  
Roche Diagnostics Ltd, Applied Science, Charles Avenue, Burgess 
Hill, West Sussex, RH15 9RY, UK; www.rocheuk.com  
Scientific Laboratory Supplies (SLS) Ltd, Orchard House, The 
Square, Hessle, East Riding of Yorkshire, HU13 0AE, UK; 
www.scientificlabs.co.uk  
Severn Biotech Ltd, Unit 2, Park Lane, Kidderminster, Worcestershire, 
DY11 6TJ, UK; www.severnbiotech.com  
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Canada; www.simport.com  
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